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CHAPTER 1: INTRODUCTION 
Background and Significance  
Shifting Demographics 
 Over the past 100 years, advances in healthcare and reductions in family sizes have 
resulted in an aging population.  Worldwide, aging trends are expected to accelerate in coming 
decades.  The worldwide population of older adults is projected to double by 2050, while overall 
population growth will increase by only 34% during this period (He, Goodkind, & Kowal, 2016).  
Economically developed countries in Europe and the United States have already begun to 
gradually experience this demographic shift; countries in Latin America and Asia will face rapid 
demographic shifts in the next 30 years (He et al., 2016).   
In the United States, the large generation of people born between the 1940’s and mid 
1960’s known as the “Baby Boomers” are becoming older.  Individuals in the Baby Boomer 
generation are expected to live longer than their ancestors.  These two factors will result in the 
number of Americans aged 65 and older doubling over the next 20 years to about 72 million 
people (Alzheimer’s Association & Centers for Disease Control and Prevention [AA & CDC], 
2013).  In addition to the increase in the absolute number of older adults, Senior Citizens are also 
beginning to represent a larger proportion of the United States population.  Although they 
represented only 9% of the population in 1960, older adults will account for 20% of the United 
States population by 2030 (AA & CDC, 2013; Mather, Jacobsen, & Pollard, 2015).  As older 
adults have greater heath care needs, these demographic shifts present a challenge for the health 
care system.      
While these “golden years” of life hold the opportunity for increased leisure and the 
enjoyment of the fruits of a life well lived, advanced age corresponds with an increased risk of 
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developing Alzheimer Disease (AD; Katz et al., 2012).  AD is very common in older adults.  
One in ten people over the age of 65 has AD, and the risk increases with advancing age (AA, 
2017).  As a result of the aging population, the number of Americans with AD is expected to 
triple to 14 million people by 2050 (Mather et al., 2015).   
Alzheimer Disease 
AD is a chronic, progressive, and irreversible neurological disease.  AD has an insidious 
onset; it results in the gradual loss of cognitive and functional abilities.  At first, it may be 
difficult to distinguish typical age-related changessuch as occasional memory lapses, episodes 
of confusion, visual changes, or moodinessfrom signs of AD (AA, 2017).  In AD, problems 
with memory loss, problem solving, confusion, interpretation of spatial-visual information, 
communication, judgement, or mood disrupt daily life (AA, 2017).  These problems worsen over 
time, and result in an inability to care for oneself, immobility, and death.  
Despite the investment of billions of public and private research dollars over the past 
several decades, no cure for AD has been identified.  The clearest risk factors for AD are non-
modifiable genetic mutations, but even genetically-susceptible individuals have great 
heterogeneity in neuropathology and cognitive performance in older age (Wirth, Villeneuve, La 
Joie, Marks, & Jagust, 2014).  Drugs have been investigated which may someday be used for 
prevention of AD by individuals who have genetic risks for developing AD-related neural 
pathologies, but more testing is needed to determine the safety and efficacy of these therapies 
(Rafii & Aisen, 2015).   
Evidence for the prevention of AD is largely inconclusive, although some risk factors 
have been identified which may have an additive effect on the development of AD.  Modifiable 
risk factors for AD may include cardiovascular disease, cerebrovascular lesions, diabetes 
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mellitus, hypertension, obesity, high cholesterol, smoking, alcoholism, high saturated fat diet, 
and depression (Solomon et al., 2014).  Activities that have demonstrated a protective effect 
against AD include high levels of education, social engagement, mentally stimulating activities, 
a heart-healthy diet, physical exercise, adequate intake of vitamins A, B complex, C, D, and E, 
and medication such as anti-hypertensives, statins, hormone replacement therapy, and 
nonsteroidal anti-inflammatory drugs (Solomon et al., 2014).  These risk and protective factors 
suggest an interaction between the pathophysiological processes of AD and other common 
chronic conditions.     
In addition to its impact on individuals, AD also has an enormous impact on family 
members.  As the disease advances, sufferers have an increased need for care and supervision 
(Okura et al., 2011).  Over 15 million Americans are unpaid caregivers for individuals with AD, 
and their work is valued at over $230 billion annually (AA, 2017).  Informal caregivers are at a 
high risk for caregiver burnout, depression, anxiety, immune dysfunction, stroke, increased pain 
symptoms, and premature death (Fonareva & Oken, 2014; Hong, Han, Reistetter, & Simpson, 
2016; Ivey, Allen, Liu, Parmelee & Zarit, 2017; Perkins et al., 2013; Sallim, Sayampanathan, 
Cuttilan, & Ho, 2015).  These overburdened caregivers have more frequent doctor appointments, 
hospitalizations, and medication use resulting in an estimated $10.9 billion in excess healthcare 
cost (Zhu et al., 2015). 
Because of the long-term course of AD, these individuals may need care for many years.  
As AD symptoms worsen over time, the needs for care become more intense.  Family caregivers 
may be supplemented by professional services such as adult day services or hired in-home 
caregivers.  When the care needs or expenses become too great, individuals are moved into 
residential institutions such as assisted living facilities or nursing homes.   
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The cost of residential long-term care services is high.  Assisted living costs over $43,000 
per year, and care provided in nursing homes costs $82,000-$92,000 per year (Genworth, 2016).  
As half of all older adults receiving Medicare benefits have less than $64,000 in savings, these 
costs are unaffordable for most individuals (MetLife, 2012).  When financial assets are depleted, 
Medicaid pays for long-term care (Centers for Medicare & Medicaid [CMS], 2017).  The 
majority of long-term care residents, about 62%, are using the Medicaid program (Rudowitz & 
Garfield, 2018).  The Medicare program is strained by these costs.  Expenditures have increased 
6.0% annually in 2006 to 2017 mostly due to the increasing enrollment of older adults with 
complex healthcare needs (Holahan & McMorrow, 2019).  Given the enormous costs of long-
term care, there is a clear financial incentive to help individuals remain in their homes for as long 
as possible.   
The total costs of AD and dementia care paid in 2017 was estimated at $259 billion (AA, 
2017).  AD is one of the most expensive medical conditions to the general public (Hurd, 
Martorell, Delavande, Mullen, & Langa, 2013).  Sources of payments for AD related care 
include Medicare (51%), Medicaid (17%), out of pocket (22%; including personal savings, 
pensions, and Social Security), and other sources such as private insurance and unpaid care 
(11%; AA, 2017).  Public sources of funding for care In addition to the high personal costs 
incurred as a result of AD, this disease represents a high cost burden on society as a whole.   
Agitation 
 Beyond the physical and cognitive effects of AD, behavioral symptoms are also common.   
Behavioral or neuropsychiatric symptoms including agitation, anxiety, apathy, delusions, 
depression, disinhibition, elation, hallucinations, irritability, sleep disorders, or social withdrawal 
are common with AD (Cummings et al., 1994; McKhann et al., 2011).  As with other 
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manifestations of AD, behavioral symptoms worsen with disease progression.  In the early stages 
of AD, the prevalence of at least one behavioral symptom ranges from 12.8-66.0% (Köhler et al., 
2016).  Incidence of these symptoms increases over the course of the disease. Cumulative 
prevalence rates for at least one neuropsychiatric symptom range between 49 and 95% in 
individuals with advanced AD (Borsje, Wetzels, Lucassen, Pot, & Koopmans, 2015).     
Of the many neuropsychiatric symptoms in AD, agitated behavioral symptoms are 
especially important.  Agitation is a broad construct encompassing inappropriate verbalizations 
or physical movements that are unrelated to needs or represent an excessive response to needs 
(Cummings et al., 2015; Cohen-Mansfield & Billig, 1986).  Agitation can include both 
aggressive and nonaggressive behaviors (Cohen-Mansfield & Billig, 1986).  Examples of 
agitated behaviors include pacing or wandering, inappropriate dress or disrobing, screaming, 
repeated questions, and hitting (Cohen-Mansfield, 1991).  Although sometimes discussed as 
distinct phenomena, aggression, fighting, irritability, resistance to care, restlessness, wandering 
are closely related concepts which can be considered expressions of agitation when they occur in 
person with dementia and cause excess disability (Cummings et al., 2015; Fauth & Gibbons, 
2014; Hurley et al., 1999; Kong, 2005).     
Agitation occurs in over 71% of individuals with AD.  Individuals with AD often 
experience distress over these symptoms, and quality of life is diminished with increasing levels 
of agitation (Hongisto et al., 2015).  Agitated behavioral symptoms increase the need for care 
and supervision of individuals with AD (Okura et al., 2011).  Caregivers report that agitation is 
the most difficult symptom of AD to manage (Chiao, Wu, & Hsiao, 2015).  Caregiver distress 
and burnout related to agitated behavioral symptoms results in early institutionalization of 
persons with AD, and may increase the risk of elder abuse (Cooper et al., 2010; Gaugler, 
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Krichbaum, & Wyman, 2009; Pérez-Rojo, Izal, Montorio, & Penhale, 2009; VandeWeerd et al., 
2013).      
Despite these dismal consequences of agitation, treating agitation is challenging.  A 
variety of promising social and environmental interventions have demonstrated no significant 
improvement in agitated behavior. Staffing ratios, aromatherapy, and light therapy do not appear 
to improve agitated behavioral symptoms (Livingston et al., 2014; Livingston et al., 2017; 
Zuidema et al., 2009).   
A few interventions have been identified which may reduce agitation in some situations.  
Environmental and behavioral interventions which have demonstrated moderate improvements 
to agitated behavioral symptoms include music therapy, staff communication training and 
sensory interventions (Deudon et al., 2009; Livingston et al., 2014). Physical exercise has many 
benefits for persons with dementia including reduced agitation, improved cognitive performance, 
and improved mood (Brett, Traynor, & Stapley, 2016).  However, many older adults including 
persons with AD have impaired mobility and are unable to access these benefits, and 
interventions to train staff to encourage exercise and social interactions are not effective in 
reducing agitation (Ballard et al., 2015).   
Pharmacological interventions are sometimes used to reduce agitated behavioral 
symptoms in persons with AD.  Although antipsychotic medications are sometimes effective in 
temporarily reducing certain agitated behaviors, their use is not routinely recommended as these 
drugs carry a high risk of side effects for older adults.  Adverse side effects may include blood 
clots, cerebrovascular events, drowsiness, tremors or movement difficulties, functional and 
cognitive decline, and death (Foebel et al., 2016; Schneider, Dagerman, & Insel).  
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While some interventions have demonstrated modest improvements in agitated 
behavioral symptoms, effects of these interventions in the clinical setting are highly variable.  To 
improve the effectiveness of current interventions and identify further interventions to improve 
agitated behavioral symptoms in persons with AD, a complete understanding of the causes of 
agitation is needed.  A causal model of agitation will help organize and understand antecedent 
factors to allow more specific and effective interventions to be identified and developed.  
Statement of Problem  
 AD is debilitating, costly, and widespread.  Difficulties related to AD are projected to 
worsen in the future due to shifting demographics and lack of treatments.  Given that the current 
state of the science of AD care offers no cure for the disease, mitigation of symptoms provides 
the best opportunity for intervention to improve quality of life and functional status for 
individuals with AD.  Because agitated behavioral symptoms are the most detrimental and costly 
symptoms associated with AD (through high prevalence, reduced quality of life for individuals, 
increased caregiver burnout, increased risk of elder abuse, and increased risk of costly 
institutionalization), the management of symptoms of agitation is the most urgent research 
priority.  At the present time, the nonpharmacological and pharmacological interventions to 
address agitated behavioral symptoms have been shown to be ineffective or risky.  Furthermore, 
since most previous research investigates the direct effects of individual factors on agitation, it is 
unclear how the constellation of symptoms and environmental factors experienced by those with 
AD may contribute to the worsening or improvement of agitation.  A holistic framework for 
understanding the causes and consequences of agitation is needed.  Therefore, this dissertation 
proposes to identify factors that worsen or improve agitation, and how the resulting level of 
agitation impacts functional status.   
8 
 
Relevance to Nursing Knowledge 
The phenomenon of agitated behavioral symptoms in persons with AD lends itself to 
study by nursing as it fits squarely within the Fawcett’s definition of concepts of interest to 
nursing’s metaparadigm including health, human beings, the environment and nursing (Fawcett 
& DeSanto-Madeya, 2013).  Health is the most important metaparadigm concept within the 
phenomenon of functional performance in older adults with cognitive decline.  It is the departure 
from normal cognitive health that defines conditions like AD, and the performance of functional 
roles that demonstrates a state of overall health.  While studying this phenomenon, the nursing 
perspective emphasizes the view that persons with AD are human beings first and sufferers of a 
condition second.  The environment is important to the study of agitated behavioral symptoms as 
it can either trigger symptoms or help reduce symptoms.  Finally, the concept of nursing is 
important to the study this phenomenon because nurses and other caregivers are in a position to 
prevent and manage agitated behavioral symptoms in persons with AD.    
 Epistemology refers to the nature of knowledge and how knowledge can be known 
(Rodgers, 2005).  In nursing, epistemology denotes knowledge that is accepted by members of 
the nursing discipline, the types and patterns of knowledge within nursing, and the evaluation 
criteria used by the discipline to accept or reject new knowledge claims (Schultz, 1988).  The 
nature of knowledge that can be described about the phenomenon of agitated behavioral 
symptoms in persons with AD will be different depending on the disciplinary perspective from 
which the phenomenon is studied.  Since this phenomenon is so closely related to the concepts of 
interest to the nursing discipline, there is an opportunity for nursing knowledge to be gained from 
the study of this topic. 
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One type of nursing knowledge is empirical knowledge.  Empirical knowledge is gained 
by making systematic observations through research (Schultz, 1988).  The credibility of 
empirical knowledge in research is dependent on adherence to widely-accepted research methods 
and the minimization of bias (Schultz, 1988).  New claims of empirical knowledge related to the 
study of agitated behavioral symptoms in persons with AD which arise from the proposed 
research will be evaluated for credibility and utility to nursing on the basis of rigor of research 
methods, minimization of bias, and assessment of how these new claims fit into the extant body 
of literature surrounding the topic.  Each additional claim of empirical knowledge can contribute 
to conceptual nursing knowledge through reflection and synthesis of multiple claims to identify 
patterns.   
Conceptual nursing knowledge is a type of knowledge that extends beyond that which is 
known through personal experience; conceptual knowledge describes the patterns shared through 
multiple patient experiences or situations and explores these patterns through theories or models 
(Schultz, 1988). Conceptual knowledge is evaluated based on the degree to which theories or 
models are useful in describing patterns of experience with coherence and logical arguments 
(Schultz, 1988).  Research to better understand the phenomenon of agitated behavior in persons 
with AD will contribute to conceptual knowledge in nursing by clarifying the relationship 
between the empirical observations of agitated behavioral symptoms in persons with AD to 
antecedents and consequences of these symptoms.  These patterns in behavior will be framed 
within a model based on the nursing Theory of Unpleasant Symptoms (TOUS).  The degree to 
which the model accurately and completely describes the observed phenomenon will validate the 
legitimacy of the TOUS.  If the model accurately reflects the phenomenon, it will be a useful tool 
which can be applied to different nursing practice situations to improve the care of patients.       
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Statement of Purpose  
 The purpose of this dissertation is to test a model of the predictors and outcomes of 
agitated behavioral symptoms among persons with AD.  The model will be structured by the 
theoretical concepts and relationships predicted in the Theory of Unpleasant Symptoms (Lenz, 
Supp, Gift, Pugh, & Milligan, 1995; Lenz, Pugh, Milligan, Gift, & Suppe, 1997).  This nursing 
theory focuses on the antecedents and consequences of symptoms within a comprehensive 
framework.  Antecedent factors are divided into three categories: situational, psychological, and 
physical factors.  Examples of situational factors include environmental influences like physical 
surroundings and interpersonal factors such as social engagement and the influence of 
caregivers.  Psychological factors include anxiety and depression.  Physical factors include sleep, 
pain, hearing loss, and disease states such as AD with its resulting decline in cognitive capacity.  
Symptom consequences are conceptualized as performance-based outcomes such as functional 
ability, performance of activities of daily living, and quality of life.  The TOUS provides a clear 
framework for understanding symptoms and proposes theoretical relationships between 
variables.  However the TOUS has not been used to describe agitated behavioral symptoms and 
has never been applied to a population of persons with AD.  
Specific Aims and Hypotheses  
Aim 1:  
Describe the phenomenon of agitated behavioral symptoms in persons with AD within the 
Theory of Unpleasant Symptoms. 
Hypothesis:  The Theory of Unpleasant Symptoms (TOUS) will adequately describe the 
antecedents and consequences of agitated behavioral symptoms in persons with AD.    
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Aim 2:  
Determine the effect of situational (physical and social environment), psychological (anxiety, 
and depression), and physiological factors (comorbidities, pain, nutritional status, hearing, 
cognitive impairment, and fatigue) on agitated behavioral symptoms in persons with AD. 
Hypotheses:   
(1) Supportive and stimulating physical and social environments will have a negative direct 
effect on agitation. 
(2) Comorbid psychological states will have a positive direct effect on agitation. 
(3) Comorbid physical conditions, pain, inadequate nutritional status, hearing loss, cognitive 
impairment, and fatigue will have a direct positive effect on agitation. 
Aim 3:  
Determine the effect of situational, psychological, and physical antecedent factors and agitation 
on performance outcomes (functional status and quality of life) in persons with AD. 
Hypotheses:   
(1) Supportive and stimulating physical and social environments will have an indirect 
positive effect on functional status and quality of life through reduced agitation. 
(2) Comorbid psychological states will have an indirect negative effect on functional status 
and quality of life through increased agitation. 
(3) Comorbid physical conditions, pain, nutritional status, hearing loss, cognitive 
impairment, and fatigue will have an indirect negative effect on functional status through 
increased agitation. 




 As the population ages, problems related to AD will become increasingly burdensome in 
the coming years.  Agitated behavioral symptoms in persons with AD are of chief concern 
because they are challenging to manage, have detrimental effects on individuals, and lead to 
costly consequences.  A complete understanding of the antecedent factors is needed to identify 
future interventions to improve functional outcomes and quality of life for persons with AD.  
While previous work has been done to study simple relationships between isolated antecedents 
or consequences of agitation, this proposed research will build upon previous work by 
identifying the relative and combined impact of each antecedent variable on agitation, and 
determine how some of these factors may work together to exert a synergistic negative effect on 
functional performance.  This knowledge will be used to identify opportunities for high impact 
interventions for future investigations.     
The empirical and conceptual nursing knowledge gained through the study of this 
phenomenon will contribute to nursing science.  Donaldson (2003) explains that nursing science 
is the science of human health within defined thematic and person-based health domains.  In 
contrast, Schoenhofer (1993) proposes that the most straightforward definition of nursing 
research is a research question which is framed within a nursing theory.  By either definition, the 
study of agitated behavioral symptoms of older adults with AD framed within the nursing TOUS 
will generate a type of unique nursing knowledge which supports the discipline of nursing and 
informs nursing practice.   
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CHAPTER 2: LITERATURE REVIEW AND THEORETICAL FRAMEWORK 
 The following review will discuss the state of the science related to AD and agitated 
behaviors among persons with AD including risk factors and associated outcomes.  A discussion 
of gaps in the literature and conceptual challenges will follow.  Finally, the application of the 
Theory of Unpleasant Symptoms framework to guide research related to agitated behavioral 
symptoms in persons with AD will be explained.   
Alzheimer Disease Overview 
 Healthy individuals may experience changes in thinking as they age.  Although 
crystallized intelligence (knowledge) and personality remain stable throughout the lifespan, fluid 
intelligence, working memory, and response time generally decline in healthy adults as they age 
(Blazer, Yaffe, & Karlawish, 2015; Bender & Raz, 2012; Harris, Brett, Johnson & Deary, 2016; 
Yuan, Voelkle, & Raz, 2018).  Occasionally, marked changes in thinking become pathological in 
older adults.  Symptoms of neuropathological changes, including a general loss of cognitive 
ability and memory impairment, are known as dementia. Although dementia symptoms may 
arise because of several different etiologies, the most common cause of dementia symptoms is 
AD.  The 2011 National Institute on Aging-Alzheimer Association criteria define possible or 
probable AD as a persistent decline in cognitive function over time that interferes with usual 
activities, and includes impairments in learning, judgment, visuospatial abilities, language, or 
changes in personality (McKhann et al., 2011).  A summary of neuropathological features of AD 
and possible etiologies of AD are reviewed in the following.        
Neuropathology of Alzheimer Disease 
For over 100 years, AD has been recognized as a neurological disease primarily affecting 
older adults.  Although many scientific advances have been made in the past century, many 
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details about the neuropathological processes that result in AD have remained elusive.  Much of 
what is known about the neurological disease states which result in the clinical expression of AD 
symptoms was learned from the postmortem analysis of the brain tissue of affected individuals.  
The microscopic and macroscopic pathologies identified in these early studies have allowed 
scientists to validate the correlations between postmortem pathologies and AD with living 
individuals with AD using MRI.   
On the microscopic level, brain tissue of individuals with AD shows amyloid plaques and 
neurofibrillary tangles which define AD.  Amyloid plaques are accumulations of pieces of the 
amyloid precursor protein called amyloid-β (Aβ; Okura et al., 2011).  Aβ proteins are found in 
the cortices and cerebral blood vessels of individuals with AD (Serrano-Pozo et al., 2011).  In 
early stages of AD, Aβ plaques tend to accumulate in the neocortex (Thal, Rüb, Orantes & 
Braak, 2002).  As AD progresses, Aβ plaques spread to cover the deeper allocortical and 
subcortical regions (Jucker, Mathias, & Walker, 2011). While Aβ is present even in the brains of 
healthy individuals, a type of Aβ that is prone to causing plaque buildup is present in excessive 
quantities in persons with AD (Puzzo et al., 2011; Shen & Kelleher, 2007).    
Neurofibrillary tangles (NFT) composed of abnormally phosphorylated and misfolded tau 
proteins are considered a hallmark of AD (Perl, 2010).  The quantity and distribution of NFT 
increases as AD progresses, and corresponds with increased dementia symptoms (Bierer et al., 
1995).  Neurons and synapses are lost in parallel to the formation of NFT, but it is unclear how 
the two phenomena are related (Serrano-Pozo, Frosch, Masliah, & Hyman, 2011).   
Neuropathological changes with NFT in AD follow a very predictable pattern over time.  
Eva and Heiko Braak (1991) categorized these changes into six stages commonly referred to as 
Braak stages.  The beginning stages are defined by diffuse NFT in the transentorhinal cortex 
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within the temporal lobe (Braak & Braak, 1991).  In the middle stages, NFT expand to involve 
the limbic system, including the amygdala, hippocampus, thalamus, hypothalamus, basal ganglia, 
and cingulate gyrus (Braak & Braak, 1991).  The final stages are characterized by widespread 
neurodegenerative changes related to continued accumulation of NFT, and NFT continue to 
spread throughout the neocortex (Braak & Braak, 1991).  In its 1997 histopathological 
diagnositic criteria for AD, the National Institute on Aging (NIA) use the Braak stages as the 
basis for definitive diagnosis of AD, with greater diagnostic certainty at higher Braak stages 
(Coleman & Dickson, 1997).   
  The systematic neurodegeneration of specific brain regions correspond to predictable 
symptoms in individuals suffering from AD.  Before any clinical symptoms of AD are apparent, 
the disease process has already begun as neurofibrillary tangles begin to appear in the 
transentorhinal cortex (Braak & Braak, 1991).  As pathologies accumulate and spread to the 
entorhinal cortex, episodic memory becomes slightly impaired because the entorhinal cortex is 
no longer able to effectively facilitate communication between the hippocampus and the 
neocortex (Tward et al., 2017; Maass, Berron, Libby, Ranganath, & Düzel 2015).  
Neurofibrillary tangles become more severe and then spread to the limbic system (including the 
prefrontal and occipitotemporal corticies); dementia syndrome results with impairments of 
executive function and spatial visualization respectively (Serrano-Pozo et al., 2011; Tam & 
Pasternak, 2017).  In the final stages of AD, neuronal death continues in brain regions previously 
affected, while pathologies continue to fan out in the frontal, superolateral, and occipaital 
directions, eventually consuming most of the neocortex and resulting in moderated or severe 
cognitive decline and motor and sensory impairment (Braak, Alafuzoff, Arzeberger, 
Kretzschmar & Tredici, 2006; Serrano-Pozo et al., 2011). 
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In addition to understanding the individual regions of the brain affected by AD, 
understanding how multiple regions function together in networks is critical to gaining insight 
into the neurological mechanisms behind neuropsychiatric clinical symptoms (Van Dam, 
Vermeiren, Dekker, Naudé, & De Deyn, 2016).  Catani, Dell’Acqua and De Schotten (2013) 
propose that the limbic system can be divided into three functionally related networks.  Memory 
and spatial orientation are functions of the hippocampal-diencephalic and parahippocampal-
retrosplenial network (Catani et al., 2013).  The default mode network facilitates attention, 
introspection and knowledge of self (Catani et al., 2013).  Emotion, language, and behavioral 
inhibition are functions of the temporo-amygdala-orbitofrontal network (Catani et al., 2013).   
This network model of neurological functioning explains why multiple brain regions are 
associated with the neuropsychiatric symptoms of AD.  Of the three networks, the temporo-
amygdala-orbitofrontal network is most affected in later stages of AD.  The temporo-amygdala-
orbitofrontal network is also most closely associated with agitated behavioral symptoms (Van 
Dam et al., 2016).  Physically agitated symptoms and aggression are associated with NFT in the 
orbitofrontal cortex, medial temporal cortex, hippocampus, frontolimbic regions, amygdala, and 
posterior cingulate (Lai, Chen, Hope, & Esiri, 2010; Poulin, Dautoff, Morris, Barrett, & 
Dickerson, 2011; Tekin et al., 2001; Trzepacz et al., 2013).  While the Braak progression of AD 
pathology would suggest that neuropsychiatric symptoms such as agitation are a late-stage 
manifestation of AD, their appearance in early AD is associated with a rapid decline in cognition 
and may serve as a marker of rapid NFT proliferation (Gallagher, Fischer, & Iaboni, 2017).  An 
understanding of the neuropathological networks underlying agitation in AD may help identify 
symptom clusters for targeted interventions.   
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Proposed Etiologies of AD  
There is still much debate about the causes of AD.  One possible explanation is known as 
the Amyloid Cascade Hypothesis.  In this theory, neuropathological changes in AD begin with 
abnormal deposits of Aβ (either through excessive production or inefficient removal), and the 
presence of the Aβ damage neurons, result in NFT, and cause AD (Van Dam et al., 2016).  This 
theory is supported by observations that the presenilin 1 and 2 genes code for a protein involved 
in processing the amyloid precursor protein, and individuals with this gene are predisposed to 
inherited AD (Hardy & Selkoe, 2002).  The amyloid hypothesis is further supported by 
observations that NFT can occur independently of Aβ (as seen in individuals with frontotemporal 
lobar degeneration with parkinsonism), but Aβ deposits are always accompanied by NFT (Van 
Dam et al., 2016; Hutton et al., 1998).  Therefore, NFT cannot cause the amyloid cascade in AD, 
but there is a possibility that Aβ may cause NFT.   
Neuroinflammation is another proposed etiology of AD.  The immune cells of the brain 
(astrocytes and microglia) are responsible for synaptic remodeling, pH balance, blood flow, 
metabolism, and phagocytosis of damaged tissue (Heneka et al., 2015; Hong et al., 2014; Reed-
Geaghan, Savage, Hise, & Landreth, 2009).  Chronic neuroinflammation may be triggered by 
Aβ, genetic mutations, peripheral inflammation, obesity, or mechanical trauma of the brain (Van 
Dam et al., 2016).  The chronic neuroinflammation activates a cascade of inflammatory 
molecules causing oxidative stress, scarring, and neuronal damage over time (Heneka et al., 
2015).  As chronic neuroinflammation has been implicated as a causative mechanism in other 
psychiatric disorders (Najjar, Pearlman, Alper, Najjar, & Devinsky, 2013) and it is also observed 
in AD, it is possible that neuroinflammation has a role in the development of AD pathologies.   
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A wide range of other theories about the pathogenesis have also been proposed.  Kozlov, 
Afonin, Evsyukov, and Bondarenko (2017) and Area-Gomez and Schon (2017) hypothesize that 
AD progression is the result of mitochondrial dysfunction and resulting metabolic failures.  In 
recognizing the similarities between the systematic spreading of pathologies in AD and in 
Creutzfeldt-Jakob disease, others view AD as a type of prion disease (Bastian, 2017).  The 
inflammatory phenomena in AD have lead others to propose that AD may be caused by 
underlying systemic infections such as Bordetella pertussis, Herpes Simplex Virus, or even 
chronic gingivitis (Harris & Harris, 2015; Rubin & Glazer, 2017; Singhrao, Harding, Poole, 
Kesavalu, & Crean, 2015).  Still others implicate metals like lead or aluminum from 
environmental exposure or endogenous iron dysregulation are key to the pathogenesis of AD 
(Lee & Freeman, 2014; Lidsky 2014; Peters, Connor, & Meadowcroft, 2015).  The lack of 
consensus and wide variety of theoretical etiologies illustrate the complex nature of AD, and 
suggest that much further research is needed to unify the variety of possible etiologies of AD.   
State of the Science: Agitation in Alzheimer Disease 
While impairments in thinking and memory are early symptoms of AD, changes in 
behavior related to AD are common symptoms as well.  Behavioral changes may include apathy, 
social withdrawal, or agitation (McKhann et al., 2011).  Because it is particularly challenging to 
manage, an increased understanding of agitated behavioral symptoms are a research priority.   
Agitation is defined by Cohen‐Mansfield and Billig (1986) as a wide range of 
inappropriate verbalizations or motor activities that are not explained by obvious needs.  
Agitation is expressed with aggressive and non-aggressive verbalizations and physical behaviors 
(Cohen-Mansfield & Billig, 1986).  Agitation is a very common symptom in AD; it occurs in 
over 71% of individuals with AD (Hendriks, Smalbrugge, Galindo-Garre, Hertogh, & van der 
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Steen, 2015; Van der Mussele et al., 2015).  Up to 85% of individuals with dementia in long term 
care facilities demonstrate at least one agitated behavioral symptom, the most common of which 
is general restlessness (Zuidema, Derksen, Verhey, & Koopsman, 2007).  The physical 
aggression component of agitation becomes more common as dementia impairment increases 
(Zuidema, de Jonghe, Verhey, & Koopmans, 2009).   
Risk Factors for Agitation 
Although symptoms of agitation are common in AD, they are not continually experienced 
by all persons with AD.  Symptoms may arise from an unidentified unmet need or without any 
known cause.  By understanding the ways in which situational, psychological, cognitive, and 
physiological factors coincide with agitated behavior, patterns of agitation become clear and 
interventions become possible. 
 Situational factors.  Environmental surroundings may contribute to agitated behavior in 
persons with AD.  Excessive noise is considered to be an environmental stressor which may lead 
to agitation (Ragneskog, Gerdner, Josefsson, & Kihlgren, 1998).  While features of the built 
environmental surroundings such as light, sound, and number of residents in a nursing home 
have not consistently demonstrated a relationship to agitation, other features of the environment 
such as social factors may have an effect (Cohen-Mansfield et al., 2012; Zuidema et al., 2009).  
Other disruptive situational stressors include activities of daily living or social 
engagements (Corcoran & Gitlin, 1992).  Individuals with cognitive decline may be less capable 
of handling external stressors, and changes to routine, excess stimulation, or changes to physical 
surroundings can cause agitation (Smith, Hall, Gerdner, & Buckwalter, 2006).  Either excessive 
stimulation (Livingston et al., 2014) or a lack of stimulation and boredom (Kolanowski et al., 
2017) can lead to agitation.   
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Interpersonal factors such as social engagement and communication impact agitation.  
The presence of familiar family members may be comforting to persons with dementia and 
reduce agitated behavioral symptoms (Digby, Lee, & Williams, 2017).  Cohen-Mansfield and 
colleagues (2012) found that engagement with any other person was associated with reduced 
agitation.   Non-therapeutic interpersonal relations between caregivers and patients can result in 
increased agitation (Ragneskog et al., 1998).  Furthermore, when patients become agitated it can 
cause psychological symptoms in caregivers, resulting in negative communication styles which 
exacerbate agitation in patients (de Vugt et al., 2004).   
Social engagement may also have an indirect effect on agitation.  Socialization is 
important for the wellbeing of older adults, and also for their cognitive health.  Social 
environment might play a role in agitated behavior through its effect on cognitive function 
because social engagement is protective against cognitive decline (Freeman, Spirgiene, Martin-
Khan, & Hirdes, 2017).  Similarly, associations between increased social isolation and 
diminished cognition were demonstrated in a longitudinal study by Bennett, Schneider, Tang, 
Arnold, and Wilson (2006).   
Psychological factors.  Psychological disturbances may co-occur with agitated 
behavioral symptoms in persons with AD.  Anxiety is experienced by 18-24% of persons with 
AD (Borsje et al., 2015).  Anxiety has been found to be more common in persons with AD who 
also have agitated behavioral symptoms, with about one third of those who have frequent 
agitation also reporting anxiety (Van der Mussele et al., 2015).     
Depression is common among individuals with AD; it has been reported in 10 to 42 
percent of with persons with AD (Borsje et al., 2015).  However, depression is more commonly 
diagnosed in individuals with vascular dementia than AD (Byers, Yaffe, Covinsky, Friedman, & 
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Bruce, 2010).  While the clinical diagnosis of depression is difficult in persons with dementia or 
AD, these individuals demonstrate significant correlations between higher levels of depressive 
symptoms and higher levels of agitation (Chen, Lin, Chen, & Liu, 2014; Volicer, Frijters, & Van 
der Steen, 2012).   
Cognitive function.  In persons with AD, cognitive function is inversely related to 
agitated behavioral symptoms.  Steinberg et at. (2006) found agitation was related to advanced 
dementia severity, and agitation was more common with dementia due to AD.  Lovheim, 
Sandman, Karlsson, and Gustafson (2008) found that the prevalence of agitation was the greatest 
in those with moderate dementia, conflicting with the findings of Steinberg et al. (2006).  In a 
study of adults with only mild cognitive impairment or early AD, Apostolova (2014) found 
agitation was most common with the amnesic types of cognitive deficits.   
  Other cross sectional studies report evidence supporting the inverse correlation between 
cognitive function and agitated behavioral symptoms.  In nursing home residents, frequency of 
agitated behavioral symptoms increased with severity of cognitive impairment related to AD 
(Ryu, Katona, Rive, & Livingston, 2005; Veldwijk-Rouwenhorst et al., 2017).  Agitation is 
present, but with low prevalence of 15% in persons with mild cognitive impairment, around 33% 
with mild dementia, and 45-71% of those with moderate to severe dementia symptoms 
(Livingston et al., 2017).  In a model of antecedents of agitation, Chen and colleagues (2014) 
found that impaired cognitive function had a direct effect on agitation, as well as an indirect 
effect on agitation through decreased functional ability and resulting depression. 
These findings are echoed with longitudinal studies.  Worsening of both cognitive 
performance and agitated behavioral symptoms over time is seen in populations of nursing home 
residents (Wetzels, Zuidema, Jansen, Verhey, & Koopmans, 2010), and among community-
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dwelling individuals with dementia (Borsje et al., 2015).  Other neuropsychological symptoms 
are common with dementia and worsen over time with agitation, including delusions, aberrant 
motor behavior and apathy (Borsje et al., 2015).  It is possible that there is an interaction between 
neuropathology, agitation, and other neuropsychological symptoms in AD.      
The correlation between agitated behavioral symptoms and cognitive decline has been 
well reported.  However the mechanisms through which cognitive impairment and agitation are 
related remain unknown.  It is unclear the extent to which worsening agitated behaviors are a 
result of increasing neurodegeneration, or if agitation is the result of other changes that are 
consequences of diminished cognitive performance.  It is clear that as agitated behavioral 
symptoms become more frequent and severe; the consequences for individuals with AD become 
more pronounced as well.     
Physical factors.  Agitation is an expected response to physical discomfort or 
dysfunction.  Agitated behavioral symptoms are seen with a range of physical complaints.  
Steinberg et at. (2006) found agitation was correlated with medical comorbidity severity.  Even 
relatively minor physical discomforts such as deviations in indoor air temperature are associated 
with increased frequency of agitated behavioral symptoms (Tartarini, Cooper, Fleming, & 
Batterham).  Non-modifiable physical traits such as male gender, younger age of diagnosis, and 
apolipoprotein E ε4 (APOE-ε4) genotype are associated with higher risk of agitation 
(Kolanowski et al., 2017; Schutte, Reed, DeCrane & Ersig, 2011).  Other physical risk factors for 
agitation include functional ability, sleep, pain, nutrition, and hearing ability which are examined 
below.   
Sleep. Sleep disturbances are more common in persons with AD than in non-demented 
older adults (Tractenberg, Singer, & Kaye, 2005).  Van der Mussele and colleagues (2015) found 
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that persons with AD exhibited more frequent and severe neuropsychiatric and behavioral 
symptoms including disinhibition, impaired emotional control, restlessness, delusions, 
hallucinations, psychosis, activity disturbances, aggressiveness, diurnal rhythm disturbances, and 
anxiety with the presence of agitation in than in those without significant agitation.  However, in 
individuals with only mild cognitive impairment, only diurnal rhythm disturbances were related 
to severity of agitation (Van der Mussele et al., 2015).  This finding suggests the possibility that 
sleep disturbances are a risk factor for agitation early in the AD trajectory.    
Pain.  Individuals with AD may have challenges in expressing themselves, and may not 
communicate their experience of pain effectively.  Their expression of pain may be demonstrated 
as agitated behaviors.  Volicer and collegues (2012) found that agitated behavioral symptoms 
and pain scores in persons with AD are correlated.  Pain was found to explain much of the 
variance in agitated behavioral symptoms in persons with dementia when factors such as 
dementia severity and functional disability were controlled (Pelletier & Landreville, 2007).  Pain 
may increase agitation directly and indirectly through reduced functional ability and increased 
depression (Chen et al., 2014).  Furthermore, pharmacological treatments for pain result in 
significant reductions in agitated behaviors (Husebo, Ballard, Cohen-Mansfield, Seifert, & 
Aarsland, 2014).  The relationship between pain and agitated behavioral symptoms illustrate the 
need to adequately assess and treat pain in people with AD.   
Appetite and Nutrition.  Dietary factors play an interesting role in the expression of 
agitated behavioral symptoms in people with AD.  Loss of appetite and poor nutritional status are 
prevalent issues for persons with AD (Kimura, Sugimoto, Niida, Toba, & Sakurai, 2018; dos 
Santos, Fonseca, Tedrus, & Delbue, 2018).  Individuals may have reduced food consumption 
while experiencing agitation or agitation may be triggered by mealtime routines (Milte, Bradley, 
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Miller, Farrer & Crotty, 2018).  Poor nutritional status is associated with worse cognitive status, 
functional ability, and agitation in persons with AD (Yildiz, Pekel, Kilic, Tolgay, & Tufan, 
2015). Importantly, dietary intake is a modifiable factor that may present an opportunity for 
targeted interventions toward improving agitated behavioral symptoms.    
Hearing loss. Hearing loss is common for all older adults.  Estimates of age-related 
hearing loss range between 2 (Sanders & Gillig, 2010) and 45 percent (Albers et al., 2015) of 
people over the age of 65 years, and is thought to double in prevalence with every additional 10 
years of age.  Hearing loss is also known to be a correlate of agitated behavior in institutionalized 
older adults (Cohen-Mansfield, Billig, Lipson, Rosenthal, & Pawlson, 1990; Vance et al., 2003).   
Longitudinal studies have found that hearing loss that is caused by central auditory 
dysfunction often precedes AD diagnosis (Gates, Anderson, McCurry, Feeney, & Larson, 2011).  
This suggests the possibility of a shared neurodegenerative process between cognitive decline in 
AD and impairments in hearing and the interpretation of sounds.  Another large longitudinal 
study found that hearing loss was in independent predictor for the development of dementia 
when controlling for age, gender, education, APOE-ε4 allele, and cardiovascular risk factors 
(Gurgel et al., 2014).  Furthermore, adults with hearing loss and dementia experienced a faster 
rate of cognitive decline than those with dementia and normal hearing (Gurgel et al., 2014).   
 These findings comport with analysis from a case-control analysis of population level 
data in Taiwan.  Hung et al. (2015) reported that the odds ratio of developing AD was 1.39 for 
individuals with hearing loss compared to those with normal hearing.  However, these analyses 
did not distinguish central from peripheral hearing loss.  The consensus that AD, central auditory 
processing, executive function, attention and memory are inter-associated suggests that there 
may be a common mechanism which impacts all of these cognitive domains.    
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Besides serving as an early warning sign of AD, hearing loss may worsen cognitive 
processing in AD due to the burden of increase cognitive load with diminished hearing.  Because 
hearing impairment requires the simultaneous use of several cognitive resources like attention 
and interpretation to decipher speech, it may be more challenging to concurrently accomplish 
other thought processes.  This is clearly demonstrated in situations where noisy backgrounds 
require more cognitive resources to understand speech, which results in impairments in other 
cognitive functions such as working memory (Tun, McCoy, & Wingfield, 2009).     
The concept of a cognitive resource-allocation framework comports with findings by 
Wingfield and Grossman (2006).  In a review of fMRI data, the authors propose a two-stage 
hearing comprehension process: First, core elements of a sentence are deciphered and processed 
sentence in the perisylvian region in cerebral hemisphere; Second, the recruitment of associated 
brain regions involved in working memory and attention allow comprehension of sentence 
salience (Wingfield & Grossman, 2006).  As older adults lose function of central auditory 
processing, other areas of the frontal and temporoparietal cortex are recruited to maintain 
auditory processing and speech comprehension abilities.  This model could explain the ability of 
many older and demented patients to maintain language comprehension while other abilities fail. 
To distinguish differences in hearing between normal older adults and those with AD, the 
two groups were compared with physiological and functional hearing tests.  Using verbal 
(phoneme identification test, word identification test) and nonverbal (environmental sound 
identification test, identification of melodies from popular music) auditory tests for patients with 
AD and age-matched controls, Eustache et al. (1995) found that both groups had similar levels of 
moderate hearing loss.  However, the AD group made significantly more errors on all functional 
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hearing assessments than the controls.  The authors report that this discrepancy illustrates 
problems with executive function and/or attention independent of hearing loss.   
Hearing loss may contribute to obstacles in accomplishing activities of daily living, but 
the effects on an individual’s lifestyle can be even farther reaching.  One of the most burdensome 
complications of hearing loss is the inability to understand speech, especially in the presence of 
background noise.  In patients with AD, vocal recognition, gender, and speaker discrimination 
were impaired compared to healthy, age-matched controls (Hailstone et al., 2011).  Hearing loss 
may contribute to impairments in psychological health because difficulties understanding speech 
may lead to social isolation, depression and reduced quality of life in some individuals 
(Niemensivu, Manchaiah, Roine, Kentala, & Sintonen, 2015; Sanders & Gillig, 2010).  A 
qualitative study from the United Kingdom described the social limitations of older adults with 
hearing impairment.  Common themes included the loss of identity, inability to communicate, 
and social isolation (Bennion & Forshaw, 2013).  Because social engagement supports healthy 
cognitive function, (Freeman et al., 2017; Bennett, et al., 2006), and cognitive function is 
inversely related to agitation, interventions to protect cognitive function by supporting social 
engagement with optimized hearing should be explored to avoid agitation.     
It is unclear whether sensory impairment from hearing loss directly causes the agitated 
behavioral symptoms or if a common underlying cause (such as neurodegeneration) is 
responsible for both the hearing loss as well as the agitated behavioral symptoms.  Hearing loss 
as a predictor of neurodegeneration and AD may be useful for increased surveillance of 
cognition and early treatment interventions.  Hearing loss as independent cause of agitation due 
to sensory impairment suggests the possibility that interventions to improve communication and 




Quality of life for persons with Alzheimer Disease.  Individuals with dementia have 
decreased quality of life (as measured by proxy reports from caregivers and self-report) as levels 
of agitation increase (Beerens, Zwakhalen, Verbeek, Ruwaard & Hamers, 2013; Hongisto et al., 
2015; Livingston et al., 2017).   Unfortunately, there is no evidence that quality of life measures 
improve with many of the interventions aimed at reducing agitation such as increased staffing 
levels or increased family visits (Livingston et al., 2014; Livingston et al., 2017; Robertson et al., 
2017).  There is an urgent need to improve quality of life for these individuals, and the 
possibility that reduced agitated behavioral symptoms can improve quality of life.   
Functional status.  Impaired functional ability, as measured by performance of activities 
of daily living, is correlated with agitation (Cohen-Mansfield et al., 2012; Chen et al., 2014).  
Functional status may also be impacted by the psychological issues such as depression, physical 
problems such as declining cognition, and environmental considerations including living at home 
(Martyr, Nelis, & Clare, 2014).  The relationship between functional status and these antecedent 
factors may be moderated by agitated behavior symptoms (Martyr et al., 2014).  It has also been 
suggested that functional ability has an indirect effect on agitation through depression, although a 
direct effect of functional ability on agitation has not been demonstrated (Chen et al., 2014).    
Risk for Admission to caregiving institutions.  Many individuals with AD are 
eventually admitted to long-term care facilities.  As agitation increases, the weekly hours of 
supervision and assistance required also increases significantly (Okura et al., 2011).  Caregiver 
burnout or caregiver distress mediates the relationship between agitated behavioral symptoms 
and admission to long-term care facilities (Gaugler et al., 2009).  Admission to long-term care 
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facilities is not only financially costly, it also reduces functional and cognitive ability as well as 
quality of life for residents (Cobo 2014; Foebel et al., 2016).  
Exposure to Psychopharmacologic treatment.  Persons with AD may be treated with 
psychoactive medications in an attempt to control or reduce agitated behavioral symptoms.  
Atypical antipsychotic medications are widely prescribed to treat agitated behavior.  As with all 
medications, adverse effects are possible while taking these drugs.  These adverse effects are in 
especially problematic for older adults.  The Food and Drug Administration (2005; 2008) has 
issued public health advisories related to the increased risk of death when antipsychotic drugs are 
used in a population of older adults with dementia. Despite guidelines designed to reduce the use 
of these drugs, prevalence of their use remains between 40 and 68 percent of institutionalized 
people with dementia (Mitka, 2012; Foebel et al., 2016).   
While atypical antipsychotic medications such as aripiprazole, quetiapine, risperidone 
and olanzapine significantly reduce agitated behavioral symptoms, they also have significant 
risks of adverse effects (Ma et al., 2014).  Adverse effects range from minor issues such as 
edema and gait abnormalities to severe problems of somnolence, urinary tract infections, 
extrapyramidal symptoms, adverse verebrovascular event and even death (Ma et al., 2014).  The 
risks of cardiovascular events and death were increased with medication dose and duration of use 
(Schneider et al., 2006).    
Besides the immediate adverse effects of antipsychotic drugs, long-term effects are also 
seen.  Individuals who are treated with antipsychotic medications were found to have declines in 
functional ability and cognition compared to those who were not medicated (Foebel et al., 2016).  
Since cognitive decline is associated with worsening agitated behavioral symptoms, the long-
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term use of antipsychotic medications and the associated cognitive decline may contribute to 
worse agitation and the need for even more medication in long term use.     
Other psychoactive medications have been tested to treat agitated behaviors in persons 
with AD. Antidepressant drugs have been used for the treatment of agitated behavioral 
symptoms in persons with AD even without depression.  A Cochrane review found a significant 
improvement in agitation after administration of selective serotonin reuptake inhibitors sertraline 
and citalopram, although not all trials have confirmed this finding (Seitz et al., 2011).  While 
generally considered safer than antipsychotic medications, antidepressants increase the risk of 
falls, electrolyte imbalances or gastrointestinal bleeding especially in older adults (Seitz et al., 
2011).   
Anxiety is common in individuals with AD, and anxiety medication may be used to treat 
agitated behavioral symptoms in these individuals (Borsje et al., 2015).  Anxiolytic agents are 
effective in treating agitation with short-term use, but can cause cognitive impairment, balance 
problems, and short-term memory impairment (Antonsdottir, Smith, Keltz, & Porsteinsson, 
2015).  Furthermore, long-term use of benzodiazepines are strongly associated with increased 
risk of development of dementia (Takada, Fujimoto, & Hosomi; 2016).    
Exposure to Physical restraint. While not as prevalent as the use of antipsychotic 
medications, physical restraints are widely used to control agitated behavioral symptoms in 
persons with AD.  It is estimated that physical restraints are used to manage agitated behavioral 
symptoms in 20 to 31 percent of persons with AD and agitated behavioral symptoms in nursing 
home settings (Foebel et al., 2016).  The use of physical restraint is also likely to contribute to 
additional psychological distress (Werner, Cohen‐Mansfield, Braun, & Marx, 1989).    
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Following a similar trend to antipsychotic medication interventions, individuals who are 
physically restrained were found to have declines in functional ability and cognition compared to 
those who were not restrained, and also compared to those who received only antipsychotic 
medications (Foebel et al., 2016).  The functional and cognitive declines were the worst in 
nursing home residents who were both physically restrained and medicated, suggesting an 
additive effect (Foebel et al., 2016).  It is possible, however, that cognitive and functional 
declines were greater in this population due to the advancing disease process itself rather than as 
a direct response to the physical restraint and medication interventions as no random assignment 
to groups were made in Foebel’s retrospective observational study.     
Caregiver Burden. Agitated behavioral symptoms are not only one of the most prevalent 
symptoms in AD, they are also one of the most distressing symptoms to caregivers (Chiao et al., 
2015; Fauth & Gibbons, 2014).  Caregiver burnout is a problem for family members who care 
for persons with AD, and is associated with immune dysfunction, increased risk of stroke, and 
increased pain (Fonareva & Oken, 2014; Hong et al., 2016; Ivey et al., 2017).  
In the hospital setting, nurses and other professional caregivers may not respond 
adequately to the care requirements of persons with AD and agitated behavioral symptoms.  In 
response to these challenging behaviors, nurses may react with avoidance or depersonalization, 
ignoring these patients and providing only basic task-oriented care without compassion (Digby et 
al., 2017).  Healthcare Providers may respond to aggression or agitated behavioral symptoms 
with physical force or chemical restraint (Nilsson, Rasmussen, & Edvardsson, 2015).  When 
patients with dementia are resistant to care, nurses may become angry or exasperated (Nilsson et 
al., 2015).  In some instances, nurses may even dehumanize these individuals resulting in the 
patients being treated cruelly with shouting, mockery or with derogatory remarks (Griffiths et al., 
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2014; Digby et al., 2017).  Digby and colleagues (2017) suggest that these unprofessional 
caregiving behaviors are the result of nurses’ attempts to gain control of patient behaviors, a lack 
of understanding or training about AD, and a lack of adequate time to look for reasons for 
agitated behavioral symptoms.  In situations where nurses are unable to provide safe and 
dignified care to persons with AD who have agitated behavioral symptoms, is not only unsafe for 
patients but also dissatisfying to staff.    
An extreme expression of caregiver burnout is the abuse or neglect of persons with AD.  
Older people with dementia symptoms are at a greater risk for verbal and physical abuse in the 
community and also in institutional settings compared to the elderly population in general (Boye 
& Yan, 2016).  Elder abuse was found to be predicted by caregiver factors such as depression or 
stress, and patient factors including functional impairment, neuropsychiatric symptoms, and 
dementia symptoms (Cooper et al., 2010; Pérez-Rojo et al., 2009; VandeWeerd et al., 2013).  
Physical abuse of persons with AD is often triggered by disruptive behaviors such as agitation, 
resistances to care, and aggression (Cooper et al., 2010; Pérez-Rojo et al., 2009; VandeWeerd et 
al., 2013).   
Gaps in the Literature 
As a whole, the current body of evidence surrounding agitated behavioral symptoms in 
AD provides evidence that (1) current interventions to improve agitated behavioral symptoms in 
persons with AD are ineffective overall, (2) many possible risk factors for agitation have been 
identified, and (3) outcomes for unresolved agitated behavioral symptoms are dire.   
Interventions with some evidence of improvement to agitated behavioral symptoms 
include environmental modifications and music therapy, communication training for caregivers, 
physical exercise, and some medications.  Light therapy, staff training to encourage social 
32 
 
interaction or exercise, and aromatherapy interventions are not efficacious.  Since 
pharmacological interventions carry high risks of dangerous adverse events and the effects of 
currently described nonpharmacological interventions are limited, there is a need to develop new 
interventions to improve agitated behavioral symptoms in persons with AD through careful 
evaluation of risks for and antecedents to agitated behaviors.   
Cognitive decline is a key risk factor for agitation, and cognitive function may moderate 
the effects of other protective factors such as social interaction and physical exercise.  It is 
unclear the extent to which worsening agitated behaviors and cognitive decline are both the 
result of increasing neurodegeneration, or if agitated behavioral symptoms are a direct response 
to increasingly impaired cognition.  Furthermore, there is no evidence to determine if supporting 
healthy cognition can improve cognitive behavioral symptoms or vice versa.    
While many situational, psychological, and physiologic factors have been found to be 
correlated with agitated behavioral symptoms, there is limited evidence to determine if these 
factors are causative or simply correlated.   Risk factors for agitation such as unidentified pain, 
insufficient sleep, inappropriate level of stimulation, or untreated anxiety or depression merit 
further exploration.  Interventions to identify and treat pain, improve sleep cycles, and provide 
appropriate stimulation may provide additional opportunities to improve agitated behavioral 
symptoms.    
Hearing loss is another important risk factor for agitated behavioral symptoms.  While 
some hearing loss may be an unavoidable result of neurodegeneration in AD, the effects of 
hearing loss are immense.  Interventions to examine the possibility of improving agitation 
directly through improvement of hearing are needed.  Additionally, interventions to improve 
communication for those with hearing impairment may improve agitation indirectly through 
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avoidance of social isolation and improved cognition.  More work is needed to investigate these 
promising interventions.    
The consequences of continuous agitated behavioral symptoms include diminished 
quality of life, caregiver burnout, chemical or physical restraint, low quality hospital care, early 
institutionalization, abuse or neglect, and adverse drug effects including death.  To avoid these 
outcomes, better interventions for agitated behavioral symptoms are urgently needed.  By 
clarifying the relationship of antecedents and risk factors of agitated behavioral symptoms, 
opportunities for effective interventions will become clear.   
Conceptual Challenges 
Dementia and Alzheimer disease.  The first conceptual challenge in researching the 
phenomenon of agitated behavioral symptoms in persons with AD is defining the population.  
The definition of AD has undergone numerous revisions.  In 1984, the National Institute of 
Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer’s Disease 
and Related Disorders Association (ADRDA) agreed on criteria to define the clinical diagnosis 
of AD based on neuropsychiatric tests and medical history (McKhann et al., 1984).  As 
knowledge about the AD neurodegenerative process and other pathophysiological processes with 
similar symptom presentations grew, new diagnostic criteria for AD were created (McKhann et 
al., 2011).   
The currently accepted definition of AD, known as the NINCDS-ADRDA criteria 
described by McKhann et al., 2011, includes a broad definition for dementia regardless of 
etiology.  This general definition of dementia includes cognitive or behavioral symptoms based 
on five criteria: symptoms that impede usual activities; are a decline from an individual’s 
baseline functioning; cannot be attributed to another psychiatric disorder; are observed through 
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subjective report as well as objective measures; and involve at least two cognitive domains such 
as memory, reasoning, visuaospatial abilities, language, or personality.  When these symptoms 
are present, but mild enough that they do not interfere with usual activities, Mild Cognitive 
Impairment (MCI) is diagnosed.  While MCI may be considered an early presentation of AD, it 
is not definitive that MCI will progress to AD.   
Dementia occurring secondary to AD is further categorized as probable, possible, and 
“Probable or possible AD dementia with evidence of AD pathophysiological process” (McKhann 
et al., 2011, p. 265).  These further delineations depend on a patient history with insidious 
symptom onset with initial presentation of memory deficits (amnestic presentation), or language, 
visuospatial, and executive deficits (nonamnestic presentation).  AD is not diagnosed if an 
individual has a history of cerebrovascular disease or features of other types of dementia such as 
Lewy body or frontotemporal dementia. The diagnosis of AD may be made with increased level 
of certainty in the presence of biomarkers or genes.   
With these stringent diagnostic criteria and the requirement of knowing each individual’s 
history and presentation, it is not surprising that so much research with older adults who 
experience cognitive decline does not attempt to differentiate dementia caused by AD from other 
dementias.  Even when Alzheimer diagnosis status is known for some participants, researchers 
may combine all individuals with dementia symptoms in analysis.   
Even the more general term, “dementia,” does not have a universally agreed upon 
definition.  The World Health Organization International Classification of Disease (ICD-10) has 
categorized dementia as a mental and behavioral disorder (World Health Organization, 2004), 
and further defines dementia on the basis of its etiology.  The American Psychiatric Association 
Diagnostic and Statistical Manual of Mental Disorders (DSM) removed the term dementia from 
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its fifth edition, instead referring to these symptoms as a neurocognitive disorder (American 
Psychiatric Association, 2013). 
Some authors have argued that the distinction between different types of dementia in 
older adults is futile.  There is a high prevalence of “mixed dementia” arising from a 
combination of vascular and AD pathologies, with an increased risk of clinical dementia 
symptoms with additional pathologies (Schneider, Arvanitakis, Bang, & Bennett, 2007).  There 
is also poor correlation between clinical diagnosis and neuropathological findings seen in 
postmortem brain examinations (Schneider, Arvanitakis, Leurgans, & Bennett, 2009).  Despite 
these imperfections, distinctions between different etiologies causing dementia are important to 
avoid extrapolating findings from one type of dementia to all types.   
 Operationalization of AD or other dementias has taken various forms in the literature.  In 
the absence of a formal diagnosis, scores on neuropsychological assessments are often used to 
label dementia and quantify severity of cognitive impairment.  The wide variety of tools 
available makes comparisons across studies more difficult.  While the benefit of these 
assessments is that the numerical scores allow for easy analysis and they do not require lengthy 
examination or expert input, tools are often limited in diagnostic accuracy in all populations and 
may only represent the cognitive domain of dementia without regard to impact on functional 
ability (Ritchie, Terrera, & Quinn, 2015).   
Agitation.  Lack of conceptual clarity is a problem in the literature describing agitation in 
AD.  Cohen-Mansfield and Billig (1986) consider four components of agitation including 
physically aggressive behavior, physically non-aggressive behavior, verbally agitated behavior, 
and hiding or hoarding.  The agitated behaviors are deemed socially inappropriate because: “It 
may be abusive or aggressive toward self or others; it may be appropriate behavior performed 
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with inappropriate frequency; and it may be inappropriate according to social standards for the 
specific situation” (Cohen-Mansfield & Billig, 1986, p. 712).  Aggression refers to destructive 
behaviors directly at people, oneself, or objects (Cohen-Mansfield, Marx, & Rosenthal, 1989).  
Cohen-Mansfield (2003) explains that agitated behavioral symptoms may be determined by an 
observer, are not necessarily disruptive, and occur in individuals both with and without dementia. 
Other definitions of agitation have been proposed.  The DSM-5 defines psychomotor 
agitation as excessive motor activity associated with a feeling of inner tension where the activity 
is usually nonproductive and repetitious and consists of behaviors such as pacing, fidgeting, 
wringing of the hands, pulling of clothes, and inability to sit still. (American Psychiatric 
Association, 2013). This definition of agitation describes the non-aggressive behavioral aspect of 
agitation described by Cohen-Mansfield and Billig (1986), but does not address aggressive or 
verbal behaviors.  The DSM-5 definition of agitation also presents research challenges because it 
is not easy to observe feelings of inner tension, and may be difficult to ascertain these feelings in 
persons with AD due to their communication limitations.   
Agitation has also been described as a set of observable behaviors that demonstrate an 
unpleasant state of excitement and do not respond to interventions to remove internal or external 
stimuli (Hurley et al., 1999).  Hurley and associates (1999) further explain that agitation is a state 
that is experienced by an individual who is alone, while the same behaviors in the presence of 
caregivers would be termed “resistance to care.”  Examples of these behaviors include pacing 
and repetitive movements or vocalizations.  This definition is problematic because, by definition, 
it cannot be improved through intervention.  Hurley’s (1999) definition assumes that all agitated 
behaviors that occur in the presence of caregivers represent a rejection of care, although the 
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individual may not realize they are rejecting care.  This definition also omits aggressive 
behaviors toward self, others or objects.  
Kong (2005) describes a conceptual framework though which agitation can be 
understood, and emphasizes that conditions preceding the agitation must be explored.  While the 
definition of agitation proposed by Cohen-Mansfield and Billig (1986) indicates that agitation is 
the presence of inappropriate behavior in the absence of need, Kong (2005) emphasizes the 
importance of assuring that physical needs are not the cause of the agitated behavioral 
symptoms.  Unmet physical or psychological needs such as pain or sleep deficits are likely to 
cause a person with dementia to express this need through motor activity or verbalizations.    
Although Cohen-Mansfield and Billig created the most widely-used definition of 
agitation in 1986, there is no universal acceptance of this definition.  Agitation describes such a 
wide range of behavioral symptoms that it overlaps several related concepts.  For example, 
agitation includes aggressive behaviors but aggression is not always present in agitated behaviors 
such as pacing (Cummings et al., 2015). Other concepts which are closely related to agitation 
including restlessness, aggression, and disturbing behaviors are often included in the conceptual 
definition of agitation (Kong, 2005).  Concepts which may be considered as a part of agitation 
such as aberrant motor behaviors including wandering or fighting (Fauth & Gibbons, 2014) and 
inappropriate verbalizations such as screaming or ceaseless talking (von Gunten, Favre, Gurtner, 
& Abderhalden, 2011) are often studied in isolation to other aspects of agitation.   
The construct of agitation contains many different symptoms, making it a challenging 
target to measure (Kolanowski et al., 2016).  Lack of agreement on the conceptual definition of 
agitation has resulted in the concept being operationalized with different tools in different 
studies.  Commonly used tools include the Cohen-Mansfield Agitation Inventory (Cohen-
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Mansfield et al., 1989), Neuropsychiatric Inventory (NPI; Cummings et al.,1994), or Behavioral 
Pathology in Alzheimer’s Disease (BEHAVE-AD; Reisberg et al., 1987; De Deyn & Wirshing, 
2001). These different instruments make cross study comparisons difficult.   
Because of a lack of agreement about the definition of agitation, an Agitation Definition 
Work Group was formed by the International Psychogeriatric Association and 928 participants 
responded to questionnaires to reach consensus.  As a result, a standard definition of agitation 
was created.  “Agitation was defined broadly as: (1) occurring in patients with a cognitive 
impairment or dementia syndrome; (2) exhibiting behavior consistent with emotional distress; 
(3) manifesting excessive motor activity, verbal aggression, or physical aggression; and (4) 
evidencing behaviors that cause excess disability and are not solely attributable to another 
disorder (psychiatric, medical, or substance-related),” (Cummings et al., 2015, p. 7).  This 
definition adds to that which was proposed by Cohen-Mansfield (1986) by the explanation that 
agitation in persons with cognitive impairment or dementia may differ in etiology and treatment 
than agitation which is seen in other conditions.  The “unmet needs” aspect of the definition is 
reframed as “an excessive response.” This definition of agitation is also unique in its recognition 
that the behavior interferes with normal or expected functioning.    
While it is yet to be seen if this new definition will replace the traditional conceptual 
definitions of agitated behavioral symptoms, its creation demonstrates the efforts that have gone 
into creating conceptual clarity from the heterogeneity in previous definitions.  Further work will 
be needed to determine the extent to which extant tools are valid to measure agitation as it has 
been conceptualized above.    
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Nursing Theory: The Theory of Unpleasant Symptoms 
Although the experience of agitated behavioral symptoms in persons with AD is very 
common, interventions to reduce agitated behavioral symptoms are still unreliable.  The 
consequences of untreated agitated behavioral symptoms are severe, ranging from diminished 
quality of life to abuse and even death.  To better understand agitated behavioral symptoms in 
person with AD, the phenomenon has been conceptualized with theories like the Need-driven 
Dementia-compromised Behavior (NDB) model (Algase et al., 1996) and the Progressively 
Lowered Stress Threshold (PLST) model (Hall & Buckwalter, 1987).    
The NDB model proposes that background factors (such as neurological status, health 
status, premorbid characteristics) and proximal factors (including physical or psychosocial needs 
and environment) result in disruptive behavioral symptoms related to dementia (Algase et al., 
1996).  The PLST model is based on the idea that the disruptive behavioral symptoms seen in 
persons with dementia are a response to overwhelming stress on the patient, and disease 
progression results in lower doses of the triggering events resulting in the stress response (Hall & 
Buckwalter, 1987).  These models have been helpful in directing environment interventions to 
minimize behavioral disruptions; however these two models are limited because they lack 
explicit attention to functional performance as a secondary outcome beyond disruptive 
behavioral symptoms. 
To understand the relationship between these environmental stressors, needs, behavioral 
symptoms, and their effects on an individual’s functional performance, another model is needed.  
Numerous situational, psychological and physical risk factors for agitated behavioral symptoms 
have been identified, but their relationship to agitation is complex and not fully understood. A 
framework is needed to organize these risks, understand their relationship to agitated behavioral 
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symptoms, and identify opportunities for future interventions.  The TOUS is a good fit to model 
these relationships.   
The Theory of Unpleasant Symptoms 
The middle-range TOUS was originally developed by Lenz and colleagues to better 
understand the symptoms of fatigue and dyspnea in the populations of women in child birth and 
individuals with lung disease (1995; Figure 1).  Despite the differences in these symptoms and 
populations, concepts that were common to both symptoms experiences were identified and 
defined in a way that could be extrapolated to other unpleasant symptom experiences (Lenz et 
al., 1995).  The TOUS was later updated to recognize the coexistence and associations between 
multiple symptoms (Lenz et al., 1997; Figure 2).  The updated theory also considers the role of 
performance outcomes in further influencing the symptom experience and antecedent factors 
(Lenz et al., 1997).   
Evaluation of TOUS 
The TOUS can be critiqued through Fawcett and DeSanto-Madeya’s theory evaluation 
criteria including theory scope, context, and content (2013).  The scope of the theory is 
constrained to the middle-range nursing phenomenon since its theoretical concepts are more 
concrete and specific than the abstract and broad concepts of grand theories.  The TOUS was 
developed with the goal of providing a guide for nursing theory and practice; the concepts and 

















Figure 2. Updated Theory of Unpleasant Symptoms (Lenz et al., 1997) 
 
The context of the nursing theory (its relation to nursing’s metaparadigm, philosophical 
claims, conceptual model, and fit within previously developed nursing knowledge) places it 
squarely within the nursing disciplinary perspective.  Nursing’s metaparadigm concepts of 
nursing, human beings, health, and the environment are each represented (Fawcett & DeSanto-
Madeya, 2013).  The concept of health is represented in the symptom experience, and antecedent 
health factors which influence symptoms (Lenz et al., 1995).  Human beings and environment 
are represented through the antecedent factors of social and physical environment (Lenz et al., 
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1995).  Nursing is indirectly related to the model itself, but Lenz et al. (1997) note that the TOUS 
is useful in developing preventative (nursing) interventions to alleviate symptoms.  Although 
philosophical claims of the TOUS are not explicitly stated, the updated TOUS reflects the 
reciprocal interaction world view (Lee, Vincent, & Finnegan, 2017).  The patient is a holistic 
being who presents symptoms which are influenced by environmental factors (Lenz et al., 1997). 
The environment and multiple symptoms have a multiplicative effect on the symptom experience 
and performance outcomes; these features create a feedback loop through which symptoms are 
reinforced through performance factors (Lenz et al., 1997).   
The content of the TOUS is evaluated on the basis of its significance, internal 
consistency, parsimony, testability, and empirical and pragmatic adequacy (Fawcett & DeSanto-
Madeya, 2013).  The theory is highly significant to nursing as demonstrated by its attention to 
the metaparadigm concepts of interest to nursing and its development process through clinical 
nursing observations and review of extant nursing literature (Lenz et al., 1995).  The internal 
consistency of the TOUS is demonstrated in the clear and concise definitions of theoretical 
concepts and provision of examples of each (Lenz et al., 1995).  There is a minor problem with 
semantic consistency in the interchangeable use of the terms symptoms/symptom experience and 
functional activities/functional performance/functional status, and performance/performance 
outcomes (Lee, Vincent, & Finnegan, 2017).  Overall, the interchangeable use of these terms 
does not interfere with the understanding of relational concepts, and allows users of the TOUS 
the flexibility to define these terms to provide the greatest utility to their own phenomena of 
interest.  The TOUS is testable; it has been used as the conceptual model in at least 152 different 
studies many of which found evidence to support the TOUS empirical and pragmatic adequacy 
(Lee, Vincent, & Finnegan, 2017).   
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This model is particularly well-suited to the study of the determinants of agitated 
behavioral symptoms in persons with AD because the TOUS was developed with the recognition 
that multiple symptoms often occur together and may exacerbate one another.  The theory 
considers antecedents to symptoms such as physiological factors, psychological factors and 
situational factors; describes the symptoms themselves in terms of distress, duration, quality, and 
intensity; and considers the outcome of beyond just the presence or absence of symptoms 
including functional abilities (activities of daily living, role performance) and cognitive 
performance (concentration, problem solving).  The inclusion of performance variables as an 
outcome is consistent with the conceptual definition of agitation described by Cummings and 
colleagues (2015).   
Variables within Theory of Unpleasant Symptoms Framework 
Symptom. The concept of agitation fits into the TOUS model as a symptom defined by 
its distress, duration, intensity, and quality.  In this study, agitation will be defined as behaviors 
consistent with emotional distress, excessive motor activities, and verbal or physical aggression 
which negatively impact an individual or others around them and which are not solely 
attributable to another disorder (Cohen-Mansfield, 1986; Cummings et al., 2015).   
Based on the model, the symptom of agitation will be impacted by the combined effects 
of physiological, psychological, and situational factors.  The agitated behavioral symptoms will 
also have an effect on performance including quality of life and functional status.  The 
relationship between agitation and other AD-related behavioral symptoms will be described. 
Other behavioral symptoms often coincide with agitation in persons with AD.  Symptoms 
of apathy, delusions, disinhibition, elation, hallucinations, and sleep disorders will also be 
examined.  The TOUS predicts that these AD-related behavioral symptoms will also be impacted 
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by physiological, psychological, and situational factors.  The AD-related behavioral symptoms 
will also have an effect on the performance outcomes of quality of life and functional status.  The 
relationship between AD-related behavioral symptoms and agitation will also be examined.    
Antecedent factors.  The three categories of agitation-causing variables include 
situational, psychological, and physical factors.  Not only are these factors thought to influence 
agitated behavioral symptoms, their relationships with each other are also considered.  
Additionally, the antecedent factors will have an independent effect on performances outcomes.   
Situational factors.  Situational factors influencing agitation include environmental 
influences and interpersonal factors.  In the proposed study, situational factors will include the 
physical and social environment.  The situational factor construct will be studied in terms of 
three effects: its correlation with physical and psychological factors; its effect on agitation; and 
its effect on performance outcomes.   
Psychological factors.  Psychological factors will be defined as anxiety and depression. 
In the proposed study, the psychological factor construct will be studied in terms of three effects: 
its correlation with physical and situational factors; its effect on agitation and other AD-related 
behavioral symptoms; and its effect on performance outcomes.   
Physiologic factors.  Physical factors will be defined as comorbidities, pain, nutritional 
status, hearing, cognitive impairment (as a marker of AD stage of progression), and fatigue.  In 
the proposed study, the physiologic factor construct will be studied in terms of three effects: its 
correlation with physical and situational factors; its effect on agitation and other AD-related 
behavioral symptoms; and its effect on performance outcomes. 
 Performance.  For the purposes of the present study, the performance construct will be 
defined as functional status and quality of life.  As indicated in the TOUS, performance will be 
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studied as a direct and indirect outcome of situational, psychological, and physical factors; it will 
also be studied as a direct effect of agitation and other AD-related behavioral symptoms.   
Model.  By considering the compounding effects of multiple symptoms that occur 
simultaneously, it is clear how other symptoms which are common in aging such as depression, 
social isolation, pain, hearing loss, or sleep difficulties may exacerbate the symptom of agitation 
and ultimately diminish quality of life and functional performance.  The TOUS model helps 
clarify and organize the seemingly unpredictable nature of agitation by providing a clear 
framework for understanding the symptom, its causes, and its effects on performance.     
Performance is the outcome variable of this theory.  Performance may include things like 
role performance, activity level, or problem solving.  These factors together may influence 
quality of life overall.  The resulting decrease in performance and function may act through a 
feedback loop to perpetuate the cognitive decline symptom and exacerbate situational, 
psychological, and physiological risk factors for even further cognitive decline.   
From this model it can be deduced that if the symptoms of agitation and other AD-related 
behavioral symptoms increase, then functional performance will decrease.  The model also 
visually depicts that a greater level of physiological impairment from AD or other dementias 
contributes to an increased frequency of agitation and other AD-related behavioral symptoms 
and ultimately further decrease functional performance.  Lastly, the resulting decrease in 
functional performance may act through a feedback loop to perpetuate the agitation symptom 
and exacerbate psychological, situational, and physiological risk factors for even further 
agitation.  The TOUS provides a framework of proposed relationships that can be empirically 
tested.    
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For the purposes of the present study, the simplified original version of the TOUS (Lenz 
et al., 1995) will guide analyses.  The correlations between antecedent factors will also be 
considered as described in the updated TOUS (Lenz et al., 1997).  Although it is clear that 
feedback mechanisms described in the updated TOUS will cause iterative, reciprocal effects 
from performance to symptoms and antecedent factors over time, only the direct paths will be 
analyzed.  Inclusion of reciprocal paths within a single model would preclude the possibility of 
path analyses.  Furthermore, cross sectional data provides only a snapshot in time: further study 
of longitudinal changes over time is needed to evaluate the feedback mechanisms described in 
the updated TOUS by reversing the model and considering functional performance and agitation 
at an early time point the predictors of later declines in antecedent factors.   
Chapter 2 Conclusion 
All older adults should look forward to the experience of aging and the ability to live 
their optimal quality of life in a safe and supportive environment.  Unfortunately, persons with 
AD who experience agitated behavioral symptoms may be unable to achieve their maximum 
potential functional performance and quality of life (Beerens, et al., 2013; Hongisto et al., 2015; 
VandeWeerd et al., 2013).  Moreover, agitated behavioral symptoms may result in strained 
relations with caregivers, early admission to residential institutions, administration of drugs with 
dangerous side effects, physical restraint, and even elder abuse (Gaugler et al., 2009; Ma et al., 
2014; VandeWeerd et al., 2013).  Current nonpharmacological interventions are unreliable or 
unsafe (Livingston et al., 2017; Foebel et al., 2016).  There is evidence that agitated behavioral 
symptoms are related to a number of situational, psychological, and physiological factors, 
however the nature of their relationship to agitation are still unclear.  There is a critical need for 
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research guided by theory such as the TOUS to organize these risks and outcomes, predict 
relationships, and identify opportunities for intervention.  
In conclusion, the TOUS provides a clear and comprehensive framework for 
understanding the phenomenon of agitated behavioral symptoms in persons with AD.  
Knowledge generated through the TOUS about agitation and cognitive decline has the potential 
to improve care for older adults with cognitive impairments and also to contribute to nursing 
knowledge.  As long as a cure for AD is unattainable, a great need exists to improve the care of 
agitated behavioral symptoms in persons with AD.     








CHAPTER 3: METHODS 
Methods 
Study Design 
This dissertation’s purpose is to test a model of predictors and outcomes of agitated 
behavioral symptoms in persons with AD.  This study used a descriptive, correlational design 
with cross-sectional data.  The specific aims of the study were tested theoretically and 
empirically.  Aim 1 seeks to describe the phenomenon of agitated behavioral symptoms in 
persons with AD within the Theory of Unpleasant Symptoms.  Aim 1 will be assessed by the 
degree to which the path model calculated from the data matches the substructed model guided 
by the TOUS, and adequately represents all of the expected theoretical concepts.  Aims 2 and 3 
seek to examine the relationships between situation, psychological state, and physical conditions 
on agitation and functional status outcomes.  These aims will be empirically tested to determine 
the presences, strength and direction of relationships between variables of interest in the model 
to evaluate the degree to which relationships hypothesized in the TOUS are supported by the 
data. 
Setting 
 This study analyzes data from previous studies of persons with AD.  The original studies 
examined genetic and environmental determinants of functional abilities, cognition and 
behavioral symptoms in persons with AD.  In the parent studies, participants were recruited from 
community and nursing home settings in the Midwest (Schutte, Maas, & Buckwalter, 2003; 




Parent studies used convenience sampling to identify nursing home facilities and 
community-dwelling individuals with AD from which all eligible participants were invited to 
join the studies. Although some parent studies collected data from participants at multiple time 
points, only baseline data for all participants were included in the present analysis.  Data from 
parent studies yielded a sample size of up to 110 participants.  Some instruments were not used 
across all studies, so sample sizes for individual measures varied between 5 and 110 participants.  
A minimum sample of 48 participants was included in each variable in the model, with other 
instruments evaluated separately.  The G*Power analysis found that a sample of 48 participants 
achieves a statistical power of 0.84 in detecting a moderate effect size (f
2
 = 0.15) for a one-tailed 
 level of 0.05 in analyses of multiple regression with four predictors (Faul, Erdfelder, Lang, & 
Buchner, 2007).   
Inclusion criteria.  Subjects were eligible to participate if they met the NINCDS-
ADRDA criteria for possible or probable AD, were over the age of 21 years, were fluent in 
English, and had the consent of a family member for participation.   
Exclusion Criteria.  Persons not meeting the inclusion criteria were excluded.   
Procedures 
All study procedures from the parent studies were approved by Institutional Review 
Boards.  Approval by the Institutional Review Board at Wayne State University was obtained 
before data analysis began.  Since the data for the dissertation research had already been 
collected, risks for participants were minimal.  Risks included the loss of privacy if protected 
health information was compromised.  This risk was minimized by accessing only de-identified 
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data safely stored in password protected electronics or hard copies of data assessment forms 
stored in locked file cabinets in a locked office.    
Recruitment.  In the community, participants were recruited through their caregivers.  In 
nursing home settings, administrators at each facility mailed letters describing the study to 
legally authorized representative of eligible participants (Schutte et al., 2011).  These 
representatives were asked to indicate if they were interested in learning more about participation 
in the study from the research team.  Interested families were contacted by telephone to describe 
the research and obtain informed consent.  From the nursing home setting, an average of 51% of 
eligible individuals chose to participate (Schutte et al., 2011).   
Data Collection. Data were collected from chart review, questionnaires administered to 
the participants, and family informant interview.  For some data, repeated measures were 
collected for participants at various time points (Schutte et al., 2011).  To assure interrater 
reliability, functional ability and cognitive impairment assessments were measured by two 
members of the research team simultaneously for the first three participants at each new facility, 
with an intraclass correlation of greater than 0.75 for all measures (Schutte et al., 2011).  Any 
discrepancies that arose were discussed and resolved by consensus (Schutte et al., 2011).      
Measures  
In the following section, descriptions of instruments used to measure each theoretical 
concept are described.  The instruments are organized by the theoretical concept measured.  In 
cases where subscales of an instrument are used, the details of the instrument are described 
within the first variable measured and the subscale is listed under the applicable theoretical 
concept.  The theoretical concept, variable, and measures are summarized in Table 1.   
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Antecedent Situational Factors.  Situational antecedent factors include measures of the 
social and physical environments.  Social environment is measured by Nursing Unit Rating Scale 
(NURS) and in terms of caregiver burden as measured by the Zarit Burden Interview (ZBI), the 
Memory and Behavior Problem Checklist-1987R (MBPC) Memory and Behavior Caregiver 
reaction subscale, and the Occupational Disruptiveness subscale of the Neuropsychiatric 
Inventory (NPI).  Physical environment is measured by the Ambiance Scale (AS) and the 
Therapeutic Environment Screening Survey (TESS).   
Nursing Unit Rating Scale (NURS).  NURS measures the social environment in 
facilities which care for care for persons with dementia (Grant, 1994).  It assesses the 
environment through interviews with staff describing six dimensions of the social environment 
including separation, stability, stimulation, complexity, control/tolerance, and continuity (Grant, 
1996).  These items are measured on Likert scales and with estimated percent of residents with 
dementia who share accommodations with cognitively intact residents (Grant, 1996).  Higher 
scores for separation indicate less intermingling between those with and without dementia 
(Grant, 1996).  High scores in the stability subscale indicate consistent staff caregiver 
assignments (Grant, 1996).  High scores on the stimulation scale indicate more noise (Grant, 
1996).  Higher complexity scores indicate a lack of programs specifically designed for persons 
with dementia (Grant, 1996).  Higher scores in the control/tolerance scale indicate less tolerance 
of behavioral symptoms that are problematic to others (Grant, 1996).  Scores on the continuity 
scale were higher when personal information was used in developing activities and individual 
care plans (Grant, 1996).   
Internal consistency of each subscale was acceptable to high with Cronbach α of .70-.95 
(Grant, 1996).  Scores between scales were weakly correlated (r = .03-.37, p < .05; Grant, 1996).  
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Discriminate validity was demonstrated with significant differences between NURS scores on 
dementia and non-dementia focused units for all subscales except continuity (Grant, 1996). 
Zarit Burden Interview (ZBI).  The ZBI measures a caregiver’s feelings of burden on a 
personal level and in terms of role strain (Hérbert, Bravo,& Préville, 2000).  It has been revised 
from its original version to include 22 questions like “Overall, how burdened do you feel in 
caring for your relative?” that are each scored between 0 (never) and 4 (nearly always; Zarit, 
Reever & Bach-Peterson, 1980; Zarit, Orr, & Zarit, 1985).  Scores range between 0 and 88 with 
higher scores indicating greater burden.   
The ZBI demonstrated good reliability and validity.  Internal consistency is high with 
Cronbach α of .92 (Hérbert et al., 2000; Al-Rawashdeh, Lennie, & Chung, 2016).  Its convergent 
validity with the Oberst Caregiving Burden Scale was good (r = .47, .58, p < .01; Al-Rawashdeh 
et al., 2016; Oberst, 1990).      
Memory and Behavior Problem Checklist 1987R (MBPC).  The MBPC was developed 
by Zarit and Zarit (1983) to measure memory deficits and challenging behaviors in individuals 
with AD, as well as the responses of caregivers to these deficits.  It was revised to include 
separate subscales for ADL and Memory/Behaviors from the perspective of the person with AD 
as well as their caregiver’s responses to the different types of behaviors (Zarit, Todd, & Zarit, 
1986).  The scale consists of 24 items with scores for frequency (0 never occurred to 5 occurs 
daily or more often) and caregiver reaction (0 no bother to 4 extremely bothersome; Zarit et al., 
1986).  In the sample included in this study, an additional frequency rating point was included 
(Schutte et al., 2003).  Nine of the items correspond to ADL, while the remaining 15 items 
correspond to memory and behavior (Zarit, Todd, & Zarit, 1986). 
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The MBPC has high internal consistency (Cronbach α = .84; Schutte et al., 2003).  This 
scale has a documented interrater reliability of 0.80 as well as test-retest reliability of 0.80 
(Gerdner, Bckwalter, & Reed, 2002; Piccininni et al., 1998).  The convergent validity of the 
MBPC compared to other measures of cognition are low to moderate (r = .69 with the Mental 
Status Questionnaire and .49 with the Mini Mental State Exam), but the discrepancy may be 
partially attributed to the inclusion of behavioral problems measured in the MBPC which are not 
measured in other cognitive tests (Gerdner et al., 2002; Kahn, Goldfarb, Pollack, & Peck, 1960; 
Folstein, Folstein, & McHugh, 1975).      
Neuropsychiatric Inventory- Nursing Home (NPI-NH).  The NPI Nursing Home 
version was adapted from the original NPI to evaluate behavioral symptoms of AD (including 
delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, elation/euphoria, 
apathy/indifference, disinhibition, irritability/lability, aberrant motor behavior, sleep and 
nighttime behavior disorders, and appetite and eating disorders) for persons with AD living in 
nursing homes (Cummings et al., 1994; Wood et al., 2000).  Modifications include rephrasing of 
questions to be more applicable to the nursing home setting.  The NPI-NH includes an inventory 
of whether or not each symptom has been present in the past month, and the frequency for those 
that are present frequency (1 = Rarely to 4 = very often), severity (1 = mild distress to 3 = severe 
distress), and disruption (0 = not at all to 5 = extremely disruptive) are measured through 
caregiver or staff interview.  The NPI-NH measures caregiver distress in response to these 
symptoms with its occupational disruptiveness scale (Wood et al, 1999).  
Internal consistency of the NPI-NH has been measured with Cronbach α of .67 (Lange, 
Hopp, & Kang, 2004).  Test-retest reliability at the 72-hour interval was good for each of the 
symptoms measured (r = .55-.88; Iverson et al., 2002).  When compared with other assessments 
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of each item individually (for example, the CMAI for agitation and Cornell Depression scale for 
depression), the NPI-NH subscales had moderate convergent and discriminant validity for each 
individual symptoms (r = .26-.59; Lange et al., 2004).  
Ambiance Scale (AS).  The AS was developed to quantify the nature of the physical 
environment of long term care facilities on persons with dementia (Algase et al., 2007).  The AS 
was adapted from a previous environmental assessment that evaluated how home-like a facility 
appeared (Struble, 1995).  The adapted AS evaluates the environment on the basis of its likely 
soothing and engaging effects on persons with dementia (Algase et al., 2007).  An observer uses 
the AS to evaluate the environment on 13 criteria and score each between -2 and +2 resulting in 
total scores between -26 to 26 (Algase et al., 2007).  Examples of environmental criteria are 
stimulating or custodial and personalized or regimented (Algase et al., 2007).   
The AS has good psychometric properties.  Good reliability of the tool’s internal 
consistency is demonstrated in Cronbach α of 0.89-0.91; interrater reliability was also good with 
no significant differences between evaluators using the same tool (t = -0.537, df = 117, p > .05; 
Algaese et al., 2007).  Construct validity was demonstrated with significant correlations between 
measures of engaging and soothing subscales (r = .49-.62, p < .01; Algase et al., 2007).   
Therapeutic Environment Screening Survey (TESS). The TESS-NH was developed to 
assess the degree to which a facility’s physical environment is equipped to meet the therapeutic 
needs of persons with dementia (Sloane et al., 2002).  The TESS-NH was developed as a result 
of a NIA initiative to study special care units focused on dementia care, and was developed from 
previous versions (Sloan et al., 2002, Sloane & Mathew, 1990).  It measures exit control, 
maintenance, cleanliness, safety, orientation cuing, privacy, unit autonomy, outdoor access, 
lighting, noise, visual/tactile stimulation, space/seating, and familiarity or home-likeness with 84 
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items; higher scores represent favorable attributes of the environment (Sloan et al., 2002).  It is a 
survey rather than a scale; each domain is score individually so no absolute score range is 
available.   
The TESS-NH has good psychometric properties.  Cronbach α for each domain ranged 
between .33 and .83 with the lowest performance on the noise domain.  Interrater reliability was 
high with an average agreement of 86.7%, and correlation of responses between .33 and 1.0; test-
retest reliability was .88 (Sloan et al., 2002).  Concurrent validity with Professional 
Environmental Assessment Procedure was strong (r = .68, p < .01; Norris-Baker et al., 1999; 
Sloan et al., 2002).   
Antecedent Psychological Factors.  Psychological antecedent factors of study include 
mood, psychosis, and elevated behavioral symptoms.  Mood is conceptualized as the affect 
presentation of persons with AD, and specifically includes depression, anxiety and apathy 
measured by the Depression, Anxiety, and Apathy subscales of the NPI.  Psychological factors 
of psychosis describe beliefs of sensory experiences that are not consistent with reality measured 
by the Delusions and Hallucinations subscales of the NPI.  Other elevated behavioral symptoms 
are conceptualized as dysregulated actions or emotions, and are measured by the Elation, 
Disinhibition, Aberrant Motor Behavior, Sleep, and Irritability subscales of the NPI, the 
Noncognative Behavioral subscale of the AD Assessment Scale (ADAS), and the Inappropriate 
behavior subscale of the Functional Abilities Checklist (FAC). 
Alzheimer Disease Assessment Scale (ADAS).  The ADAS was designed as a test that 
could detect longitudinal changes in AD patients, and measures two aspects of AD: cognitive 
and non-cognitive (emotional and behavioral) symptoms (Rosen, Mohs, & Davidson, 1984).  
The maximum possible score is 115 points, and points are deducted throughout the interview as 
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errors occur (Rosen et al., 1984).  The cognitive subscale includes 70 of the total points, and 
measures memory, language, praxis, and commands (Rosen et al., 1984).  The remaining 45 
points measure behavior. 
Internal Consistency reliability was very high (Cronbach α = .97; Kørner, Lauritzen, & 
Bech, 1996).  Interrater reliability was high in initial testing (.65 - .99; p < .001; Rosen et al., 
1984).  ADAS was found to have very strong concurrent validity with other measures of 
Alzheimer Disease symptoms (GDS, Clinical, Global Impressions, Cambridge Cognition 
Examination, and MMSE; r = .89-.95, p < .001; Kørner et al., 1996).    
Functional Abilities Checklist (FAC). FAC was developed by the University of Iowa 
College of Nursing for Alzheimer’s Family Role studies.  The FAC consists of 28 items to 
measure four areas of functional ability including self-care, inappropriate behaviors, cognitive 
status, and agitation (Swanson, Maas, & Buchwalter, 1994).  These constructs are measured with 
questions about activities of daily living such as dressing, eating, grooming, as well as questions 
about behaviors such as resisting assistance for feeding, agitation at night, threatening others 
(Swanson et al., 1994).  Information is gathered by caregivers about behaviors from the past 
week, and each item is scored between 1 (never) and 4 (multiple times per day) with high scores 
indicating a high level of functional impairment (Swanson et al., 1994).  Because two of the 
items have a “not applicable” response, subscales are scored by averaging the given responses 
resulting in scores of 1-4 for each subscale.   
Internal consistency demonstrated moderate to high reliability (Cronbach α = .52-.89; 
Swanson et al., 1994).  Test retest reliability was good (r = .77; Swanson et al., 1994).  
Concurrent validity was demonstrated with a high correlation to the Geriatric Rating Scale which 
also measures functional abilities (r = .84; Swanson et al., 1994).   
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Antecedent Physiological Factors.  Physical antecedent factors include comorbidities, 
pain, nutritional status, hearing, cognitive impairment, and fatigue.  Comorbid physical 
conditions are measured by the Cumulative Illness Rating Scale-Geriatrics (CIRS-G).  Pain is 
measured by the Pain Assessment in Advanced Dementia (PAIN-AD).  Nutritional Status is 
measured by the Mini Nutritional Assessment-Short Form (MNA-SF) and NPI Appetite 
subscale.  Hearing loss is measured by the Hearing Handicap Inventory for Elderly Screening 
(HHIE-S), and by hearing data in the Long Term Care Minimum Data Set (MDS 3.0).  Cognitive 
Impairment is measured by the Mini Mental State Exam (MMSE), Severe Impairment Battery 
(SIB), the cognitive subscale of the ADAS, the memory behaviors frequency of the MBPC, and 
the cognitive status subscale of the FAC.   
Cumulative Illness Rating Scale-Geriatrics (CIRS-G).  The CIRS-G was developed 
from the original CIRS to reflect the health concerns that are important to Geriatric populations 
(Lin, Lin, & Gurel, 1968, Miller & Towers, 1991).  The assessment is administered by a health 
care provider who identifies which body systems have issues and rates the severity of each issue.  
Scores are calculated by the total number of health systems with illnesses, the severity rating for 
each illness from 0 (no problem) to 4 (extremely severe), the severity index (ratio of the total 
score to the number of systems with problems), and the number of categories with a rating of 3 
or 4 (Miller & Towers, 1991).   
Interrater reliability was good; correlations were found between .78-.85 for total score 
and .81-.83 for number of categories for outpatients and inpatients respectively (Miller et al., 
1992).   Convergent validity was measured against a physician’s rating of a patient’s overall 
health on a scale of 0-50 with moderate agreement (r = .48, p < .05; Miller et al., 1992).   
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Pain Assessment in Advance Dementia (PAIN-AD).  Pain-AD was developed as an 
observational scale to quantify severity of pain symptoms in persons with advanced dementia 
(Warden, Hurley, & Volicer, 2003).  Categories (including breathing, vocalizations, facial 
expression, body language, and consolability) are scored from 0 (normal) to 2 (severe symptoms 
such as noisy labored breathing, hyperventilation etc.); total scores range from 0 to 10 with 
higher scores indicating more severe pain (Warden et al., 2003).   
Internal consistency is very reliable (Cronbach α = .85; DeWaters et al., 2008).  Interrater 
reliability is also very high with a correlation of .98 when vignette videos were assessed 
(DeWaters et al., 2008). Concurrent validity was high when the PAINAD was measured against 
the 0-10 numeric rating scale in populations of cognitively intact and impaired patients (r = .735, 
.915, p <.001; DeWaters et al., 2008) Convergent validity was also tested by comparing PAIN-
AD scores with nurse and physician ratings of pain.  Pain ratings from health providers were 
significantly correlated with PAIN-AD scores, but with less agreement than self-reported 
measures (r = .44 - .69; Zwakhalen, 2012). 
Mini Nutritional Assessment-Short Form (MNA-SF).  The MNA-SF is a six-item 
assessment of nutritional status (Rubenstein, Harker, Salvà, Guigoz, & Vellas, 2001).  The 
MNA-SF is an abbreviated version of the original 18-item MNA (Guigoz, Jensen, Thomas, & 
Vellas, 2006; Rubenstein et al., 2001).  The six items include questions about intake of food, 
weight changes, mobility, stress or diseases, dementia or depression, and body mass index yield 
total scores of 0-14 points with lower scores indicating a greater risk for malnutrition 
(Rubenstein et al., 2001).    
Reliability of the MNA-SF internal consistency was good with Cronbach α = .65 
(Guigoz, et al., 2006).  Interrater reliability was good with a kappa = .78 for assessments of 
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institutionalized elderly (Guigoz, et al., 2006).  Convergent and Divergent validity were 
demonstrated by MNA-SF’s strong sensitivity of 97.9% and specificity of 100% to detect 
malnutrition compared to a clinical nutritional status assessment (Rubenstein et al., 2001). 
Hearing Handicap Inventory for Elderly Screening (HHIE-S). The HHIE-S was 
developed as an assessment to identify hearing loss in older adults (Ventry & Weinstein, 1982).  
The HHIE-S includes 25 items which correspond to emotional and social/situational subscales 
(Ventry & Weinstein, 1982).  An example of a social/situational example is “Does a hearing 
problem cause you to attend parties less often than you would like?” ((Ventry & Weinstein, 
1982, p. 129).  Each question is answered with a yes (4 points), sometimes (2 points), or never (0 
points) (Ventry & Weinstein, 1982).  Total scores range from 0-100, and higher scores indicate 
greater impairment (Ventry & Weinstein, 1982).  
Cronbach α of the HHIE-S was .95, .93. and .88 for the total score and emotional and 
social/situational subscales respectively (Ventry & Weinstein, 1982).  Using pure-tone 
audiometry to evaluate hearing loss in the better ear, the HHIE-S was found to have good 
convergent validity with a significant correlation (r = .61; Weinstein & Ventry 1983).  The 
assessment was found have good to great construct validity (53-72% sensitivity, 70-84% 
specificity), with some variation depending on the type and degree of hearing loss used as a cut 
point to define hearing loss (Lichtenstien,Bess, & Logan, 1988). 
Long Term Care Minimum Data Set (MDS 3.0). The MDS 3.0 is a standardized 
assessment of physical, clinical, psychological, psycho-social, and life care wishes of older 
adults who live in long term care facilities (Saliba & Buchanan, 2012).  All long-term care 
facilities that participate in Medicare or Medicaid programs are required to maintain these data 
for their residents (Saliba & Buchanan, 2012).  The goal of the wide collection of these data is to 
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report quality indicators, decide Medicare payments, and to assure appropriate care plans are 
developed (Morris et al., 2003).  It takes just over one hour to complete on average (Saliba & 
Buchanan, 2012).   
Development testing revealed that interrater reliability between research nurses and 
facility staff was good to excellent (.85-.90; Saliba & Buchanan, 2012).  Validity on the basis of 
agreement between with diagnoses from hospital claims compared to MDS data found a positive 
predictive value above .7 for major diagnoses (Mor, Intrator, Unruh, & Cai, 2010).  Because of 
the wide range of categories covered, the performance of each individual assessment must be 
assessed individually.  The greatest threat to the reliability and validity of the MDS is known as 
“paper compliance,” where documentation in the form is completed to appease quality indicator 
standards, but does not accurately reflect the clinical reality of higher rates of delirium, 
depression, pain, and low oral intake (Rahman & Applebaum, 2009). 
Mini Mental State Exam (MMSE).  The Mini Mental State Examination (MMSE; 
Folstein et al., 1975) was originally developed as a brief evaluation of the cognitive state of 
psychiatric patients including those with affective disorders, psychoses, and dementia syndromes 
excluding mood and abnormal though processes. Scores on the MMSE range from 0-30 with 
higher scores indicating better cognition (Folstein et al., 1975).  The MMSE contains two 
sections.  The first section assesses registration of three words, short-term memory used to recall 
the words, orientation to time and place, and attention to calculation through verbal responses 
(Folstein et al., 1975).  The second section assesses language through naming objects, the ability 
to follow verbal and written commands, and writing.  The second section also assesses visual 
spatial skills through the participant’s ability to copy a complex polygon shape (Folstein et al., 
1975).   
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Reliability of internal consistency has been demonstrated in a population of hospitalized 
individuals (Cronbach α = 0.96; Tombaugh & McIntyre, 1992).  Interrater reliability of the 
MMSE was demonstrated by Folstein et al., (1975) with a high correlation of scores obtained by 
two examiners in hospitalized and community-dwelling individuals (.83, p < .001).  The MMSE 
demonstrated test-retest reliability with no significant differences between scores obtained 24 
hours apart for acute psychiatric conditions, or 28 days apart for dementia syndromes (as 
measured by non-significant Wilcoxon T = 45, 42, p > 0.05), and high correlations between first 
and second test scores for both groups (r =.89, .98 p < .0001; Folstein et al., 1975).  Concurrent 
validity is demonstrated with the agreement between MMSE scores and the expert clinical 
diagnosis of cognitive difficulty (Mann-Whitney U 4, p < .001; Folstein et al., 1975).  The 
MMSE scores are similar to the Wechsler Adult Intelligence Scale (WAIS-I; Wechsler, 1955), 
with strong correlations demonstrated between MMSE and WAIS-I Verbal IQ and Performance 
IQ domains (r = .78, .66, p < .001; Folstein et al., 1975).   
Construct validity is supported by observations that MMSE scores improve when acute 
cognitive conditions are treated (including acute depression, metabolically induced delirium, and 
head trauma; Folstein et al., 1975), and with diminished scores reflecting cognitive decline over 
time in longitudinal studies of persons with AD (Tombaugh & McIntyre, 1992).  Construct 
validity of the MMSE is also supported by its high sensitivity to correctly identify those with 
cognitive impairment as well as it specificity to correctly identify those who are cognitively 
intact.  The MMSE’s specificity for dementia is usually moderate to high (66-100%), but MMSE 
may overestimate cognitive impairment in African Americans, individuals with lower than 8
th
 
grade educational attainment, and those with sensory impairment (Foreman, Fletcher, Mion, 
Simon, & Faculty, 1996; Leveille et al., 1998; Tombaugh & McIntyre, 1992).  The differential 
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performance of these groups on the MMSE threatens the validity of the MMSE as a tool to 
identify dementia.  However, the MMSE is a screening tool for cognitive impairment; it is not 
intended to provide a definitive diagnosis of AD and not valid for that purpose (Monroe & 
Carter, 2012). 
Severe Impairment Battery (SIB). SIB is designed to measure cognition in those with 
severe cognitive limitations such as advanced AD for whom other tests of cognition are 
impractical or result in a floor effect (Saxton, McGonigle-Gibson, Swihart, Miller, & Boller, 
1993).  The SIB includes 40 items yielding scores between 0-100 with low scores indicating 
impairment in cognition (Saxton et al., 1993).  The scale can be divided into nine subscales 
measuring social interaction, memory, orientation, language, attention, praxis, visuospatial 
ability, and construction through writing and verbal responses (Saxton et al., 1993).  For an 
example of items used to assess memory, participants are asked to recall a sentence and the name 
of the examiner (Saxton et al., 1993).   
Internal consistency of the SIB is very high (Cronbach α = .97; Ahn, Kim, Ku, Saxton, & 
Kim, 2006).  In its development testing, interrater reliability was very high with a perfect 
correlation of overall scores (r = 1.0), and good correlations between scores on each subscale (r 
= .87 – 1.0, p < .001; Saxton et al., 1993).  Test-retest reliability was also high at the 14 day 
retest interval (r = .85, p <.001; Saxton et al., 1993).  Concurrent validity was measured against 
the MMSE, and good correlations between scores on the two tools were found (r = .74, p < .001; 
Saxton et al., 1993).   
Symptom: Agitation.  The symptom of interest is Agitation.  Agitation is the primary 
outcome of interest in this study.  Agitation is measured by the Cohen-Mansfield Agitation 
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Inventor (CMAI), the agitation subscale of the FAC, and the agitation/aggression subscale of the 
NPI.     
Cohen-Mansfield Agitation Inventory (CMAI).  The CMAI was developed to quantify 
agitated behaviors in nursing home residents, and has also been used in community and acute-
care hospital settings (Cohen-Mansfield et al., 1989; Koss et al., 1997; Kupeli et al., 2017).  The 
CMAI a questionnaire composed of 29 agitated behaviors (Cohen-Mansfield et al., 1989).  
Examples of agitated behaviors include: “Pace, aimless wandering; inappropriate dress or 
disrobing; and screaming” (Cohen-Mansfield, 1991, p. 22).  Each behavior is given a frequency 
score on a seven-point rating scale (1 = never, 7 = several times per hour; Cohen-Mansfield, 
1991).  Behaviors are reported by caregivers, and scores pertain to activities occurring over the 
past two weeks (Cohen-Mansfield, 1991).  Later versions of the CMAI include a five-point 
disruptiveness scale, with a scores ranging between 1 (never) and five (extremely disruptive; 
Cohen-Mansfield, 1991).   
Total scores range from 29 to 203; however the use of subscales for the different factors 
of agitation is preferred (Cohen-Mansfield 1991).  Some versions of the CMAI include two 
additional ratings: a score of eight indicating that the behavior would have occurred if not 
prevented (for example, the individual would have been pacing, but could not due to being 
physically restrained), or a score of nine if the behavior is not applicable (such as an amputee 
being physically unable to kick; Cohen-Mansfield, 1991).  Originally, three factors of agitated 
behaviors were identified including physical aggression, verbal aggression, and nonaggressive 
behaviors (Cohen-Mansfield et al., 1989; Finkel, Lyons & Anderson, 1992).  Later studies 
identified four factors by separating nonaggressive behaviors into verbal and physical 
nonaggressive factors (Rabinowitz et al., 2005).  More recently, the scale was found to be 
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described by only two factors categorized as aggressive and nonaggressive behaviors (Kupeli et 
al, 2017).  Cohen-Mansfield (1991) recognizes that the factors contributing to agitated behavior 
differ based on population and circumstances, and suggests that researchers conduct their own 
factor analysis.  
Criteria for identifying agitated or not agitated status involves dividing the responses into 
factors (such as aggressive, physically nonaggressive behavior, and verbally nonaggressive 
behavior) and examining the frequency of behaviors.  For example, someone who demonstrated 
agitated and aggressive behavior with at least one aggressive behavior occurring at a frequency 
of several times a week, or at least two aggressive behaviors occurring at a frequency of once or 
twice a week, or at least three aggressive behaviors occurring at a frequency of less than once a 
week, or two aggressive behaviors occurring at a frequency of less than once a week but still 
occurring and one at a frequency of once or twice a week would be characterized as 
demonstrating an aggressively agitated status (Cohen-Mansfield 1991).  Alternatively, Cohen-
Mansfield (1991) suggests that behaviors could be weighted based on level of disruptiveness and 
combined accordingly.  While these methods are useful for categorizing agitation versus not 
agitation, total scores from each factor subscale are most commonly used in analysis of research 
data.   
The internal consistency reliability of the CMAI has generally been high.  For the scale 
overall and aggressive, physically-nonaggressive, verbally agitated, and hiding or hording 
behaviors, Cronbach α are all .62 to .91 (Finkel et al., 1992; Rabinowitz et al., 2005).  Due to the 
subjective nature of this rating, interrater reliability of the disruptiveness scale is indeterminate.  
Concurrent validity has been demonstrated by comparing the CMAI to the Behavioral 
Syndromes Scale for Dementia (BSSD; Devanand et al., 1992), the Behavioral Pathology in 
69 
 
Alzheimer’s Disease (Behave-AD; Reisberg et al., 1987), and the Ryden Aggression Scale’s 
physically aggressive behavior subscale (RAS-PABS; Ryden, 1988).  Moderate correlations 
were found between the CMAI and BSSD (.40-.52, p < .05) as well as the Behave-AD (.27-.43, 
p < .05), although correlations were nonsignificant on night shifts (Finkel et al., 1992).  The 
CMAI had moderate agreement with the RAS-PABS (Cohen’s κ = .544, p < .001), and the 
agreement increased substantially when only the physically aggressive behavior subscale of the 
CMAI was compared to the RAS-PABS (Cohen’s κ = .733, p < .001; Whall et al., 2013). 
In the development of the CMAI, Cohen-Mansfield and coworkers (1989) found high 
interrater reliability between three assessors in a population of nursing home residents.  
Discrepancies of one point or less was considered agreement on scores, and correlations 
averaged .88-.92 (Cohen-Mansfield et al., 1989).  Zuidema et al., (2010) reported interrater 
reliabilities of .61 to .73 on the three agitation subscales in a population of Dutch nursing home 
residents.  Conversely, Finkel and others (1992) found lower interrater reliability of only .41, 
with the lowest agreement of only .26 on the physically nonaggressive behaviors subscale in a 
population of institutionalized elderly adults.  In the community, interrater reliability (as 
measured by discrepancies of zero or one point) was high at .92 (Koss et al., 1997).       
Performance outcome:  Functional status and quality of life.  Functional Status and 
quality of life are secondary outcome variables.  Functional Status is conceptualized as the 
ability to engage in activities to care for oneself, and is measured by the self-care subscale of the 
FAC, Global Deterioration Scale (GDS), Functional Assessment Staging Tool (FAST), MBPC 
ADL subscale, and information about functional abilities status from the MDS 3.0.  Quality of 
Life conceptualized as the degree to which one can perform usual roles and find fulfillment in 
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life.  Quality of life is measured by the Quality of Life in AD (QOL-AD), AD Related Quality of 
Life (ADRQL), and the Health Survey 36 Short Form (SF-36).   
Global Deterioration Scale (GDS).  GDS is used to evaluate the stage of severity in AD 
symptoms from 1 (no cognitive decline) to 7 (very severe cognitive decline) through a 50-point 
assessment measuring memory, executive function, and social function (Reisburg, Ferris, de 
Leon, & Crook, 1982).  Each stage is described with associated clinical characteristics including 
functional status, behavioral and psychiatric problems (Reisberg et al., 1982).  It was designed to 
help caregivers or families understand the disease course of AD, and set realistic expectations for 
the performance abilities and care needs of individuals with AD (Reisberg et al., 1982).   
The authors state that they developed the GDS with a conceptual approach rather than 
through psychometric and statistical methods; therefore internal consistency was not measured 
(Eisdorfer et al., 1992).  Good interrater reliability has been found using the GDS (r = .82; 
Foster, Sclan, Welkowitz, Boksay, & Seeland; 1988).  Convergent validity was found between 
GDS stage and PET scans of brain regions affected by AD lesions which utilize less glucose (r = 
.69-.83, p < .05; Ferris et al., 1980).  
Functional Assessment Staging (FAST). The FAST is a functional assessment 
questionnaire for individuals with AD.  It was developed by Reisberg (1986) through an 
expansion of the functional components of the GDS to describe progressive functional changes 
in AD.  Like the GDS, the FAST corresponds to the seven stages of AD with decreased 
functional ability at higher levels (Reisberg, 1986).  The FAST further divides the late stages of 
AD with eleven sub-stages describing the functional considerations of GDS stage 6 and 7 in 
greater detail (for a total of 16 FAST levels; Reisberg, 1986).   
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Interrater reliability for the FAST was high (ICC 0.87, p < .01; Sclan & Reisberg, 1992).  
Concurrent validity between the FAST and ten other psychometric measures of AD were highly 
correlated (r = .59-.73; p < .01, Reisberg et al., 1984). Concurrent validity with the Ordinal 
Scales of Psychological Development (used as a measure of AD severity stage) was correlated 
with FAST (r = -.79, p < .01; Sclan & Reisberg, 1992). 
Quality of Life in AD (QOL-AD). QOL-AD was designed as a tool to measure quality of 
life specifically in persons with dementia (Logsdon, Gibbons, McCurry, & Teri, 1999).  It 
contains 13 questions covering physical health, mood, memory, social relationships, participation 
in meaningful activities, financial situation, overall assessment of self, and quality of life 
(Logsdon et al., 1999).  Each item is rated by the individual on a four-point Likert scale from 1 
(poor) to 4 (excellent; Logsdon et al., 1999).  Total scores range from 13 to 52 with higher scores 
indicating a higher quality of life (Logsdon et al., 1999).  This assessment includes one version 
for participants to self-report their QOL, and another version for caregivers to report each 
question as a proxy for the participant.  Composite scores are calculated by doubling the self-
reported score, adding in the proxy reported score, and then dividing by three (Logsdon et al., 
1999).    
The QOL-AD has good internal consistency Cronbach α for self-reported, proxy-
reported, and composite scales (.88, .87, .90, Geschke et al., 2013; Logsdon et al., 1999).  Test-
test reliability was acceptable for both patients and caregiver reports (ICC = .76, .92; Logsdon et 
al., 1999).  Divergent validity was noted with lower correlations to MMSE scores (r = .12, .02, p 
> .05 for patient and caregiver responses), and convergent validity was noted with significant 
correlations to other measures of each domain such as reports of engagement in activities, 
psychological status, and physical functions with higher correlations between caregiver reports 
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of these items (Logsdon, Gibbons, McCurry, & Teri, 2002).  Generally, self-rated scores are 
higher than proxies, but this phenomenon is addressed by the increased weighting of the self-
rated score in the calculation of composite score (Geschke et al., 2013; Huang et al., 2009; 
Logsdon et al., 2002; Logsdon et al., 1999). 
AD Related Quality of Life (ADRQL). ADRQL is another measure of Quality of Life for 
individuals with AD.  It was developed through focus groups with caregivers of individuals with 
AD and expert panels (Rabins, Kasper, Kleinman, Black, & Patrick, 1999).  It measures five 
domains (social interaction, awareness of self, feelings/mood, enjoyment of activities, and 
response to surroundings) through observations of actions and assessments of subjective states.  
Scores are calculated with quality of life indicators weighted by the importance of each domain 
(as ranked by caregiver input during tool development).  Responses are recorded from the 
caregiver of the person with AD as a proxy in a structured interview format.  Questions pertain to 
behaviors observed in the past 2 weeks; respondents are asked to agree or disagree if a statement 
describes the person with AD (for example “He/She smiles or laughs when around other people;” 
Rabins et al., 1999, p. 42).  The total score is obtained by determining the percent of affirmative 
points scored in each domain; higher scores indicate a higher quality of life.    
Cronbach α was .86 for the total scale; subscales ranged from .56 to .86 indicating 
acceptable to good reliability of internal consistency (Kasper, Black, Shore, & Rabins, 2009).  
Content validity is supported by the development of the scale through qualitative methods of data 
collection from patients, experts, and the literature (Rabins et al., 1999).    
Health Survey 36 short form (SF-36).  The SF-36 questionnaire measures health-related 
quality of life (Ware & Sherbourne, 1992).  It was designed to measure health status in the large 
Medical Outcomes Study (Ware & Sherbourne, 1992).  It can be divided into subscales 
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describing physical function, role limitations related to health problems, pain, social function, 
emotional well-being, role limitations related to emotional problems, energy/fatigue, and 
perceived general health (Ware & Sherbourne, 1992).  Scores from each domain are transformed 
to a range of 0 (poor health) to 100 (excellent health; McHorney, Ware, & Raczek, 1993). 
Internal consistency has been demonstrated with high Cronbach α (.81-.88; Steward, 
Hays, & Ware, 1988).  Convergent and discriminant validity tested well against comorbid 
disease burden and other measures of these factors (McHorney et al., 1993). In persons with 
dementia, Cronbach α was good for most subscales (.64-.92 on each subscale), but slightly lower 
for individuals whose MMSE scores were below 16 (.51-.90; Geschke, Fellgiebel, Laux, 
Schermuly, & Scheurich, 2013).  Concurrent validity with the QOL-AD has been demonstrated 
with significant correlations between self-rated scores and QOL-AD composite scores (r = .29-
.62; p < .05; Geschke et al., 2013). 
Other Participant Information:  In addition to the formal instruments, further 
individual information was collected including: demographic data (age, sex, racial/ethnic 
background, level of education, and type of career); age at time of AD diagnosis; years since 
initial diagnosis; type of residence (community or institutional dwelling).   
Data Analysis  
Data Management  
Original data were stored in an electronic database.  Data were managed and analyzed 
using the Statistical Package for the Social Sciences (SPSS) version 25.0.  Path analyses were 
calculated with the Analysis of a Moment Structures (AMOS) graphics module of SPSS.  First, 
data were converted into SPSS format.  Next, individual data files from specific instruments and 
studies were matched by participant identification numbers and added to a new SPSS file.  
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Duplicate observations and time points were removed, as well as variables that were not 
pertinent to the current study.   
Missing Data 
Missing data is present in most large datasets (Kline, 2011).  This study is no exception.  
As this secondary analysis pulled data from multiple sources of data, there were frequent 
occurrences of missing data.  Not all studies used the same instruments to measure data, and 
there were also isolated cases of item-level missing data.  Missing data assessed for pattern and 
frequency.  Variables measured in only a single study with fewer than 20 responses were 
removed.  Remaining variables were tested for significant differences between participants with 
missing data and those with measured data.  Little’s Test for Missing Completely at Random 
found significant patterns of missing data, indicating that imputation techniques are inappropriate 
for this sample (χ
2
 = 167.9, p < .001; Little, 1988).  Missing Value Analysis in SPSS was then 
used to identify the maximum subset of data with complete responses for main analyses.  Other 
variables were analyzed individually with missing cases removed list wise as secondary 
outcomes. 
Sample Summary Analysis 
All variables were individually summarized through descriptive statistics.  Central 
tendency (measured with mean, median, and/or mode) and dispersion (measured by standard 
deviation, range and/or interpercentile measures) were calculated to define the data within the 
sample.   
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Data Analysis for each Specific Aim 
Aim 1: Describe the phenomenon of agitated behavioral symptoms in persons with AD 
within the Theory of Unpleasant Symptoms. 
Hypothesis:  The Theory of Unpleasant Symptoms will adequately describe the antecedents and 
consequences of agitated behavioral symptoms in persons with AD.   
Aim 1 is evaluated by the degree to which the final path analysis model represents all theoretical 
constructs predicted in the TOUS.  First, an exploratory factor analysis is used to reduce the 
empirical measures into factors that represent each of the theoretical concepts suggested by the 
TOUS (Munro, 2005).  A large number of variables are present in the existing data set (8 
demographic measures and 40 instruments).  One of the greatest conceptual strengths held by the 
TOUS is its extremely broad scope in considering all possible antecedents and consequences 
relevant to an individual’s experience of symptoms (Lee, Vincent, and Finnegan, 2017).  From 
the pragmatic perspective of theory testing however, it is not feasible to include variables that 
fully capture each possible dimension of the concepts described in the TOUS into a single 
testable model.  To reconcile this challenge, the data were reduced and summarized through an 
exploratory factor analysis.   
Next, the relationships between theoretical constructs were tested with path analysis.  
Variables that describe each of the three main concepts within the TOUS (antecedents, 
symptoms, and performance outcomes) are analyzed through exploratory factor analysis.  The 
resultant factors then take the place of measured data within the path model as proxy variables 
for the indicators which they represent.  The path analysis is used to test the main relationships in 
TOUS and determine the degree to which the composition of model matches the variables 
described in TOUS.  
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Path analysis calculates regressions between each factor, and examines direct effects of 
independent (exogenous) variables on dependent (endogenous) variables as well as indirect 
mediator effects of independent variables (Munro, 2005).  Path analyses provide evidence about 
whether or not the hypothesized model fits the observed data (Munro, 2005).  The hypothesized 




Aim 2: Determine the effect of situational (physical and social environment), 
psychological (anxiety and depression), and physiological factors (comorbidities, pain, 
nutritional status, hearing, cognitive impairment, and fatigue) on agitation in persons 
with AD. 
Hypothesis:   
(1) Supportive and stimulating physical and social environments will have a negative direct 
effect on agitation. 
(2) Comorbid psychological states will have a positive direct effect on agitation. 
Figure 3.  Proposed path model of predictors and outcomes of agitation.   
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(3) Comorbid physical conditions, pain, inadequate nutritional status, hearing loss, cognitive 
impairment, and fatigue will have a direct positive effect on agitation. 
Aim 2 was tested with the examining the regression coefficients in the path analysis model 
best fitting the data.  The magnitude, direction, and significance of the path coefficients from 
situational, psychological, and physical factors to agitation were evaluated.  Bivariate 
relationships (Pearson’s correlation) between individual measures and the agitation outcome 
were also used to test these hypotheses.   
Aim 3:  Determine the effect of situational, psychological, physical antecedent factors 
and agitation on performance outcomes (functional status and quality of life) in 
persons with AD. 
Hypothesis:   
(1) Supportive and stimulating physical and social environments will have an indirect 
positive effect on functional status and quality of life through reduced agitation. 
(2) Comorbid psychological states will have an indirect negative effect on functional status 
and quality of life through increased agitation. 
(3) Comorbid physical conditions, pain, nutritional status, hearing loss, cognitive 
impairment, and fatigue will have an indirect negative effect on functional status through 
increased agitation. 
(4) Agitation will have a negative direct effect on functional status and quality of life.   
Aim 3 was tested by examining the regression coefficients in the path analysis model best 
fitting the data.  The magnitude, direction, and significance of the path coefficients from 
situational, psychological, and physical factors to functional ability were evaluated.  The paths 
from agitation to functional ability were also examined.  Bivariate relationships (Pearson’s 
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correlations) between individual measures and the functional performance outcome are also used 




CHAPTER 4: RESULTS 
 The results chapter is divided into five sections.  This chapter begins with a description of 
the study sample.  In this descriptive statistics section, demographic data and descriptive 
information for all study instruments is summarized.  In the second section, preliminary analyses 
of correlations between instruments measuring each study variable are presented.  The final three 
sections report results of analyses for each of the three specific aims.  The first aim is evaluated 
by first performing an exploratory factor analysis.  Next the path analysis results relating the 
factors are presented.  The second aim is tested by evaluating relationships between the 
independent variables and outcome of agitation with an examination of path coefficients.  The 
third aim is tested by evaluating relationships between the independent variables and the 
performance outcomes.  The final 2 sections concerning aims 2 and 3 conclude with results of 
bivariate Pearson’s correlation analyses to explore relationships between key variables that were 
not captured in the path analysis.    
Description of Sample and Key Variables 
Study Sample Characteristics 
 Data from a sample of 110 individuals with AD were analyzed in this study.  A summary 
of demographic data is presented in Table 2.  Most participants were female (72.9%, n = 72).  
Nearly all of the participants identified as white (96.3%, n = 103).  Participants had most 
commonly had attained a high school diploma (27.2%, n = 22), with more reporting higher 
educational attainment than lower (45.7%, n = 37 above high school diploma).  Participants most 
commonly reported blue-collar work experience (22.4%, n = 19).  Ages of participants ranged 
from 59 to 101 years with a mean of 83.3 years (SD = 8.3).  The time since AD diagnosis ranged 
from 0 to 23.7 years with a mean of 9.2 years (SD = 5.2).   
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Table 2. Demographic Characteristics of the Sample 
Sample Demographics n Percentage 
Gender 107  
     Male 29 27.1 
     Female 
 
78 72.9 
Ethnicity 107  
     White 103 96.3 
     African American 1 0.9 
     Hispanic 1 0.9 
     Native American 1 0.9 
     Other 
 
1 0.9 
Level of Education 81  
     Attended grade school 2 2.5 
     Completed 8
th
 grade 13 16.0 
     Attended high school 7 8.6 
     High school diploma 22 27.2 
     Attended college 16 19.8 
     Associate degree 9 11.2 
     Bachelor’s degree 6 7.4 
     Postgraduate courses 2 2.5 
     Master’s degree 3 3.7 
     Ph.D. 
 
1 1.2 
Occupation 85  
     Professional 12 14.1 
     White-collar 13 15.3 
     Blue-collar 19 22.4 
     Farmer 6 7.1 
     Homemaker 17 20.0 
     Other 17 20.0 
     None 
 
1 1.2 
Residence 110  
     Community dwelling 27 24.5 
     Institutional care residence 83 75.5 
   
Sample Continuous Demographics Mean ± SD Range 
Age in years 83.3 ± 8.3 59.0 – 101.6 





Descriptive Results for Key Variables  
 All instruments used to collect data were examined for central tendency and dispersion of 
scores with means, standard deviation, and range of reported scores.  The possible range of 
scores is also reported.  The sample size of each instrument is also reported.  Results are 
summarized in Table 3.  Data for some measures were not available (Nursing Unit Rating Scale, 
Ambiance Scale, Therapeutic Environment Screening Survey, and Long Term Care Minimum 
Data Set 3.0).  Results are discussed by study variable below.   
Instruments measuring situation.  Four instruments measured data about situation related 
to caregiver reactions.  All scales were scored with higher scores indicating more caregiver 
burden.  The ZBI had only five respondents, the two MBPC subscales had 28 respondents each, 
and the NPI Occupational disruption scale had 48 responses.  All scales indicated low to 
moderate levels of caregiver burden with maximum scores of less than 61% of possible points.  
Mean scores all fell between 10% (MBPC ADL Caregiver Reaction subscale) and 28% (MBPC 
Memory and Behavioral Caregiver Reaction subscale) of the maximum possible points.   
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Table 3. Descriptive Results by Instrument 






Situational Antecedents      
     Zarit Burden Interview score  5 0-88 5-38 18.20 12.19 
     MBPC Memory and behavior  
          caregiver subscale  
28 0-96 4-58 26.54 14.63 
     MBPC ADL Caregiver reaction  
          subscale  
28 0-36 0-12 3.64 3.63 
     NPI Occupational disruptiveness  
         subscale 
48 0-60 0-24 6.42 6.54 
Psychological Antecedents      
     NPI Depression subscale 48 0-12 0-8 0.94 1.83 
     NPI Anxiety subscale 48 0-12 0-12 0.73 2.56 
     NPI Apathy subscale 48 0-12 0-12 5.35 4.97 
     NPI Delusions subscale 48 0-12 0-12 1.08 2.60 
     NPI Hallucinations subscale 48 0-12 0-12 0.56 1.99 
     NPI Elation subscale 48 0-12 0-4 0.23 0.91 
     NPI Disinhibition subscale 48 0-12 0-9 0.58 1.90 
     NPI Motor subscale 48 0-12 0-12 2.21 3.97 
     NPI Sleep subscale 48 0-12 0-12 0.40 1.85 
     NPI Irritability subscale 48 0-12 0-12 3.10 3.78 
     ADAS Non-cognitive behavioral  
          subscale 
52 0-45 0-28 6.31 5.52 
     FAC Inappropriate behavior subscale  81 1-4 1-4 2.92 0.90 
Physical Antecedents      
     Cumulative Illness Rating Scale-  
          Geriatrics 
18 0-56 3-31 18.56 6.91 
     Pain Assessment in Advanced  
          Dementia 
18 0-10 0-7 0.89 1.64 
     Mini Nutritional Assessment 18 0-14 4-13 7.78 2.46 
     NPI Appetite subscale 48 0-12 0-12 1.94 4.10 
     HHIE-S 5 0-100 6-22 13.60 5.90 
     Mini Mental State Exam  5 0-30 14-30 22.80 6.30 
     Severe Impairment Battery  72 0-100 0-100 51.45 36.68 
     ADAS Cognitive subscale 15 0-70 10-48 33.27 13.23 
     MBPC Memory Behaviors Subscale 31 0-120 19-111 56.03 25.15 
     FAC Cognitive Status subscale  82 1-4 1.00-3.80 1.75 0.83 










Agitation      
     Cohen-Mansfield Agitation Inventory  66 29-203 29-86 43.27 12.65 
     FAC Agitation subscale  83 1-4 1.00-4.00 1.88 0.77 
     NPI Agitation subscale 48 0-12 0-12 3.56 4.18 
Functional Performance       
     FAC Self-care subscale  83 1-4 1.13-4.00 3.01 0.64 
     GDS/FAST 91 1-11 3-9 5.56 1.27 
     MBPC ADL subscale 31 0-45 0-21 8.65 5.93 
     ADRQL 5 0-100 83.6-100 95.36 6.84 
     QOL-AD 5 13-52 36-43 39.40 2.61 
     SF-36 5 0-100 84-100 92.60 6.12 
NOTE: Memory and Behavior Problem Checklist-1987 (MBPC); Neuropsychiatric Inventory 
(NPI); Activities of Daily Living (ADL); Alzheimer Disease (AD); Alzheimer Disease 
Assessment Scale (ADAS); Functional Abilities Checklist (FAC), Hearing Handicap Inventory 
for Elderly Screening (HHIE-S); Global Deterioration Scale (GDS); Functional Assessment 
Staging Tool (FAST); Alzheimer Disease Related Quality of Life (ADRQL); Quality of Life in 
Alzheimer Disease (QOL-AD); Health Survey 36 Short Form (SF-36)
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Instruments measuring psychological states.  Twelve scales measured psychological states 
and behaviors.  All scales were scored with higher scores indicating more symptoms or 
behavioral difficulties.  Ten subscales of the NPI (depression, anxiety, apathy, delusions 
hallucinations, elation, disinhibition, aberrant motor behaviors, sleep, and irritability) each had 
48 responses.  The ADAS non-cognitive behavioral subscale included responses from 52 
individuals, and the FAC inappropriate behavior subscale included responses from 81 
individuals.   
Overall, a variety of responses were observed on most of the subscales, with the exception of 
the elation, depression, and disinhibition subscales with highest recorded responses of only 4, 8, 
and 9 out of 12 possible points.  Apathy was the NPI subscale with the highest average score (M 
= 5.35, SD = 4.97), whereas elation was reported the least (M = 0.23, SD = 0.91).  ADAS non-
cognitive behavioral subscale responses fell to the lower end of the possible range, with a 
maximum reported score of 28 out of 45 possible points, and a mean score of 6.31 (SD = 5.52).  
FAC inappropriate behavior scores represented the entire possible range of responses, with a 
mean score of 2.92 out of 4 (SD = 0.90).      
Instruments measuring physical comorbidities.  Ten instruments measured several 
dimensions of physical factors including: CIRS-G quantifying comorbid disease burden; Pain in 
AD; nutrition and eating behaviors measured by the MNA and NPI appetite subscale; Hearing 
measured by the HHIE-S; Cognition measured by the MMSE, SIB, ADAS Cognitive subscale, 
MBPC memory-behaviors subscale, and FAC cognitive status subscale.  Scales were interpreted 
with higher scores indicating greater impairment, except for the MNA, MMSE, and SIB in which 
lower scores indicated more impairment.   
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The largest samples were obtained with the FAC cognitive subscale and SIB (n = 82 and 72 
respectively). The NPI appetite and MBPC memory behaviors subscales had samples of 48 and 
31 participants respectively.  Samples of 15 to 18 responses were returned in the CIRS-G, Pain in 
AD, MNA, and ADAS Cognitive Subscale.  Small samples (n = 5) were returned for the HHIE-S 
and MMSE.  Most samples included scores representing the full spectrum of possible responses.  
The least variety of responses was observed with the HHIE-S (observed scores ranged from 6-
22; possible scores ranged from 0-100), the CIRS-G (observed scores ranged from 3-31; possible 
scores ranged from 0-56) and the MMSE (observed scores ranged from 14-30; possible scores 
ranged from 0-30).  All of the scores with limited ranges of reported scores also had few 
responses.   
The greatest levels of impairment were compared across scales with the percent of possible 
points (or inverse in the case of MNA, MMSE, and SIB).  Overall, participants had moderate 
levels of cognitive impairment on average as measured by the SIB and ADAS cognitive 
subscales.  The highest average levels of impairment were recorded by the SIB (M = 51.45, SD = 
36.68; lower scores indicate greater impairment), ADAS cognitive subscale (M = 33.27, SD = 
13.23), MBPC memory behaviors subscale (M = 56.03, SD = 25.15), and the MNA (M = 7.78, 
SD = 2.46; lower scores indicate greater risk for malnutrition).  The lowest average level of 
impairment was measured by the Pain-AD with mean response of 0.89 (SD = 1.64).   
Instruments measuring agitation.  The three instruments measuring agitation were the 
CMAI, FAC agitation subscale, and NPI agitation subscale.  Sample sizes were 66, 83, and 48 
respectively.  All three instruments were scored with higher values indicating more agitated 
behavioral symptoms.  The NPI agitation and FAC agitation scales returned responses from the 
entire range of possible scores; the CMAI returned a maximum of only 86 out of 203 possible 
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points.  On average, the scales indicated low to moderate levels of agitation.  The CMAI had the 
lowest mean score compared to total possible points (M = 43.27; SD = 12.65) and the FAC 
agitation subscale had the highest mean score compared to total possible points (M = 1.88, SD = 
0.77).    
Instruments measuring functional performance.  Seven instruments measured the 
functional ability and quality of life dimensions of functional performance.  Functional ability 
was measured by the FAC self-care subscale, GDS/FAST, and the MBPC ADL subscale.  
Higher scores indicated greater functional impairment.  Measures of functional ability had 91, 
83, and 31 responses for the GDS/FAST, FAC self-care, and MBPC ADL subscales.  Quality of 
life was measured by the ADRQL, QOLAD, and HS-36.  High scores indicated higher quality of 
life.  Quality of life measures each had 5 responses.   
The measures of functional ability had good representation of the full range of possible 
scores.  The mean scores of the FAC self-care subscale and GDS/FAST were high (M = 3.01, 
8.65; SD = 0.64, 1.27), indicating a high degree of difficulty with functional ability.  The mean 
score of the MBPC ADL subscale was lower (M = 8.65, SD = 5.9), indicating less difficulty with 
functional ability measured by this instrument and within this community-dwelling subset of the 
sample.  The measures of quality of life all measured relatively high quality of life, with a 
highest percent of possible points obtained on the ADRQL (M = 95.36, SD = 6.84).   
Preliminary Statistical Analysis 
Correlations Between Measures of Concepts 
Situational factors.  Correlations between measures of situation were calculated.  For the 
concept of situational factors, correlations between caregiver measures were only available for 
the two subscales of the MBPC because different tools were used in each different parent study 
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sample.  Moderate Pearson’s correlations were found between the MBPC memory behavior and 
MBPC ADL caregiver reaction subscales (r = .59, p < .001).   
Psychological states.  Correlations between measures of psychological states and 
behaviors are presented in Table 4.  Low correlations were found between depression and 
anxiety (r = .31, p = .034), delusions (r = .36, p = .012), and disinhibition (r = .35, p = .014), 
with a low inverse correlation to the FAC inappropriate behavior (r = -.39, p = .007).  Low to 
moderate correlations were also found between anxiety and delusions (r = .49, p < .001), 
disinhibition (r = .45, p = .001), aberrant motor behavior (r = .39, p = .006), and irritability (r = 
.35, p = .016).  A low inverse correlation was found between apathy and disinhibition (r = -.34, p 
= .019). Delusions were moderately correlated with hallucinations (r = .51, p < .001), 
disinhibition (r = .47, p = .001), aberrant motor behavior (r = .42, p = .003), and irritability (r = 
.38, p = .007).  Low correlations were observed between hallucinations and aberrant motor 
behavior (r = .45, p = .001) and irritability (r = .37, p = .009).  Elation was correlated with no 
other psychological instruments.  Disinhibition was moderately correlated with aberrant motor 
behavior (r = .47, p = .001), and ADAS non cognitive behavior (r = .51, p = .004).  Aberrant 
motor behavior was weakly correlated with irritability (r = .39, p = .007).  Sleep disturbances 
were not significantly correlated with other factors.   
 Physical factors.  Correlations between physical factors are presented in Table 5.  A very 
strong inverse correlation was seen between the CIRS-G and MMSE scores (r = -.96, p = .011).  
A moderately strong correlation was seen between MNA and SIB (r = .62, p < .006).  SIB scores 
had a low inverse correlation with FAC cognition scores (r = -.30, p = .015).  The ADAS 
cognitive scale was strongly correlated with the FAC cognition scores (r = .88, p < .001).  The 
MBPC memory scale was moderately correlated with FAC cognition scores (r = .65, p = .030).  
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The NPI appetite subscale, HHEI-S, and Pain Scores were not correlated with other measures.  
Comparisons were not possible between ADAS cognitive subscale, MBPC memory behaviors 
subscale, and HHIE-S and other scales because of small sample sizes of these tools.   
 Agitation.  Correlations between measures of agitation are presented in Table 6.  
Significant low correlations were found between the CMAI and FAC agitation subscale (r = .39, 
p = .002).  Correlations between CMAI and NPI agitation subscale or FAC and NPI agitation 
subscales were not significant.   
 Performance outcomes.  Correlations between measures of quality of life and functional 
ability performance outcomes are presented in Table 7.  Significant low correlations were found 
between the FAC self-care and GDS/FAST scores (r = .43, p < .001).  Scores for GDS/FAST 
had low correlations with MBPC ADL (r = .40, p = .025), and strong inverse correlations to 
ADRQL (r = -.96, p = .010).  Scores of instruments measuring quality of life were not correlated 
with each other, although sample sizes were small.  Correlations between measures of quality of 
life and the FAC self-care subscale or MBPC ADL subscale could not be calculated because 
these tools were not used in the same studies.   
 






Table 4. Pearson Correlations: Psychological Measures R
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NOTE: Neuropsychiatric Inventory (NPI); Depression (Depress); Hallucinations (HLNs); 
Alzheimer Disease Assessment Scale (ADAS); Non-cognitive (non cog); Functional Abilities 
Checklist (FAC), Inappropriate Behavior (inapp. behav.) 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Table 5. Pearson Correlations: Physiological Measures. 
Results:  
r  
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   1 .a .a .029 
 
.a .a -.075 
 




.a .a .a 
MMSE      1 .783 
 
.a .a .a 











        1 .651* 
 
NOTE: Cumulative Illness Rating Scale–Geriatrics (CIRS-G); Mini Nutritional Assessment 
(MNA); Severe Impairment Battery (SIB); Memory and Behavior Problem Checklist-1987 
(MBPC); Alzheimer Disease (AD); Alzheimer Disease Assessment Scale (ADAS); 
Functional Abilities Checklist (FAC), Hearing Handicap Inventory for Elderly Screening 
(HHIE-S).  
* Correlation is significant at the 0.05 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed). 
.a = No comparative sample was available. 
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Table 6. Pearson Correlations: Agitation Measures. 
Results: r  



















  1 
NOTE: Functional Abilities Checklist (FAC); Neuropsychiatric Inventory (NPI).   
** Correlation is significant at the 0.01 level (2-tailed). 
 
 
Table 7. Pearson Correlations: Performance Outcome Measures. 
Results: r  
    
FAC 
Self-care  
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QOLAD     1 -.674 
 
NOTE: Functional Abilities Checklist (FAC); Global Deterioration Scale (GDS); Functional 
Assessment Staging Tool (FAST); Memory and Behavior Problem Checklist-1987 (MBPC); 
Activities of Daily Living (ADL); AD related quality of life (ADRQL); Quality of life in AD 
(QOL-AD); Health Survey Short Form (SF-36)  
** Correlation is significant at the 0.01 level (2-tailed).      
* Correlation is significant at the 0.05 level (2-tailed).      








Aim 1: Results of Statistical Analysis 
Aim 1: Describe the phenomenon of agitated behavioral symptoms in persons with AD within 
the Theory of Unpleasant Symptoms. 
Hypothesis:  The Theory of Unpleasant Symptoms will adequately describe the antecedents and 
consequences of agitated behavioral symptoms in persons with AD as determined by the best-
fitting path analysis.    
The first aim sought to describe the phenomenon of agitated behavioral symptoms in 
person with AD within the Theory of Unpleasant Symptoms (TOUS) by constructing a path 
model based on the theory, and then determining if the model that best fits the data contains all 
important concepts described in the theory.  To test the hypothesis that the TOUS adequately 
describes all aspects of agitated behavioral symptoms, instruments that best describe the 
theoretical concepts were first identified through exploratory factor analysis.  Then, a path 
analysis of these factors was calculated to identify the model that best fits the data.   
Exploratory Factor Analysis 
Antecedent Factors.  The TOUS indicates that predictors of symptoms fall into three 
categories:  situational, psychological, and physiological predictors.  Exploratory Factor Analysis 
was used to determine which of the instruments measured related concepts.  The Missing Values 
Analysis identified the instruments which had been used most consistently to provide a complete 
sample of 48 participants.  The NPI subscales, FAC subscales, and SIB were included in the 
analysis.  Because the SIB instrument is scored with higher values indicating less impairment, 
scores were recoded to inverse scoring to match the scoring scheme for other instruments and aid 
in ease of comparison.  MBPC subscales, ADAS subscales, ZBI, CIRS-G, Pain Assessment in 
AD, MNA, HHEI-S, and MMSE were not included in this analysis.   
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The remaining data were suitable for Exploratory Factor.  The sample of 48 participants 
measured across all 15 instruments is sufficient for the minimum of two observations per 
variable, and approaching the preferred ratio of 5-6 observations per variable after further 
variables were removed from the analysis pool later in the process (Kim & Mueller, 1978; 
Tabachnick & Fidell, 2013).  As demonstrated in the correlation matrix previously presented in 
Tables 4 and 5, numerous variables had correlations above .30 to further support the use of 
exploratory factor analysis for these data.  The Kaiser-Meyer-Olkin Measure of Sampling 
Adequacy was above the recommended value of .50 at .632 (Kaiser, 1974).  Finally, statistical 
significance found in Bartlett’s Test of Sphericity indicates that the correlation matrix provided 
by the data is appropriate for factor analysis (Munro, 2005; χ2 = 240.6, p < .001). 
The first iteration of the factor analysis revealed that the NPI elation measure did not load 
strongly on any factors.  This matches findings from the correlation Table 4, and NPI elation was 
removed from further analysis.  On the next analysis, NPI sleep and apathy subscales were not 
loaded strongly on any factors with eigenvalues above 1, and these were also eliminated from 
further analysis.   
Principal components method of extraction was used to identify factors from SIB scores, 
FAC inappropriate behavior and cognitive status subscales, and NPI occupational disruption, 
depression, anxiety, delusions, hallucinations, disinhibition, aberrant motor behavior, and 
irritability subscales.  The percentage of the variance in each variable which is explained by all 
extracted factors, or extracted communalities of each factor, is illustrated in Table 8.  
The Scree Plot was examine to determine the number of factors that best describe the data 
(see figure 4).  The scree plot illustrates a marked change in slope after component number 3.  
This “elbow” point in the graph illustrates that three factors should be extracted, as further 
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factors explain less and less additional variance.  The three factor solution is further supported by 
the criteria of extracting only factors with eigenvalues greater than 1, as well as matching the 
three factors suggested by the TOUS. 
Table 8. Communalities between predictor variables 
Instrument Initial Extraction 
NPI Occupational disruptiveness  1.000 0.809 
NPI Depression subscale 1.000 0.564 
NPI Anxiety subscale 1.000 0.695 
NPI Delusions subscale 1.000 0.646 
NPI Hallucinations subscale 1.000 0.885 
NPI Disinhibition subscale 1.000 0.670 
FAC Inappropriate behavior  1.000 0.795 
FAC Cognitive Status subscale 1.000 0.432 
SIB (Inverse) 1.000 0.671 
NPI Aberrant Motor Behavior  1.000 0.549 
NPI Irritability subscale 1.000 0.539 
 
NOTE: Neuropsychiatric Inventory (NPI), Functional Abilities Checklist (FAC), Severe 
Impairment Battery (SIB). 
 
 
















Scree Plot: Predictor factors 
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Table 9. Total Variance Explained: Predictor Variables 
      Initial Eigenvalues    _ 
Extraction Sums of 
Squared Loadings 





























































1 3.844 34.946 34.946 3.84 34.946 34.946 2.683 24.388 24.388 
2 2.215 20.134 55.08 2.22 20.134 55.08 2.469 22.447 46.835 
3 1.197 10.877 65.958 1.2 10.877 65.958 2.104 19.123 65.958 
4 0.903 8.205 74.163 
      
5 0.897 8.156 82.318 
      
6 0.603 5.484 87.802 
      
7 0.529 4.813 92.616 
      
8 0.305 2.776 95.392 
      
9 0.236 2.147 97.54 
      
10 0.14 1.27 98.81 
      
11 0.131 1.19 100 
      
NOTE: Extraction Method: Principal Component Analysis. 
 
The eigenvalues and percent of explained variance for all possible factors is illustrated in 
Table 9.  Only the first three factors (components) demonstrated eigenvalues greater than 1.  
Together, these three factors explained 65.96% of the total variance.  Only rotational calculations 
for these three factors were calculated.   
Because the factor scores will be used in other analyses, it was important to use orthogonal 
rotation methods to assure that the resulting factor scores are not correlated with other factors; 
thus avoiding problems with multicollinearity assumptions in multivariate statistical procedures.  
Varimax rotation was calculated to simplify interpretation of the factors.  As shown in Table 9, 
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the rotation procedure does not change the percent of explained variance; it only affects the 
distribution of the variance on each factor.   
Next, the rotated component matrix was examined to evaluate and name the extracted factors 
(Table 10).  Factor loadings represent the correlation between scores of individual measures and 
each of the factors.  The first factor was named “Situation-Caregiver” because it represented the 
largest loading for the NPI Occupational disruptiveness subscale. It also contained high loadings 
of the FAC cognitive status, and NPI delusions, hallucinations, motor behavior, and irritability 
subscales.  The second factor was named “Psychological” and contained high loadings for NPI 
depression, anxiety, delusions, disinhibition, motor behavior, irritability, and occupational 
disruptiveness subscales.  The third factor was named “Physical-Cognitive” and contained high 
loadings for the inverse SIB scores, FAC cognitive status and inappropriate behavior subscales, 
and NPI depression subscale.  Because several variables were significantly loaded onto more 
than one factor, a simple structural solution was not achieved.   
Table 10. Rotated Component Matrix: Predictor Variables 
            Component            - 
Variable 1 2 3 
NPI Occupational disruptiveness  0.652 0.614  
NPI Depression   0.370 -0.598 
NPI Anxiety   0.820  
NPI Delusions  0.667 0.444  
NPI Hallucinations  0.901   
NPI Disinhibition   0.805  
FAC Inappropriate behavior    0.887 
NPI Motor Behavior  0.570 0.455  
NPI Irritability  0.665 0.304  
FAC Cognitive Status  0.358  0.520 
SIB (Inverse) 
 
  0.801 
NOTE:  Neuropsychiatric Inventory (NPI); Functional Assessment Checklist (FAC); Severe 
Impairment Battery (SIB).  Extraction Method: Principal Component Analysis; Rotation 
Method: Varimax with Kaiser Normalization. 
Small factor loadings >0.3 are suppressed. 
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The magnitude of the rotation applied to the original factors to obtain the rotated factor 
solution was surveyed in the Component Transformation Matrix. By examining the scores 
outside of the center diagonal (scores 1, 1; 2, 2; 3, 3) it was determined that the rotation for 
components one and two were large with all rotations above 0.5.  Component 3 was calculated 
with a small rotation because all transformations in column 3 were below 0.5. 
Agitation.  Agitation was measured by the CMAI, FAC agitation subscale, and NPI agitation 
subscale.  There were 48 complete cases available for analysis.  The KMO Measure of sampling 
adequacy was at the low, but acceptable (KMO = .59).  Bartlett’s Test of Sphericity was 
significant only at the .05 level (χ2 = 10.146, p = .017), indicating that the data may not be 
perfectly suited for exploratory factor analysis, but still acceptable.  There was also a moderate 
correlation between FAC agitation and CMAI scores (Table 6: r = .39, p < .01), further 
supporting the application of exploratory factor analysis. 
The communalities of extracted variance shown in Table 11 indicate that the NPI agitation 
subscale had the least variance explained by the factor analysis (37.6%).  The FAC agitation 
subscale and CMAI had similar percentages of variance explained by the extracted factor.   Table 
12 illustrates that only one factor was extracted.  This factor explained only 51.69% of the total 
variance of all three measures.  Factor rotation was not possible as only one factor was 
calculated. 
Table 11. Communalities between Agitation Measures 
 
 Initial Extraction 
FAC Agitation subscale 1.000 .578 




NOTE: Functional Abilities Checklist (FAC); Neuropsychiatric Inventory (NPI); Cohen-
Mansfield Agitation Inventory (CMAI). 
Extraction Method: Principal Component Analysis. 
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Table 12. Total Variance Explained: Agitation Factor 
           Initial Eigenvalues         _ Extraction Sums of Squared Loadings 








1 1.551 51.694 51.694 1.551 51.694 51.694 
2 0.824 27.477 79.171    
3 0.625 20.829 100.000    
NOTE:  Extraction Method: Principal Component Analysis. 
 
The factor loading of each of the three agitation measures on the single extracted factor is 
shown in Table 13.  The correlation of the NPI agitation subscale and the extracted factor was 
.61.  The FAC agitation subscale and CMAI each had higher factor loadings, indicating a higher 
correlation between these measures and the factor score.   
Table 13. Agitation Component Matrix 
 Component 1 
FAC Agitation subscale 0.761 




NOTE:  Functional Abilities Checklist (FAC); Neuropsychiatric Inventory (NPI); Cohen-
Mansfield Agitation Inventory (CMAI). 
Extraction Method: Principal Component Analysis. One component extracted. 
 
Performance Outcomes.  The functional abilities aspect of the performance outcome 
theoretical concept was measured by the FAC self-care subscale and GDS/FAST scale.  There 
were 48 complete cases available for analysis.  Other measures of functional performance were 
not included in the analysis because of the lack of overlapping cases.  The KMO Measure of 
sampling adequacy was at the lowest range of acceptable values (KMO = .50).  Bartlett’s Test of 
Sphericity was significant (χ2 = 12.25, p < .001), indicating that the data are acceptable for 
exploratory factor analysis.  There was a moderate correlation between FAC self-care and 
GDS/FAST scores (Table 7: r = .43, p < .001).  
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The communalities of extracted variance indicate that both measures of functional ability had 
71% of their variances explained by the extracted factor (named Functional Performance factor).  
Table 14 illustrates that the single factor describing both measures accounted for 71% of the total 
explained variance.  Factor rotation was not possible as only one factor was calculated.  Finally, 
the component matrix indicated that both the FAC self-care subscale and GDS/FAST scores had 
a factor loading of .844.  This factor loading shows that the correlation between original FAC 
self-care and GDS/FAST scores had a correlation of .84 with the extracted factor.   
Table 14. Total Variance Explained: Performance Outcome Factor 
 Initial Eigenvalues Extraction Sums of Squared Loadings 








1 1.425 71.251 71.251 1.425 71.251 71.251 
2 0.575 28.749 100.000    
NOTE: Extraction Method: Principal Component Analysis. 
Path Analysis 
Before analyzing the path analysis, the data were checked against the assumptions for path 
analysis.  Path analysis has several assumptions in common with multiple regression, as well as 
unique assumptions for path analysis.  Theoretically-based assumptions that are unique to this 
method include the assumption that the independent and dependent variables are correlated, 
independent variables occur before dependent variables in time, and that the relationship 
between independent and dependent variables is nonspurious and does not disappear when 
effects of additional variables are controlled (Munro, 2005).  The first two assumptions are met 
through the theory that guided the construction of the model; the third assumption is difficult to 
confirm with certainty because all possible confounding variables cannot be measured with 
certainty.     
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Statistically-based assumptions for path analysis also assume that correlated, independent 
variables have a relationship that is represented by the size of their correlation coefficients, since 
these relationships cannot be directly measure with this method (Munro, 2005).  Since 
independent variables were rotated factors, their correlation was zero and the assumption was 
met.  The model is assumed to be recursive:  it moves only in one direction (Munro, 2005).  This 
assumption was met by all proposed relationships moving from the independent variables toward 
the dependent variables.  Variables should include interval level data, although occasionally 
dummy-coded data can be acceptable (Munro, 2005).  In this analysis, all variables were 
measured on ratio and interval level scales.  Finally, path analysis assumes that all variables are 
measured without error (Munro, 2005).  The data included in this model approached a lack of 
measurement error as no outliers were observed and all measures had good psychometric 
properties. 
Statistical assumptions are identical to assumptions of regression analysis (Munro, 2005).  It 
is assumed that relationships between the exogenous and endogenous variables are linear, and 
other patterns of relationships are not interpreted.  Residual differences between observed values 
and values predicted by the line of regression are not correlated with other residual values and 
also not correlated with exogenous variables in the model.     
Using the factors calculated above, the path model following the TOUS was constructed and 
tested (see Figure 5).  The goodness-of-fit between the model and the data was evaluated with a 
chi-square test.  The null hypothesis stated that the model was consistent with the data.  The chi-
square of Model A was statistically significant and the null hypothesis was rejected; the model 
was not a good fit for the data (χ2= 24.68, df = 3, p <.001).    
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To identify a better fitting model, the analysis was modified to include direct paths between 
predictors and Functional Performance.  A strong relationship was found between the predictor 
Physical: Cognitive factor and Functional Performance outcome factor.  The fit of Model A was 
improved upon by adding the direct effects of the predictor Physical: Cognitive factor to the 
Functional Performance factor as the outcome (see Figure 6).  The chi-square results of this 
model indicate that the null hypothesis could not be rejected and Model B is consistent with the 
data (χ2= 2.418, df = 2, p =.299).   
 
 





According to Pedhazur (1982), larger probabilities for the chi-square goodness-of-fit test 
indicate the best fitting model.  To explore if the model could be further optimized to fit the data, 
two additional paths were investigated.  Since the only statistically nonsignificant path calculated 
in Model B was the path from Agitation to the Functional performance outcome, this path was 
removed.  The resulting model, labeled Model C, is displayed in Figure 7.  The removal of the 
path between Agitation and Functional Performance did increase p value of the statistical 
significance of the model compared to the first two iterations (χ2 = 2.518, df = 3, p =.472).    
 






The model indices were then modified a final time to reverse the direction of the relationship 
between Agitation and Functional Performance.  The final model, labeled Model D, is illustrated 
in Figure 8. Model D provided the best fit to the data (χ2 = 1.049, df = 2, p =.592).  Further 
modifications resulted in no further improvements in model fit.   
 





This final model partially supports the hypothesis of Aim 1.  All three of the predicted 
antecedents to agitation are present in the final model, and have been assigned as interrelated 
predictors of agitation as described in the TOUS.  The symptom of agitation is influenced by the 
situational, psychological, and physical antecedent factors, which is consistent with the 
relationship predicted by the TOUS.  The outcome of function performance is present in the final 
model; however the model best fitting the data suggests that the relationship flows in the 
opposite direction as predicted by the TOUS.  Rather than functional performance being the 
result of agitation, the model suggests that agitation is generally the result of greater functional 
impairment, although the exact relationship was not statistically significant.  The regression 
coefficients derived from Model D are examined in detail in the following sections describing 
statistics for Aims 2 and 3.    
Figure 8. Path Model D 
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Aim 2: Results of Statistical Analyses 
Aim 2: Determine the effect of situational (physical and social environment), psychological 
(anxiety and depression), and physiological factors (comorbidities, pain, nutritional status, 
hearing, cognitive impairment, and fatigue) on agitation in persons with AD. 
Hypothesis:   
(1) Supportive and stimulating physical and social environments will have a negative direct 
effect on agitation. 
(2) Comorbid psychological states will have a positive direct effect on agitation. 
(3) Comorbid physical conditions, pain, inadequate nutritional status, hearing loss, cognitive 
impairment, and fatigue will have a direct positive effect on agitation. 
Aim 2 was tested with the examining the regression coefficients in the path analysis model 
best fitting the data.  The magnitude, direction, and significance of the path coefficients from the 
situational, psychological, and physical factors to agitation are evaluated.  Bivariate relationships 
(Pearson’s correlation) between individual situational, psychological, and physical measures and 
the agitation measures are also examined to support these hypotheses.   
Regression results from Path Analysis 
The regression coefficients from the exogenous predictor variables (Situation-Caregiver, 
Psychological, and Physical-Cognitive factors) to Agitation and Agitation to Functional 
Performance are given in Table 15.  Standardized path coefficients are used to allow for direct 
comparisons between different paths.   All three of the exogenous predictor variables (Situation- 
Caregiver, Psychological, and Physical-Cognitive factors) have statistically-significant, positive 
effects on Agitation, supporting hypotheses 1, 2, and 3 of aim 1.  Taken together, the predictors 
explain approximately 63% of the variance in Agitation (R
2












Outcome  Predictor B S.E. P ß  
Agitation <--- Situation- Caregiver 0.509 0.09 < .001 0.504  
Agitation <--- Psychological 0.446 0.09 < .001 0.442  
Agitation <--- Physical- Cognitive 0.583 0.179 0.001 0.579  
Agitation <--- Functional- Outcome -0.207 0.18 0.251 -0.217 .628 
Functional 
Outcome 
<--- Physical- Cognitive 0.858 0.097 < .001 0.812 .660 
NOTE: Standard Error = S.E.;  
R
2 
= Squared Multiple correlation for dependent variables.   
 
 
Next, the paths were evaluated for direct, indirect, total, and spurious effects on agitation.  
The effects in table 16 were calculated with the decomposition of path correlations method 
(Smyth & Yarandi, 1992).  Taking into consideration the indirect effect of the Physical-
Cognitive factor on Agitation, it was determined that the strongest relationship was demonstrated 
in the effect of the Situation-Caregiver factor to the Agitation factor (B = .509, p <.001).  Of note 
was the spurious component calculated from the product of the direct effects of Physical-
Cognitive to Agitation and Physical-Cognitive to Functional Performance paths, added to the 
direct effect of Functional Performance on Agitation.  This finding suggests that Functional 
Performance and Agitation have the Physical-Cognitive factor as a common cause.   
 
Table 16. Direct, Indirect, and Total Effects on Agitation 
 Effect 
Variable Direct Indirect Total Spurious 
Situation-Caregiver 0.504 0 0.504 0 
Psychological 0.442 0 0.442 0 
Physical-Cognitive 0.579 -0.176 0.403 0 




Other Analyses for Aim 2 
Hypothesis 1. To further examine the hypothesis that supportive and stimulating physical 
and social environments will have a negative direct relationship with agitation, correlations 
between agitation measures (FAC agitation subscale, CMAI, and NPI agitation subscale) and 
individual measures of situation were examined in Table 17.  For the 5 participants with both 
ZBI and CMAI scores measured, there was a very strong correlation between caregiver burden 
and cognitive impairment (r = .96, p = .006).  The NPI occupational disruptiveness subscale was 
moderately correlated with both CMAI (r = .55, p < .001) and NPI agitation measures (r = .58, p 
< .001).  Agitation as measured by the FAC was not correlated with any measures of the social 
environment.  Caregiver reactions as measured by the MPBC subscales were not correlated with 
measures of agitation.  This exploratory evidence from individual correlation calculations 
partially supported hypothesis 1 of aim 2: additional individual measures of caregiver burden 
were correlated with measures of agitation with the exception of the FAC agitation subscale and 
MBPC caregiver subscales in a small community sample.   
Table 17. Pearson Correlation of Agitation and Social Environment Measures 
Results: r  Agitation Measures  
Social Environment Measures CMAI FAC Agitation NPI Agitation 
Zarit Burden Interview Score  .956** 
n = 5 
.a .a 
MBPC  
Memory and Behavior Caregiver reaction  
.a .274 
n = 11 
.a 
MBPC  
ADL Caregiver reaction  
.a .283 
n = 11 
.a 
NPI Occupational disruptiveness  .552** 
n = 48 
.119 
n = 48 
.583** 
n = 48 
NOTE:  Memory and Behavior Problem Checklist-1987 (MBPC); Activities of Daily Living 
(ADL); Neuropsychiatric Inventory (NPI); Cohen Mansfield Agitation Inventory (CMAI); 
Functional Abilities Checklist (FAC), Hearing Handicap Inventory for Elderly Screening 
(HHIE-S).  
** Correlation is significant at the 0.01 level (1-tailed). 




Hypothesis 2. To further examine the hypothesis that the comorbid psychological states 
will have a positive direct relationship with agitation, correlations between psychological 
measures and agitation measures were examined in Table 18.  The NPI depression (r = .39, p = 
.007) and anxiety (r = .41, p = .004) subscales had a weak association with CMAI.  A moderate 
correlation was observed between the NPI delusion subscale and the CMAI (r =.52, p < .001); it 
also demonstrated a weak correlation with the NPI agitation subscale (r =.36, p = .011).  NPI 
hallucinations subscale was weakly correlated with the NPI agitation subscale (r =.40, p = .004).  
The NPI disinhibition (r = .59, p < .001) and aberrant motor behavior subscales (r = .50, p < 
.001) both demonstrated a moderate relationship with the CMAI; NPI aberrant motor behavior 
was also weakly correlated with NPI agitation (r = .29, p = .048).  NPI sleep subscale was 
weakly correlated with the FAC agitation subscale (r =.31, p = .035).  The NPI irritability 
subscale demonstrated moderate correlation with both the CMAI (r = .51, p < .001) and the NPI 
agitation subscales (r = .68; p < .001).  The ADAS non-cognitive behavioral subscale had a weak 
correlation with the FAC agitation subscale (r =.47, p = .001).  The FAC inappropriate behavior 
subscale was weakly correlated with the NPI agitation subscale (r =.29, p = .048).  No 
correlations were observed between NPI apathy or elation subscales and any measures of 
agitation.   
Overall, the FAC agitation subscale had the fewest correlations with psychological 
measures.  The CMAI and NPI agitation subscales were similarly correlated with psychological 
measures.  Only the NPI delusions, aberrant motor behavior, and irritability subscales were 
correlated with more than one measure of agitation.  This exploratory evidence from individual 
correlation calculations partially supported hypothesis 2 of aim 2: most individual measures of 
comorbid psychological states were correlated with at least one measure of agitation.  
109 
 
Table 18. Pearson Correlations of Agitation and Psychological Measures 
 
Results: r  Agitation Measures 
Psychological 
Measures 
CMAI  FAC Agitation   NPI Agitation  
NPI Depression  .385** 
n = 48 
-.098 
n = 48 
-.051 
n = 48 
NPI Anxiety  .410** 
n = 48 
.064 
n = 48 
.110 
n = 48 
NPI Apathy  -.222 
n = 48 
-.076 
n = 48 
.114 
n = 48 
NPI Delusions  .518** 
n = 48 
.134 
n = 48 
.362* 




n = 48 
-.015 
n = 48 
.404** 
n = 48 
NPI Elation  -.057 
n = 48 
.144 
n = 48 
.095 




n = 48 
.267 
n = 48 
.062 
n = 48 
NPI Aberrant 
Motor Behavior  
.503** 
n = 48 
.171 
n = 48 
.287* 
n = 48 
NPI Sleep  .241 
n = 48 
.305* 
n = 48 
.116 
n = 48 
NPI Irritability  .508** 
n = 48 
.176 
n = 48 
.676** 





n = 30 
.465** 
n = 51 
.205 





n = 59 
.210 
n = 81 
.287* 
n = 48 
NOTE: Cohen-Mansfield Agitation Inventory (CMAI); Functional Abilities 
Checklist (FAC); Neuropsychiatric Inventory (NPI); Alzheimer Disease 
Assessment Scale (ADAS). 
* Correlation is significant at the 0.05 level (1-tailed). 
** Correlation is significant at the 0.01 level (1-tailed). 
 
Hypothesis 3.  Correlations between physical measures and agitation measures were 
examined in Table 19 to further examine the hypothesis that physical aspects of health including 
comorbid physical conditions, pain, inadequate nutritional status, hearing loss, cognitive 
impairment, and fatigue have a direct, positive relationship with agitation.  There was a 
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moderately strong correlation between scores on Pain in Advanced Dementia measure and the 
CMAI (r =.69, p = .001).  A strong inverse correlation was observed between MMSE and CMAI 
scores (r = -.82, p = .045).  A weak inverse correlation was observed between and SIB scores 
and NPI agitation (r = -.28; p = .028).  No correlations were observed between the FAC agitation 
subscale and any physical measures.  No correlations were observed between agitation and 
CIRS-G, MNA, NPI appetite subscale, or the HHIE-S measures.   
This exploratory evidence from individual correlation calculations partially supported 
hypothesis 3 of aim 2: few additional individual measures of comorbid physical conditions were 
correlated with measures of agitation.  Individual measures of physical conditions were not 
correlated with more than one measure of agitation.  Measures of cognitive impairment (MMSE 
and SIB) were correlated with agitation measures as identified in the path model.  Additionally, 
only pain was identified as a physical measure correlated with agitation. 













Table 19. Pearson Correlations of Agitation and Physical Measures 
 
Results: r  













n = 18 
-.150 
n = 13 
.006 
 n = 13 
Pain AD .689** 
n = 18 
.263 
n = 13 
.334 




n = 18 
-.021 
n = 13 
.107 




n = 48 
-.187 
n = 48 
.058 
n = 48 
HHIE-S .030 












n = 66 
-.173 
n = 67 
-.279* 
n = 48 
NOTE: Cohen-Mansfield Agitation Inventory (CMAI); Functional Abilities Checklist 
(FAC); Neuropsychiatric Inventory (NPI); Hearing Handicap Inventory for the 
Elderly – Short Form (HHIE-S); Alzheimer Disease Assessment Scale (ADAS). 
* Correlation is significant at the 0.05 level (1-tailed). 
** Correlation is significant at the 0.01 level (1-tailed). 
.a = No comparative sample available. 
   
Aim 3:   
Aim 3:  Determine the effect of situational, psychological, physical antecedent factors and 
agitation on performance outcomes (functional status and quality of life) in persons with AD. 
Hypothesis:   
(1) Supportive and stimulating physical and social environments will have an indirect 
positive effect on functional status and quality of life through reduced agitation. 
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(2) Comorbid psychological states will have an indirect negative effect on functional status 
and quality of life through increased agitation. 
(3) Comorbid physical conditions, pain, nutritional status, hearing loss, cognitive 
impairment, and fatigue will have an indirect negative effect on functional status through 
increased agitation. 
(4) Agitation will have a negative direct effect on functional status and quality of life.   
Aim 3 is tested by examining the regression coefficients in the path analysis model best 
fitting the data.  The magnitude, direction, and significance of the path coefficients from 
situational, psychological, and physical factors to functional ability are evaluated.  The paths 
from agitation to functional ability are also examined.  Bivariate relationships (Pearson’s 
correlation) between individual measures and the functional performance outcome were also 
examined to test these hypotheses.   
Regression results from Path Analysis 
The regression coefficients from the exogenous predictor Physical-Cognitive factor to the 
Functional Performance factor and from the Functional Performance Factor to Agitation are 
given in Table 15.  This model indicated that only the Physical-Cognitive exogenous predictor 
factor had a significant effect on the Functional Performance factor (B = 0.858, p < .001).  The 
direct effect of the Physical-Cognition factor on the Functional Performance factor explained 
about 66% of the variance in Functional Performance (R
2 
= .660).  This finding supports 
hypothesis 3 to the extent that the Physical-Cognition factor has an effect on Functional 
Performance, but provides evidence against hypothesis 1 and 2 as no relationships between 
Situation-Caregiver or Psychological factors and the Functional Performance factor were found.   
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The path model suggests that there is no important relationship between agitation and 
functional performance (B = -0.207, p = .47; Table 15).  Rather, the path model indicates that 
both agitation and functional performance are the result of the Physical-Cognitive factor 
(spurious effect B = .470; Table 16).  Hypothesis 4 is not supported by these data.   
Additional Analyses to test Aim 3:   
 Hypothesis 1.  Correlations were calculated between situational measures and measures 
of functional outcomes to explore the hypothesis that supportive and stimulating physical and 
social environments will have a positive relationship with functional status and quality of life 
(Table 20).  Zarit Burden Inventory was strongly correlated with GDS/FAST scores (r = .83, p = 
.042), and also had a strong negative correlation with ADRQL scores (r = -.93; p = .013) in the 5 
participants who had all measures.  The MBPC caregiver reaction to ADL subscale was weakly 
correlated with the MBPC ADL subscale (r = .34, p = .028).  No correlations were observed 
between MBPC or NPI occupational disruptiveness scales and measures of functional 
performance outcomes.  Overall, exploratory evidence from individual correlation calculations 
partially supported hypothesis 1 of aim 3: additional individual measures of caregiver burden 










Table 20. Pearson Correlations of Functional Performance and Situational Measures 
Results: r Functional Status Measures Quality of Life Measures 
 FAC 
Self-care  
GDS/FAST  MBPC 
ADL  





.a .828*  
n = 5 
.a -.923* 
n = 5 
-.310 
n = 5 
-.100 






n = 11 
.303 
n = 28 
.143 
n = 28 





n = 11 
.284 
n = 28 
.341* 
n = 28 





n = 48 
.111 
n = 30 
.a .a .a .a 
NOTE:  Memory and Behavior Problem Checklist-1987 (MBPC); Activities of Daily Living 
(ADL); Neuropsychiatric Inventory (NPI); Cohen Mansfield Agitation Inventory (CMAI); 
Functional Abilities Checklist (FAC), Global Deterioration Scale/Functional Assessment 
Staging Tool (GDS/FAST). Alzheimer Disease Related Quality of Life (ADRQL), Quality 
of Life in Alzheimer Disease (QOLAD) 
* Correlation is significant at the 0.05 level (1-tailed). 
** Correlation is significant at the 0.01 level (1-tailed). 
.a = No comparative sample available. 
 
Hypothesis 2.  Correlations were calculated between psychological measures and measures 
of functional outcomes to explore the hypothesis that comorbid psychological states will have a 
negative relationship with functional status and quality of life (Table 21).  A weak correlation 
was measured between NPI apathy and FAC self-care subscales (r = .30, p =.018).  A weak 
correlation was also measured between the ADAS non-cognitive behavioral and FAC self-care 
subscale (r = .32, p =.010).  The FAC inappropriate behavior subscale was moderately correlated 





Table 21. Pearson Correlations of Functional Performance and Psychological Measures 





GDS/FAST  MBPC 
ADL  





NPI Depression  -.126 
n = 48 
-.062 
n = 30 
.a .a .a .a 
NPI Anxiety  .021 
n = 48 
-.051 
n = 30 
.a .a .a .a 
NPI Apathy  .303* 
n = 48 
.241 
n = 30 
.a .a .a .a 
NPI Delusions  -.001 
n = 48 
.024 
n = 30 
.a .a .a .a 
NPI Hallucinations  .021 
n = 48 
.007 
n = 30 
.a .a .a .a 
NPI Elation  .201 
n = 48 
-.046 
n = 30 
.a .a .a .a 
NPI Disinhibition  -.084 
n = 48 
-.058 
n = 30 
.a .a .a .a 
NPI Aberrant motor 
behavior  
.095 
n = 48 
.208 
n = 30 
.a .a .a .a 
NPI Sleep  .043 
n = 48 
-.032 
n = 30 
.a .a .a .a 
NPI Irritability  .129 
n = 48 
.036 
n = 30 




n = 51 
.133 
n = 52 
.271 
n = 10 




n = 81 
.485** 
n = 62 
-.083 
n = 11 
.a .a .a 
NOTE: Cohen-Mansfield Agitation Inventory (CMAI); Functional Abilities Checklist 
(FAC); Neuropsychiatric Inventory (NPI); Alzheimer Disease Assessment Scale (ADAS) 
Memory and Behavior Problem Checklist-1987 (MBPC); Activities of Daily Living (ADL); 
Neuropsychiatric Inventory (NPI); Global Deterioration Scale/Functional Assessment 
Staging Tool (GDS/FAST). Alzheimer Disease Related Quality of Life (ADRQL), Quality of 
Life in Alzheimer Disease (QOL-AD). 
* Correlation is significant at the 0.05 level (1-tailed). 
** Correlation is significant at the 0.01 level (1-tailed). 
.a = No comparative sample available  
 
No correlations were found between functional status measures and NPI depression, anxiety, 
delusions, hallucinations, elation, disinhibition, aberrant motor behavior, sleep, or irritability 
subscales.  Comparative samples were not available to calculate correlations for measures of 
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quality of life.  MBPC ADL scores could only be compared to ADAS non-cognitive behavioral 
and FAC inappropriate behavior subscales, though no correlations were found.  In general, this 
exploratory evidence from individual correlation calculations demonstrates further evidence 
against hypothesis 2 of aim 3: additional individual psychological measures were not well 
correlated with measures of functional status with the exception correlations between functional 
status and general measures of AD-related behavioral symptoms (ADAS non-cognitive 
behavioral subscale and FAC Inappropriate behavior subscale) and the NPI apathy subscale.   
Hypothesis 3.  Correlations were calculated between physical measures and measures of 
functional outcomes to explore the hypothesis that comorbid physical conditions, pain, 
nutritional status, hearing loss, cognitive impairment, and fatigue will have a negative 
relationship functional status and quality of life (Table 22).  CIRS-G scores were moderately to 
highly correlated with FAC self-care (r = .60, p =.015), and GDS/FAST functional status 
measures (r = .93; p = .011).  CIRS-G scores had a strong inverse correlation with the ADRQL 
measure of quality of life (r = -.93, p = .011) for the 5-13 participants with measurements.  
Nutritional status measured by the MNA was strongly correlated with QOLAD measures (r = 
.90, p = .019, n = 5).  Hearing scores were strongly correlated with quality of life measured on 
the SF-36 (r = .83, p = .042, n = 5).  Mini mental state exam scores had a strong inverse 
correlation with GDS/FAST measures of functional status (r = -.84, p = .036, n = 5), and were 
strongly correlated with quality of life as measured by the ADRQL (r = .91, p = .017, n = 5).  
Cognition as measured by the SIB had a moderate inverse correlation with FAC self-care (r = -
.57, p < .001, n = 67) and GDS/FAST functional status measures (r = -.54, p = .015, n = 53), and 
a very strong positive relationship with ADRQL (r = .97, p = .004, n = 5). 
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Correlations between Pain AD and the NPI appetite subscale with measures of functional 
performance outcomes and were not observed.  Correlations between physical measures and the 
MBPC ADL subscale could not be calculated due to lack of overlapping participants.  Many of 
the correlations that were observed were based on small samples of less than 15 participants and 
should be interpreted with caution.  The results of these exploratory analyses provided evidence 
that partially supported hypothesis 3 of aim 3: some individual measures of comorbid physical 
conditions were correlated with measures of functional status and quality of life.     
Table 22. Pearson Correlations of Functional Performance and Physical Measures 
Results: r 
(p) 





GDS/FAST  MBPC 
ADL  




n = 13 
.931* 
n = 5 
.a -.931* 
 n = 5 
.192 
n = 5 
-.395 
n = 5 
PainAD .210 
n = 13 
-.691 
n = 5 
.a .475 
n = 5 
.140 
n = 5 
-.155 
n = 5 
MNA -.441 
n = 13 
-.085 
n = 5 
.a .113 
n = 5 
.899*  
n = 5 
-.694 




n = 48 
-.025 
n = 30 
.a .a .a .a 
HHIE-S .a -.250 
n = 5 
.a .255 
n = 5 
 -.215 
n = 5 
.826*  
n = 5 
Mini Mental 
State Exam  
.a -.844* 
n = 5 
.a .908* 
n = 5 
-.344 
n = 5 
.617 





n = 67 
-.543** 
n = 53 
.a .967** 
n = 5 
.300 
n = 5 
.098 
n = 5 
NOTE: Cumulative Illness Rating Scale-Geriatrics (CIRS-G); Mini Nutritional Assessment 
(MNA); Neuropsychiatric Inventory (NPI); Hearing Handicap Inventory for the Elderly – 
Short Form (HHIE-S); Severe Impairment Battery (SIB); Functional Abilities Checklist 
(FAC); Global Deterioration Scale/Functional Assessment Staging Tool (GDS/FAST); 
Memory and Behavioral Problems Checklist, Activities of Daily Living (MBPC ADL);  
Alzheimer Disease Related Quality of Life (ADRQL), Quality of Life in Alzheimer Disease 
(QOLAD).   
* Correlation is significant at the 0.05 level (1-tailed). 
** Correlation is significant at the 0.01 level (1-tailed). 
.a = No comparative sample available. 
118 
 
Hypothesis 4.  Correlations were calculated between agitation measures and measures of 
functional performance to explore the hypothesis that agitation will have a negative relationship 
functional status and quality of life (Table 23).  Weak correlations were found between the 
CMAI and GDS/FAST measure of functional status (r = .31; p = .018, n = 47), as well as a 
strong inverse relationship between the CMAI and ADRQL (r = -.96, p = .006, n = 5).  The FAC 
agitation subscale had a weak correlation with the FAC self-care subscale (r = .19, p = .040, n = 
83).  Agitation measured by the NPI agitation subscale had no significant correlations with 
functional status measures, although the weak correlation with the FAC self-care subscale 
approached significance (r = .23, p = .057, n = 5).  Correlation calculations were limited by small 
sample size for quality of life measures with little overlap in observed participants.  This 
evidence from individual correlation calculations partially supported hypothesis 4 of aim 1: some 
individual measures of agitation were correlated with individual measures of functional status 
and quality of life.   
Table 23. Pearson Correlations of Functional Performance and Physical Measures 
Results: r 
(p) 












n = 61 
.306* 
n = 47 
.a -. 955** 
n = 5 
.192 
n = 5 
-.106 




n = 83 
-.165 
n = 64 
.250 
n = 11 
.a .a .a 
NPI Agitation .231 
n = 48 
.131 
n = 30 
.a .a .a .a 
NOTE: Cohen-Mansfield Agitation Inventory (CMAI); Functional Abilities Checklist (FAC); 
Neuropsychiatric Inventory (NPI); Hearing Handicap Inventory for the Elderly – Short Form 
(HHIE-S); Alzheimer Disease Assessment Scale (ADAS), Global Deterioration 
Scale/Functional Assessment Staging Tool (GDS/FAST). Alzheimer Disease Related Quality of 
Life (ADRQL), Quality of Life in Alzheimer Disease (QOLAD). 
*. Correlation is significant at the 0.05 level (1-tailed). 
**. Correlation is significant at the 0.01 level (1-tailed). 
.a = No comparative sample available. 
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CHAPTER 5: DISCUSSION 
 The central purpose of this dissertation was to test a model of agitated behavioral 
symptoms in persons with Alzheimer disease within the framework defined by the Theory of 
Unpleasant Symptoms (TOUS; Lenz et al., 1995).  Specifically, this dissertation sought to (1) 
describe the phenomenon of agitated behavioral symptoms in persons with AD within the 
constructs predicted in the TOUS; (2) to investigate the relationships between situational, 
psychological, and physiological factors on agitated behavioral symptoms in persons with AD; 
and (3) to investigate the relationships between functional performance outcomes and situational, 
psychological, and physiological factors and agitated behavioral symptoms.  To a large extent, 
the TOUS was found to accurately predict most (though not all) of the observed relationships. 
This discussion is divided into three main sections.  The first section describes the 
conclusions drawn from study results and compares them to expected findings from extant 
literature.  Second, limitations of the results interpretation and study methods are discussed.  The 
chapter concludes with recommendations for future research.       
Research Conclusions 
Support for the Theory of Unpleasant Symptoms 
The TOUS is a middle-range theory developed to guide research and practice around a 
variety of unpleasant symptom experiences (Lenz et al., 1997).  It was originally developed to 
describe linear relationships between influential factors, symptoms, and outcomes (Lenz & Gift, 
1998).  Later, authors expanded the TOUS to more broadly consider interrelationships between 
predictors and reciprocal interactions between symptoms, outcomes and predictors.  Therefore, 
the original version of the TOUS was selected to guide the hypotheses and path model in the 
present study.  The TOUS defined variables of interest by category and relationship to 
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symptoms.  Main study results pertaining to the variables and relationships hypothesized by the 
TOUS are discussed first, followed by a discussion of results by individual variables.   
 Variables.  Overall, the TOUS provided a good framework for identifying and 
categorizing variables that may affect agitation.  The antecedent category contained three types 
of variables (physiologic, psychologic, and situational) that are thought to influence a single 
symptom (agitation) that is measured by its distress, duration, intensity, and quality.  The 
performance outcome category includes functional status, and was theorized to be affected by the 
symptom.  These variables were all represented to some extent within the final path model.   
Situation-Caregiver. This study measured the antecedent concepts with eleven 
instruments.  The exploratory factor analysis identified three factors summarizing the 
instruments that corresponded to the three antecedent categories proposed by the TOUS.  The 
concept of situational antecedents paralleled to the factor named Situation-Caregiver.  The 
Situation-Caregiver factor included occupational disruption measured on the NPI as well as 
measures of delusions, and partially measured hallucinations, aberrant motor behavior, 
irritability, and cognitive status measured by the FAC.    
The NPI occupational disruptiveness scale has previously been applied to the 
measurement of caregiver burden, especially for professionals caring for those with AD in 
institutional settings (Tan, Wong, & Allen, 2005).  In such environments, the NPI Occupational 
Disruptiveness (OD) subscale measures staff burnout that results in added costs, staff turnover, 
and impedes optimal care (Tan et al., 2005).  Outward expressions of hallucinations, delusions, 
irritability, and aberrant motor behaviors rather than inward depression, anxiety or cognitive 
decline aggravate caregiver burden, which supports the identification of these outward and 
inward variables into separate factors (Hiyoshi-Taniguchi, Becker, & Kinoshita, 2018; Reed et 
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al., 2020; Tan, 2005).  The FAC cognitive status subscale was not expected to be loaded onto the 
caregiver burden factor as previous studies have found cognition to be unrelated to caregiver 
burden (Reed et al., 2020).  Although the FAC cognitive status scale loaded minimally onto the 
Situation-Caregiver factor, it loaded more strongly onto the Physical-Cognitive factor.  
Psychological. The Psychological factor was primarily defined by NPI anxiety, 
depression, and disinhibition with minor loadings of occupational disruptiveness, delusions, 
motor behavior, and irritability.  This factor structure is generally consistent with symptom 
cluster “emotion and disinhibition” which includes depression and disinhibition identified by 
Nagata and colleagues (2016).  The variables describing the Psychological factor are also 
consistent with AD-related impairments of the neural networks connecting with the angular 
cingulate cortex which is thought to cause deficits in emotional regulation and impulse control 
(dos Santos Tascone & Bottino, 2013).    
Physical-Cognitive.  The final predictor factor was named Physical-Cognitive and was 
defined by the SIB scores, FAC cognitive status, FAC inappropriate behaviors, and had a 
negative factor load for NPI depression.  It is possible that some of the items on the FAC 
inappropriate behavior subscale measure such a broad range of behaviors that many overlap with 
signs of diminished cognition.  Because depression is a risk factor for developing AD as well as 
an early sign of the disease, the negative loading of depression on the Cognitive-Physical factor 
was surprising (Defrancesco et al., 2017).  An explanation for the negative loading of depression 
on the cognition factor is that individuals with very advanced AD no longer express depression 
in a way that is immediately recognizable as their capacity for complex communication declines, 
and therefore less depression may be reported during late-stage disease when impaired cognition 
is most pronounced.   
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Although the TOUS originally conceptualized cognitive functioning as a component of 
performance outcome, its position was modified in this study.  Because diminishing cognition is 
an expected consequence of the physical neurodegeneration in AD, it was conceptualized here as 
an indicator of the physiologic antecedent concept.  Hutchinson and Wilson (1998) reached a 
similar conclusion about blurred theory components when applying the TOUS to interpreting 
qualitative data about behavioral symptoms in AD.  Despite these minor conceptual challenges, 
work by Hutchinson and Wilson (1998) and this present study ultimately concluded that the 
TOUS remains useful in this population because of its emphasis on the complexity of 
interactions among symptoms.     
Although the exploratory factor analysis of all of the variables measuring antecedent 
concepts did not achieve a simple structure with each measured indicator corresponding to a 
single factor, this is consistent with the description of the original TOUS model.  For example, 
the TOUS identifies that social support contributes to both the psychological and situational 
concept (Lenz et al., 1995).   
Agitation. The symptom of agitation was measured with three tools that considered each 
of the proposed aspects of the symptom experience: duration (frequency), distress, intensity 
(severity) and quality (specific agitated behaviors).  The tools included the FAC agitation 
subscale, the NPI agitation subscale, and the CMAI.  Although the term “symptom” is normally 
reserved for self-reported subjective experiences by individuals, the diminished cognition in AD 
reduces the reporting capability of individuals with AD.  Therefore, symptoms in AD are 
generally reported by proxy observation of discernible behavioral signs of suspected symptoms 
(Hutchinson & Wilson, 1998).   
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Performance Outcome.  Performance outcomes were measured by a factor containing 
the FAC self-care subscale and the FAST/GDS scores.  The use of both tools was useful as the 
FAST/GDS scores individuals along an expected trajectory of the loss of ADLs over the disease 
course, while the FAC self-care subscale allowed more individualization of scores with questions 
about specific tasks that were difficult for participants and the frequency of these challenges 
(Reisberg, 1986; Swanson, Maas, & Buchwalter, 1994).   
Relationships.  The original TOUS defined simple, direct relationships between the three 
categories of antecedents (physiologic, psychologic, and situational) to a single symptom with 
one final direct relationship between the symptom and performance outcomes (Lenz et al., 1995).   
The first major finding from this study was that the path model guided by the TOUS was a good 
fit to the relationships in the observed data with one notable exception.  The predicted 
relationship of a direct positive effect of agitation on functional impairment was not supported by 
the model.  When the relationship between agitated behavioral symptoms and function 
performance outcomes were reversed, the optimal model for the data was produced.  Although 
this arrangement produced the best-fitting model overall, the specific relationship between 
agitation and function was not statistically significant. 
As predicted by the TOUS, the final model showed strong support for the relationships 
between situation and agitation, psychological symptoms and agitation, and physical health on 
agitated behavioral symptoms-.  The model found no support for the effects of situational and 
psychological predictors on functional performance or the relationship between agitated 
behavioral symptoms and functional outcome.  A relationship between physical predictors and 
functional outcome was supported.  The spurious relationship calculated between agitation, 
functional outcome, and physical factors indicated that agitation and functional outcomes were 
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both the result of physical factors as opposed to any direct relationship between agitation and 
functional outcome.     
 One explanation for the lack of a significant relationship observed between agitated 
behavioral symptoms and performance outcomes could be attributed to an incomplete 
measurement of the performance outcome concept.  While this study thoroughly measured 
functional ability with two distinct instruments, adequate sample was not available to consider 
quality of life indicators in the model.  Functional status decline with AD progression is a 
consistent and expected finding, even with the most supportive care interventions (Reuben et al., 
2019).  It is possible that measurements of quality of life would provide a more stable measure of 
a modifiable performance outcome that is less directly tied to disease progression.   
The consideration of important performance outcomes such as functional status and 
quality of life was seen as a major strength of the TOUS compared to other similar theories such 
as the needs-driven dementia-compromised behavior (NDB) framework (Algase et al., 1996), the 
unmet needs model (Cohen-Mansfield, 2000), and the Progressively Lowered Stress Threshold 
(PLST) model (Hall & Buckwalter, 1987).  It may be possible that because of the all-
encompassing nature of the AD degenerative process, a theory that is tailored to the experiences 
of this specific population would be more effective in conceptualizing relationships than a theory 
like TOUS which describes symptom experience regardless of specific population.  Lenz and 
Gift (1998) report that the development of the TOUS was from a theory primacy approach 
starting with the clinical problem of symptom complaints across diverse clinical populations.  
Theories developed from the perspective of substantive area primacy are centered on the specific 
needs of unique patient populations, such as AD patients, and may be better tailored to 
describing the phenomenon of agitated behavioral symptoms in AD patients (Kim, 1996).   
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A path model to describe agitated behavioral symptoms in AD was previously reported 
by Chen and colleagues (2014).  Chen’s model was developed from the NDB framework and 
unmet needs model.  There are several similarities between these models and the TOUS.  All of 
the theoretical models include physical health, pain, psychological health, depression and 
environmental predictors that affect agitated behaviors (Algase et al., 1996, Cohen-Mansfield, 
2000; Lenz et al., 1995).  The biggest difference between the models is the conceptualization of 
cognitive impairment as a predictor of problematic behavioral symptoms in AD in the NDB and 
unmet needs models while the TOUS does not explicitly conceptualize AD-related cognitive 
decline as a predictor.  The models also differ in the relationships between agitation and 
functional ability with NBD and unmet needs model categorizing functional ability as a predictor 
of agitation and TOUS considers it an outcome.   
The path model identified by Chen et al. (2014), found that agitation was directly affected 
by cognitive function and depression.  Indirect effects on agitation were found from pain and 
functional ability through depression. Functional ability was found to be affected by cognitive 
function and pain.  The model identified in this study agreed with Chen’s model to a large extent.  
Both models found agitation to be influenced by cognitive factors and psychological factors 
(including depression).  Both models failed to find a direct relationship between functional 
ability and agitation (regardless of its hypothesized causative or outcome placement).  Both 
models found that cognitive factors influenced both agitation and functional ability. 
Key differences between the two models include the measured variables, study sample 
characteristics, explained variance, and the overall model fit.  The model identified in the current 
study included additional measures of psychological states, caregiver-related situational factors, 
and multiple measures of agitation, but did not measure pain.  Chen et al., (2014) included in 
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their study sample 405 older adults with dementia (not specifically AD), who resided in nursing 
homes in Taiwan.  The sample from which this study’s model was generated included 48 
participants from community and institutional settings in Midwestern United States.  The model 
generated in the present study explained nearly 63% of the variance in agitation while Chen’s 
model explained only 11%.  The model in this study also found that 66% of the variance in 
functional ability was explained by the cognitive factor while Chen’s model found 52% of the 
variance in functional ability was explained by cognitive function and pain.  Overall, both 
models fit their datasets, although the model generated in the present study had a better fit 
compared to Chen et al., (2014).  Taken together, these models confirm the important impact of 
cognitive function and psychological factors on agitation.  Our study adds the importance of the 
impact of caregiver burden on agitation.      
 With all of the strengths and weaknesses of the TOUS taken together, the fit between the 
data in this study and the TOUS is satisfactory in explaining the phenomenon of agitated 
behavioral symptoms in AD.  When testing a theory to explain research data, the theory should 
aid the researcher in expanding knowledge and exploring a small part of the larger phenomenon 
of interest in depth (Artinian, 1988).  It is not necessary that the theory explain all of the data but 
is more useful in the interpretation of some aspects.  Especially when approaching a secondary 
analysis of data, the model is not expected to perfectly match the data since the theory was not 
used to guide instrument selection or to plan research methods (Lenz & Gift 1998).  Regardless 
of these barriers, the TOUS provided a useful framework for formulating hypotheses and 
organizing the variables and relationships in the phenomenon of agitated behavioral symptoms in 
AD.  The TOUS provided valuable insight to guide research exploration and to illuminate key 
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nursing interventions to improve care for this population.  Further exploratory evidence within 
each variable category is discussed below.   
Support for individual relationships 
Situation.  The effect of situational caregiver burden was found to have the greatest 
impact on agitation in the path model.  This finding is consistent with previously reported 
research that negative interactions between overburdened caregivers and individuals with AD 
can worsen agitation severity in this population (de Mauléon et al., 2019; de Vugt et al., 2004; 
Ragneskog et al., 1998).  The direction of the relationship is called into question by other 
findings that conceptualized caregiver burden as a result of agitation (Chiao, Wu, & Hsiao, 2015; 
Hiyoshi-Taniguchi et al., 2018).  When viewed from a reciprocal-interactive perspective as 
outlined in the updated TOUS (Lenz et al., 1997), the direction of the interaction is 
inconsequential because caregiver burden and agitation are constantly interacting and creating 
feedback within each other.   
Findings from the path analysis were further supported with exploratory data from 
subsets of participants.  Correlations between a specific measure of situation (the Zarit Burden 
Interview and NPI occupational disruption scale) and measures of agitation (the CMAI and NPI 
agitation subscale) were found.  A nearly perfect correlation was found between the ZBI and 
CMAI for the 5 participants with both measures, and the NPI occupational disruptiveness scale 
was moderately correlated with both CMAI and NPI agitation. 
Psychological states.  The final path model showed strong support for the relationships 
between psychological symptoms and agitation. It was previously demonstrated that 
psychological disturbances often co-occur with agitated behavioral symptoms in persons with 
AD  (Borsje et al., 2015; Chen et al., 2014; Van der Mussele et al., 2015).  This research further 
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confirms co-occurrences of psychological disturbances and agitation, and suggests that states of 
psychological distress may exacerbate agitated behavioral symptoms in persons with AD.   
In addition to the evidence supporting the relationship between increased psychological 
disturbances and agitation discovered through the path analysis, additional exploratory evidence 
further supports these findings.  The ADAS non-cognitive behavioral scale was correlated with 
the FAC agitation scale.  While not measured in the path analysis, this provides further evidence 
supporting the relationship between agitation and other neuropsychiatric symptoms in AD across 
different instruments of measurement.   
Physical Health.  The path analysis found a strong relationship between the cognitive 
aspect of physical health and agitated behavioral symptoms.  This relationship is consistent with 
previously reported findings of increasing agitation with diminishing cognition (Chen et al., 
2014; Livingston et al., 2017; Ryu et al., 2005; Veldwijk-Rouwenhourst et al., 2017).  
Contradictory evidence was reported by Lovheim et al., (2008) who reported that agitation 
increased with cognitive decline only to the point of moderate dementia impairment, and then 
subsided.  Disagreements in previous reports of the relationship between agitated behavioral 
symptoms and cognitive measures may be attributable to definition of dementia with agitation 
being more prevalent in dementia related to AD than other types of dementia (Apostlova et al., 
2014; Steinberg et al., 2006).  
Although other measures of physical comorbidities were not measured in the path 
analysis, exploratory evidence suggested the existence of correlations between pain and 
agitation.  The relationship between pain and agitation has been demonstrated in many previous 
studies (Pelletier & Landreville, 2007; Volicer et al., 2012).  Volicer and collegues (2012) only 
found a relationship between agitation and pain when dementia severity and functional disability 
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were controlled, and Chen (2014) found an indirect relationship between pain and agitation 
through the effect of pain on depression and functional disability suggesting that the relationship 
between agitation and pain is sometimes complex.  Findings that the treatment of pain reduces 
agitated behaviors suggest that agitated behavioral symptoms can be a response to untreated pain 
(Husebo, Ballard, Cohen-Mansfield, Seifert, & Aarsland, 2014).  The modifiable relationship 
between pain and agitation demonstrates the need to assess and treat pain in persons with AD. 
Surprisingly, exploratory evidence did not identify relationships between cumulative 
disease burden (CIRS-G), nutritional measures (MNA, NPI Appetite), or hearing (HHIE-S) and 
agitation.  Sample sizes for these exploratory comparisons were small (n = 5-18), which may 
have contributed to the lack of observed relationships.  Although correlations cannot determine 
cause and effect relationships, these are interesting findings that could be explored further in 
future analyses.   
Agitation. Agitation was measured with three different tools concurrently: CMAI, FAC 
agitation subscale, and NPI agitation subscale.   Surprisingly, these measures demonstrated 
minimal intercorrelation among measures (only CMAI and FAC agitation subscale were 
significantly correlated).  There were, however, strong correlations between CMAI and NPI 
disinhibition, aberrant motor behavior, and irritability subscales, between the FAC agitation 
subscale and the ADAS non-cognitive behavioral subscale, and also between the NPI agitation 
subscale and NPI aberrant motor behavior and NPI irritability subscales.    
This clearly demonstrates the inconsistencies with which AD-related agitation is 
described by different authors and is measured by different tools.  With the broadest definition of 
agitation, Cohen-Mansfield and Billing (1986) consider verbal aggression, physical aggressive 
and non-aggressive behaviors, as well as hording to all measure different aspects of the broader 
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construct of agitation.  This overlaps with related concepts that others describe as restlessness, 
aggression, aberrant motor behaviors, or inappropriate behaviors (Cummings et al., 2015, Kong, 
2005).  While some researchers narrow the conceptual definition of agitation to exclude related 
factors, others measure agitation broadly and may simply explain the broad construct as 
“agitation and aggression” (de Mauleon et al., 2019).  This broad approach seems to be the most 
effective since the reported consequences of agitation-related challenging behavioral symptoms 
in AD are similar, including increased caregiver burden and institutionalization (de Mauleon et 
al., 2019; Dufournet et al., 2019).  No evidence was found to support different patient outcomes 
for different types of agitation, but if future evidence suggests that different types of agitation do 
impact different outcomes, then the narrow definition of agitation would be appropriate.   
Functional Outcomes.  In the present study, functional outcomes were conceptualized 
both as functional abilities and quality of life.  Only measures of functional ability were 
measured in the path analysis due to sample size constraints.  The model found no support for the 
effects of situational and psychological predictors on functional performance or the relationship 
between agitated behavioral symptoms and functional outcome.  This may be attributable to 
caregiver perceptions of functional deficits as less burdensome that other AD-related symptoms 
(Dufournet et al., 2019).  Many caregivers report less psychological burden from physical and 
cognitive AD-related deficits than from agitation. However, these three factors are directly tied 
to over 84% of nursing home admissions for persons with AD and all merit in-depth exploration 
(de Mauleon, 2019; Dufournet et al., 2019).    
A relationship between physical predictors and functional outcome was supported by the 
path model.  The spurious relationship calculated between agitation, functional outcome, and 
physical factors indicated that agitation and functional outcomes were both the result of physical 
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factors as opposed to a direct relationship between agitation and functional outcome.  This is 
consistent with the disease course of AD causing both functional and cognitive decline and 
worsening neuropsychiatric symptoms as neuropathological changes worsen (Braak & Braak, 
1991; Tward et al., 2017; Maas et al., 2015; Serrano-Pozo et al, 2011; Tam & Pasternak, 2017).  
No other factors measured in this analysis contributed any noticeable effect on this relationship.   
Exploratory evidence based on small samples indicated that caregivers felt more 
burdened when individuals with AD had later-staged illness (ZBI was correlated with 
GDS/FAST stage, n = 5), and that burdened caregivers rated lower quality of life for individuals 
with AD (ZBI was correlated with ADRQL, n = 5).  Previous findings have also indicated that 
caregiver-reported quality of life for individuals with dementia diminished as the disease 
progresses, and that these changes are often accompanied by increasing levels of agitation 
(Livingston et al., 2017).  Quality of life is an important outcome that should be measured in 
additional research.   
Functional performance outcomes and psychological factors were not found to be related 
in the path analysis, and no additional significant findings were uncovered through individual 
analyses.  There were no participants with concurrent measures of quality of life and 
psychological indicators, so no conclusions can be drawn.   
Exploratory evidence was found to support the relationship between increased comorbid 
disease burden and worsening function status as well as quality of life (CIRS-G correlations to 
FAC self-care, n = 13; GDS/FAST scores, n = 5; and ADRQL, n = 5).  Other authors examining 
quality of life from the perception of both caregivers and patients have also found lower quality 
of life and functional status in individuals with high comorbid disease burden in AD, and 
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attributed lower quality of life ratings to issues pertaining to dignity, disease development, health 
and function, and safety issues (Verloo, Salina, Fiorentino, & Cohen, 2018).   
Further initial evidence suggests a correlation between worsening nutritional status and 
lower quality of life, although the sample was small (MNA was correlated with QOL-AD, n = 5).  
These findings are consistent with previous research that nutrition, weight, and quality of life 
declined over a one-year study of persons with AD (Suominen et al., 2015).  Suominen and 
collegues (2015) also reported that tailored nutritional interventions resulted in little change in 
quality of life and no change in nutritional status.  As reduced oral intake is an expected outcome 
of advanced-stage AD, it is important to evaluate the stage of AD when considering aggressive 
dietary interventions (Ferrell, Twaddle, Melnick, & Meier, 2018).  Avoidance of forced feeding 
can be part of compassionate end of life care (Post, 2001). 
Limitations 
Limitations of methods   
This dissertation was a secondary analysis of cross-sectional, descriptive data from 
multiple parent studies.  Cross-sectional studies are limited by their snapshot perspective on 
study variables.  In contrast, longitudinal studies are particularly important to studying 
degenerative diseases like AD by examining the declining trajectory over time rather than 
instantaneous observations.  Individual variations between baseline features can complicate the 
separation of signal from noise in the analysis of differences.  To help clarify differences 
between individuals which are attributable to AD-related decline and differences between 
individuals at baseline, longitudinal measurements are the gold standard for all aspects of AD 
research from neuroimaging, to biomarkers to cognition (Jack et al., 2014; Raz & Kennedy, 
2009; Xu et al., 2014).    
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Original parent studies employed a convenience sample for enrollment of participants.  
Eligible participants and their caregivers voluntarily enrolled in the study without random 
selection.  Without random sampling, there may have been systematic error introduced to the 
data due to unmeasured similarities between participants which limits the ability of results to be 
generalized.   
Secondary analysis provides unique limitations as well as benefits compared to original 
research. In secondary analysis, the researcher is committed to measuring study variables with 
the instruments that have already been used. Therefore, careful evaluation of psychometric 
properties was necessary.  It was also important to assure that research questions could be 
adequately addressed by the existing data set.  Benefits of secondary analysis include accessing 
larger pools of participants than would otherwise be possible and that secondary analysis can be 
used to answer new research questions without further burdening vulnerable populations 
(Wickham, 2019).  Despite its limitations, secondary analysis is a useful and appropriate method 
for answering the observational and theory-based research questions examined in this research 
study. 
Limitations of results  
 There are limits to generalization of these research findings to wider populations.  The 
individuals in this sample were mostly females and almost entirely white.  Male gender is has 
previously been associated with agitation and aggression in AD (Kolanowski, 2016).  
Conversely, female gender has been associated with higher levels of psychosis (delusions and 
hallucinations) in AD (Nagata et al., 2017).  It has been suggested that caregiver burden 
experienced by female family members caring for agitated males with AD may be related to 
traditional gender roles causing some females to perceive helplessness or inappropriateness in 
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controlling these challenging behaviors (Tan et al., 2005).  It is unclear if females who suffer 
from AD have a different presentation, experience, or consequences to agitated behavioral 
symptoms or if their symptoms are interpreted differently than males.  The lack of individuals 
from non-white backgrounds in this sample presents a barrier to wide generalization of these 
results as individuals with racial or ethnic minority backgrounds may have unique 
socioeconomic circumstances, physical comorbidities, or social environments impacting 
agitation.   
Traditionally, symptoms are characterized as subjective experiences known only to the 
individual, whereas signs are observable by others (MacBryde & Blacklow, 1983).  In AD, 
diminishing mental ability caused by the disease interferes with an individual’s ability to 
recognize and express their symptom experience.  For this reason, AD symptoms are usually 
considered to include any manifestation of AD as observed by individuals or their caregivers 
(Hutchinson & Wilson, 1998).   It is not known how accurately these observable signs represent 
the internal symptom experience of individuals (Lenz & Gift, 1998).  The extent to which signs 
are recognized by outside observers presents a barrier to understanding the true symptom 
experience in this population.   
Although many of the hypothesized relationships surrounding the symptom experience of 
agitation were supported through the analysis of the data, agitation and other background factors 
did not demonstrate the expected relationships with functional performance outcomes and 
quality of life measures.  Many potentially important variables like stability of place of 
residence, family support, social isolation, hearing loss, comorbid disease burden, pain, and 
quality of life were not measured in the model.  These factors could affect the results.    
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There is still not enough evidence to definitively determine a comprehensive list of 
antecedents and consequences to agitation, and more evidence is needed to decide for certain if 
the TOUS is the best model for understanding this phenomenon.  The original version of the 
TOUS provided a simple and straightforward model from which the symptom experience could 
be understood.  The updated version of the TOUS introduced more complexity.  It may provide a 
better understanding of the symptom experience from a longer term view, but also created a less 
specific, recursive model of the symptoms where every variable essentially impacts every other 
variable concurrently.  This type of relationship does not lend itself well for cross sectional 
analysis, and so little support for the updated TOUS can be determined by the present analysis.   
Although limitations in this research are acknowledged, the results do contribute to a 
wider body of knowledge to improve the care of individuals with AD and their family members.  
Importantly, it demonstrates a unique application of the Nursing TOUS to guide a model of 
agitated behavioral symptoms in individuals with AD.  From this theory-guided model, 
predictors of agitated behavioral symptoms were identified, and limitations to the application of 
TOUS in persons with AD were suggested. 
Recommendations for Future Research 
 This study has partially validated the utility of the TOUS in describing and predicting 
agitated behavioral symptoms in persons with AD.  Further research into other possible 
antecedents to agitated behavioral symptoms as well as consequences of agitation are necessary 
to provide further guidance to the utility of the TOUS in the population, and to identify 




More testing of the TOUS is necessary to determine its utility in understanding 
behavioral symptoms in persons with Alzheimer Disease.  The qualitative research by 
Hutchinson & Wilson provides an excellent example of how the TOUS can be applied to 
systematically understanding the symptoms of AD through real-world episodic cases.  Rather 
than asking participants about experiences from the prior week or month, specific instances of 
problematic behaviors were examined within the TOUS framework.  From these examples, 
antecedents can be identified to reduce future recurrences of the problematic symptoms or 
performance outcomes.  The same approach could be applied to the development of an 
intervention support caregivers in managing episodes of agitated behaviors.  Because the 
application of the TOUS to populations with AD has been mixed, future studies should also 
compare results to other available nursing theories like the NDB (Algase et al., 1996), unmet 
needs framework (Cohen-Mansfield, 2000), and PLST (Hall & Buckwalter, 1987) models of 
behavior in AD.   
The TOUS should be tested over longer time frames to determine if the updates made in 
the second version of the TOUS mitigate some of the deficiencies in the original version.  
French, Crawford, Bova, and Irwin (2017) found that many of the antecedent factors identified in 
their understanding of chronic cough were improved by managing the symptoms itself, 
supporting the hypothesized feedback loop proposed in the updated model of the TOUS.  A 
similar analysis could be examined within the phenomenon of agitated behavioral symptoms in 




 Other environmental factors (such as the physical surroundings, changes to daily 
routines, level of stimulation, noise, social engagement) have previously demonstrated a 
relationship with agitated behavioral symptoms (Corcoran & Gitlin, 1992; Kolanowski et al., 
2017; Livingston et al., 2014; Ragneskog et al., 1998; Smith et al., 2006).  These specific 
environmental variables were not tested within the situational theoretical construct of the TOUS 
in the current study.  Testing the effects of these factors on agitated behavioral symptoms and 
functional performance outcomes would add evidence to the extent and importance of 
environmental variables that may impact outcomes within the TOUS, and also potentially 
provide evidence for interventions to improve these outcomes.   
Because depression and anxiety are themselves symptoms of Alzheimer disease, future 
studies could consider premorbid psychiatric illness rather than only comorbid psychiatric states.  
This follows the method suggested by Kolanowski and colleagues (2017).  This method could 
further elucidate the independent effects of premorbid psychiatric concerns rather than 
neuropsychiatric symptoms that occur as a direct result of the course of AD symptoms.   
 This research found that the role of caregiver burden is very important in explaining 
agitated behavioral symptoms.  As this is one of the few modifiable antecedents of agitated 
behavioral symptoms in AD, this area should be prioritized for future intervention research.  In 
an initial trial of a comprehensive dementia care program, Rueben and colleagues (2019) found 
that individualized dementia care plans, dementia management skills training, and caregiver 
support groups helped improve neuropsychiatric symptoms and caregiver burden after one year, 
although functional ability continued to decline.  Programs like this should be optimized through 
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continued research and targeted to improve support for caregivers throughout the disease 
progression.  Similar programs should be tested to determine efficacy for professional caregivers.    
Finally, future research should focus on diverse populations and include participants from 
racial and ethnic minority backgrounds.  Interpreted within the TOUS, racial or ethnic 
experiences could potentially contribute to differential expressions of agitation through physical 
or situational antecedent risks.  Physical risks such as cardiovascular disease and other comorbid 
health conditions are more prevalent African American and Hispanic populations (Chin, Negash, 
& Hamilton, 2011).  Social risks for minority populations are extensive and may include 
environment, educational background, stigmatization, and access to care (Dilworth-Anderson, 
Pierre, & Hilliard, 2012; Weuve et al., 2017).  More research is necessary to validate the degree 
to which the TOUS adequately describes the impact of these risk factors on agitated behavioral 
symptoms in AD.  Future research should focus on modifiable risk factors to target future 
interventions.   
Agitation 
 Greater conceptual clarity is still a major concern in defining and describing this 
phenomenon.  Although some work to clarify the concept has been made through efforts such as 
the Agitation Definition Work Group of the International Psychogeriatric Association, its 
definition of agitation has not been fully translated into research as evidenced by the continued 
use of tools that operationalize agitation narrowly.  This research emphasizes the close 
association of agitation and related concepts like irritability or aberrant motor behaviors.  Future 
research may consider combining closely related concepts into a single “agitation/aggression” 
factor (de Mauleon et al., 2019). This is especially important with the recognition that different 
individuals may have different expressions of “behaviors consistent with emotional distress” 
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(Cummings et al., 2015, p. 7).  To definitively end the disagreements over which behaviors 
should and should not be included in the conceptualization of agitation, research into specific 
components of agitation should seek to understand if these behaviors occur independently of one 
another, and if their causes or consequences are different. If no differences are found, then the 
broad definition of agitation and related behaviors should prevail.   
Functional outcomes 
 Quality of life measures are of utmost importance in evaluating care decisions made on 
behalf of older adults with AD.  While treatment for AD remains elusive, AD is a terminal 
illness.  As such, principles of palliative care, such as maximization of comfort and quality of 
life, are paramount outcomes in caring for this population (Volicer & Simard, 2015).  Although 
these outcomes were not fully investigated in the present study, they warrant thorough research 
in the future.   
Implications for Nursing Practice 
 Agitation is a common but distressing behavioral symptom in persons with AD.  
Agitation is unpleasant for both individuals as well as their professional and family caregivers 
(Chiao et al., 2015, Hongisto et al., 2015, Tan et al., 2005). The model of agitated behavioral 
symptoms in AD described in this research is useful for nursing practice in the assessment of 
patient needs, planning for long term care needs, and implementing nursing interventions.   
 Persons with AD are often unable to fully communicate their needs, especially as the 
disease progresses.  For this reason, it is especially important for nurses to assess any possible 
physical, psychological or situational cause of agitation.  This research suggests that untreated 
pain may be expressed as agitation, and should be carefully assessed.  Psychological states may 
be resultant of the AD process (Borsje et al., 2015; Chen et al., 2014; Van der Mussele et al., 
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2015), but should also be assessed as possible contributing factors to expressions of agitation (de 
Mauleon et al., 2019).   
As AD is a long-lasting illness, long-term needs should be assessed and discussed with 
caregivers.  When individuals with AD are cared for in the home, their situation should be 
monitored and needs for additional services should be frequently reassessed as their situation 
changes over time (Reuben et al., 2019).  Although the impact of agitation and its antecedents on 
quality of life was not fully investigated in this study, it remains an important outcome as 
identified in the TOUS.  While planning the for the long-term care needs of individuals with AD, 
end of life plans should be discussed at the earliest opportunity to assure that quality of life 
remains a priority in all care planning decisions (Ferrell et al., 2018).   
This model, as well as previous evidence, has clearly demonstrated the close relationship 
between caregiver distress and agitated behavioral symptoms in AD (de Mauleon et al., 2019).  
Nursing interventions to prevent or relieve the distress in both professional and family caregivers 
are necessary for the wellbeing of the caregivers as well as a means of improving the agitated 
behavioral symptoms directly.  Interventions that have demonstrated improvements in the 
caregiver experience include respite care for family members, communication training, and 
support groups (Barbosa, Nolan, Sousa, & Figueiredo, 2015; Reuben et al., 2019).  These 
interventions should be implemented for both professional and informal caregivers of persons 
with AD. 
Conclusion 
 As the United States and much of the world consider ways to confront the impending 
surge of older adults who are likely to require care for AD and its related symptoms, research 
into mitigating the most challenging symptoms of this devastating disease are critically 
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important.  This research found that the TOUS can provide a valid and important conceptual map 
for understanding, predicting, and potentially controlling agitated behavioral symptoms in older 
adults with AD.  Until treatment or prevention of AD is possible, more work is necessary to 
minimize symptoms and maximize functional performance to enable older adults with AD and 
those who provide care to live with the most independence and dignity as possible.  This 
research supports the use of the TOUS as a framework to guide this effort, and provides evidence 
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Degree: Doctor of Philosophy 
Background:  Worldwide population trends are shifting with the population of Elders 
expected to dramatically increase in absolute and relative numbers in coming years.  Alzheimer 
Disease (AD) is a common and costly disease of aging with agitation being the most poorly 
managed and detrimental behavioral symptom of the condition.  The Nursing Theory of 
Unpleasant Symptoms provides a conceptual basis for understanding agitated behavioral 
symptoms associated with AD in the context of its antecedent causes and outcomes of the 
symptoms.   
Purpose: The purpose of this dissertation was to model the predictors and outcomes of 
agitated behavioral symptoms in persons with AD.  The specific aims were: (1) Describe the 
phenomenon of agitated behavioral symptoms in persons with AD within the Theory of 
Unpleasant Symptoms; (2) Determine the effect of situational, psychological, and physiological 
factors on agitation in persons with AD; (3) Determine the effect of situational, psychological, 




Methods:  A descriptive, correlational, cross-sectional, secondary analysis research 
design will be employed.  The original data were collected in communities and in Nursing 
Homes settings in the Midwestern US.  A convenience sampling of facilities yielded 120 
participants. 
Results:  Exploratory factor analysis identified three antecedent factors to agitated 
behavioral symptoms: Situation-Caregiver, Psychological, and Physical-Cognitive.  The path 
analysis model closely represented all variables and relationships predicted in the TOUS (χ
2
 = 
1.049, df = 2, p = .592). Significant relationships between situation and agitation (B = 0.51, p < 
.001), psychological symptoms and agitation (B = 0.446, p < .001), and physical health on 
agitated behavioral symptoms (B = 0.58, p = .001) were found, and explained 63% of the 
variance in agitation.  The model found no support for the effects of any measured factors on 
performance outcomes, except the effects of the Physical: Cognitive factor (B = 0.86, p < .001) 
which explained 66% of the variance in functional performance.   
Implications:  The TOUS provides a good model to identify causes of agitated behaviors 
in AD.  This study emphasizes the need for greater support of caregivers of persons with AD 
because caregiver burden is an important modifiable antecedent to agitated behavioral 
symptoms.  Future research should investigate interventions to reduce professional and informal 
caregiver burnout and study the effects of reduced caregiver burnout on improvements in 
agitated behavioral symptoms in persons with AD.  Future research should also evaluate quality 
of life outcomes to better determine if the relationships between symptoms and performance 
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